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ABSTRACT 
 
The Detection and Occurrence of Triclabendazole Resistance in Fasciola hepatica in 
Sheep in England and Wales 
 
Juriah Kamaludeen 
 
Sheep are at risk from the disease fasciolosis, caused by Fasciola hepatica.  For sheep, 
triclabendazole (TCBZ) is the drug of choice as it kills the early, immature stages of the 
parasite. However, TCBZ is becoming increasingly ineffective due to emergence of 
resistance. The aim of this thesis was to identify the most appropriate diagnostic test to 
detect infection with F. hepatica in sheep, the optimum faecal egg count reduction 
method to detect TCBZ resistance, and thirdly to assess the prevalence of TCBZ 
resistance in Britain.  In Chapter 2, three different techniques that have been described 
in the literature to diagnose F. hepatica infection: faecal egg counts (FEC), coproantigen 
ELISA and a PCR-based assay, were compared.  The objectives were to compare the 
sensitivity of these techniques to detect early infection in experimentally infected sheep 
and measure the efficacy of TCBZ against a susceptible isolate. For this, a total of 12 
sheep were infected with 200-215 TCBZ susceptible metacercariae and infection was 
tracked on a weekly basis from 0 to 14 weeks post-infection (wpi) at which point they 
were divided into two groups of six. Group 1 was left untreated and Group 2 animals 
were treated with TCBZ (Fasinex
®
; 10 mg/kg) per os.  Faecal samples were collected on 
the day of treatment and daily until 10 days post treatment (dpt).  At 10 dpt, all sheep 
were killed for liver fluke recovery and enumeration. Results showed that the 
coproantigen ELISA could detect infection from 5 wpi (2/12 sheep), and all sheep were 
positive by 8 wpi. FEC was less sensitive at detecting early infection, 1/12 animal 
became positive at 7 wpi and all sheep were positive at 11 wpi. The PCR failed to detect 
infection at any time point. The efficacy of TCBZ against F. hepatica was 97% with 
p<0.001. There was no correlation between the coproantigen levels and FEC for all 
sheep, R
2
 = 0.031 (Spearman’s test p = 0.21) at 14 wpi. The study confirmed that the 
coproantigen ELISA is more sensitive in detecting early fluke infection compared to 
FEC. All six sheep in Group 2 were positive by FEC and 4 of these were also positive 
by coproantigen ELISA at 10 days post treatment with TCBZ; at post-mortem, between 
one and 13 flukes were recovered in all but one animal. 
Chapter 3 describes a pilot study conducted to improve the design of a previously 
described composite faecal egg count reduction test (cFECRT).  Firstly we determined if 
it was necessary to sample the same 20 sheep before and post treatment, or if two 
random groups of 20 sheep could be sampled for the two counts.  Samples from 44 
sheep from Farm 1 and 105 sheep from Farm 2 were collected and individual egg counts 
determined.   Bootstrap analysis showed that the same 20 sheep had to be sampled pre-
treatment and at 21 dpt. The coproantigen ELISA and FEC were compared on individual 
samples and composite samples from 20 sheep on five farms. Faecal samples were 
collected prior to treatment, 7 and 21 dpt to determine the optimum time to collect the 
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post-treatment sample. A comparison revealed that the results of the individual 
coproantigen ELISA were more informative compared to composite ELISA values for 
detection of infected sheep. The results also showed that sample testing at 21 dpt can 
help avoid false positive results. 
 
Chapter 4 describes two TCBZ resistance prevalence studies.  Firstly a total of 20 farms 
in the county of Cumbria were approached.  Sixteen farms submitted samples and 13 
farms had pre-treatment counts sufficiently high to conduct the FECRT, and evidence of 
TCBZ failure was detected on all 13 farms. Secondly a survey of TCBZ resistance was 
conducted in three regions of Britain, North East England, South West England and 
South Wales.  Two hundred and fifty farms were contacted, 42 farms took part in the 
study.  Of the 42 farms who submitted pre-treatment samples, seven had pre-treatment 
counts of 100eggs per gram or higher.  Evidence of TCBZ failure was observed in 4 of 
those 7 farms, all from North East England.  Using questionnaire data, descriptive 
statistics showed that there was no significant difference (T-test p = 0.82) between 
resistance status and total number of ewes on a farm.  Evidence from the present study 
suggests that TCBZ resistance is common on sheep farms in some parts the UK but 
further work is needed to establish a national prevalence. 
 
Overall, this study demonstrated that the coproantigen ELISA test is able to detect pre-
patent fluke infections when compared to FEC. However, this work highlights that the 
coproantigen ELISA performs differently in experimentally infected sheep compared 
with naturally infected sheep. Further evaluation of the coproantigen ELISA is needed if 
it is to be used with confidence for detecting TCBZ resistance in the field.  Whilst this 
study identified TCBZ to be a problem on some sheep farms it was not possible to 
determine the prevalence of TCBZ resistance in England and Wales, This highlights the 
need to monitor TCBZ efficacy on a farm by farm basis in England and Wales. 
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CHAPTER 1  
INTRODUCTION 
 
1.1 The importance of Fasciola hepatica 
Liver fluke disease or known as fasciolosis, is an economically important disease of 
sheep and cattle worldwide. Fasciolosis, caused by the trematode parasite Fasciola 
hepatica, results in tremendous economic loss to farmers in the UK livestock industry 
due to rejection of infected cattle and sheep livers (McKenna et al., 2002; Sanchez-
Vazquez and Lewis, 2013). Liver fluke infection also causes economic losses due to 
costs of drug treatment, the need for farm management strategies and adverse effects on 
productivity, including reduction on milk and meat production, wool production, animal 
health, growth rates, development and fertility (Mezo et al., 2011; Oakley et al., 1979; 
Sargison and Scott, 2011b).  Fasciolosis is also recognised as an important disease in 
humans (Winkelhagen et al., 2012). Infection with F. hepatica and its sister species 
Fasciola gigantica constitutes a major public health problem and fasciolosis is now 
considered as a neglected tropical disease (Gonzalez et al., 2011; Mas-Coma, 2005). 
These two trematodes have different geographical distributions. In the low-altitude 
tropics, fasciolosis is usually caused by F. gigantica, whereas F. hepatica is more 
common in the high-altitude tropics and in temperate regions throughout the world.  
Outbreaks of F. hepatica have a wider range in Europe, the Americas and Oceania 
(Bennema et al., 2009) whereas F. gigantica is typically limited to tropical regions and 
is mainly found in Southern Asia, Eastern Asia, Middle East, Eastern Europe and Africa 
(Torgerson and Claxton, 1999). In the UK, only F. hepatica species is present and 
infects a large variety of livestock commonly cattle and sheep, in which infection rates 
may reach 90% (Boray, 1999).  Whilst sheep and cattle are the main host species for 
liver fluke it can infect pigs and donkeys (Valero et al., 2001) and other hosts such as 
deer, hares and rabbits (Walker et al., 2011).  
In sheep, fasciolosis can cause morbidity and mortality, which can be divided into acute, 
sub-acute and chronic disease.  Acute fasciolosis occurs two to six weeks after sheep 
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ingest large numbers of metacercariae in a short period of time.  The acute form of the 
disease is a result of immature larvae migrating from the duodenum to the liver causing 
severe damage and haemorrhage to the liver parenchyma due their migration.  Acute 
fasciolosis is far more common in sheep than in cattle. The clinical signs are 
characterized by anaemia and sudden death. When considering options for diagnosis and 
treatment, the primary target is considered these early stages of the parasite. Similarly 
the subacute form of disease is caused by migration of immature fluke through the liver 
parenchyma after sheep ingest very large numbers of metacercariae over a period of 
several weeks or months. The lesions are less severe, but sudden death of previously 
healthy animals could occur. Other evidence of problems includes reduced grazing 
activity and also lethargy, pallor, abdominal pain and dyspnoea (Sargison and Scott, 
2011b).  Outbreak of the disease in the UK is mostly seen in October through to spring 
after animals become infected in the summer or from late spring until early summer if 
initially infected during winter (Table 1.1). However, acute fasciolosis can occur 
throughout the year (Kenyon et al., 2009; Sargison and Scott, 2011b). Subacute fluke 
infection in sheep may manifest as poor reproductive performance such as fertility 
problem, reduced twinning rates and protracted lambing periods (Sargison, 2008). Other 
clinical signs reported in sheep is liver enlargement but this can only be detected by 
using ultrasonograpahic examination (Scott et al., 2005). In addition, fasciolosis may 
predispose to secondary bacterial infection with Clostridium novyi type B or D (known 
as black disease), which causes sudden death in unvaccinated sheep (Sargison and Scott, 
2011b). The chronic phase begins after approximately four to five months after 
ingestion of metacercariae, due to the presence of mature adults in the bile ducts.  
Weight loss and reduced wool quality are commonly seen in chronic fasciolosis due to 
blood feeding activity of adult flukes in the bile ducts (Sargison and Scott, 2011b).  
There are concerns about the effects of a chronic fluke infection with abortion in heavily 
pregnant sheep (Anon, 2010). Outbreak of the disease is mostly seen during late winter 
and spring (following summer infection of snails). Thus, F. hepatica has a big impact on 
the sheep industry; not only in of terms of animal welfare but also major economic 
losses through mortality, ill-thrift, treatment and veterinary costs.  Table 1.1 summarises 
three clinical scenarios of fasciolosis, the season and stages of liver fluke involved.  
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Table 1.1 Disease type, seasonali ty and liver fluke stage within UK 
sheep flocks   
 
Clinical sign Peak incidence (month) Fluke stages 
Acute July to December Immature 
Sub-acute October to January Adult and immature 
Chronic January to April Adult 
Source: Adapted from SCOPS website.  
(http://www.scops.org.uk/endoparasites -liver-fluke.html).  
 
Fasciolosis is now recognised as a major parasitic infection responsible for production 
losses in the UK which amount to approximately £300 million per year to the cattle 
industry; £3 million per year of which is due to liver condemnation at slaughter itself 
(http://www.eblex.org.uk/). Estimation of financial losses of subacute fasciolosis in 
sheep industry is being £8.73 per ewe, due to death and costs of drug treatments 
(Sargison and Scott, 2011b). 
 
1.2 The life cycle of Fasciola hepatica 
The life cycle of F. hepatica is complex due to the need for an intermediate snail host. 
In western Europe, Great Britain specifically, the lymnaeid snail responsible for F. 
hepatica transmission is Galba (Lymnaea) truncatula (Taylor, 1949). In the UK, G. 
truncatula are primarily responsible for spreading fasciolosis but in Ireland F. hepatica 
have been detected in other molluscs; Succinea sp. and Radix peregra (Relf et al., 2009).  
The definitive host range for F. hepatica is very broad including sheep, cattle, buffalo, 
goat, horse, donkey and rabbit or humans. The life cycle of F. hepatica is shown in 
Figure 1.1. The mature adult flukes are localized in the bile ducts of the liver of 
ruminant hosts (Andrews, 1999).  Sheep acquire infection by ingestion of metacercariae, 
the infective stage.  Metacercarial cysts can be found attached to the grass blades or on 
vegetation such as watercress (Boray, 1969). Following ingestion, the metacercariae 
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excyst in the small intestine after approximately one hour, then burrow through the 
intestinal wall. They then migrate through the peritoneal cavity to the liver parenchyma 
and into the bile ducts where the flukes complete their maturation.  Fasciola hepatica 
are hermaphrodites capable of both self- and cross-fertilization and large proportion of 
each adult fluke consists of reproductive organs (Hanna et al., 2006).  Adult parasites 
have the potential to produce up to 25, 000 eggs per day (Happich and Boray, 1969b).  
Adult flukes in the bile ducts of sheep shed eggs into the host faeces where they are then 
passed out onto pasture. The eggs embryonate in 9 to 10 days given warm (above 10 °C) 
temperatures and with the presence of moisture (Schmidt and Roberts, 2005). The 
miracidia (free-living larval stages) hatch out from the eggs and swim actively to find 
and penetrate an intermediate host, G. truncatula. Once inside the infected snails, 
miracidia undergo three developmental stages from sporocyst, to rediae and finally, 
cercariae. These stages represent an extensive multiplication within the intermediate 
host.  The free-swimming cercariae are shed from the snail and become encysted on 
vegetation near the surface of water (Kendall and McCullough, 1951) and then develop 
to the infective metacercariae stage. The liver fluke life cycle is completed when the 
definitive host, typically sheep and cattle, ingest metacercariae on pasture (Andrews, 
1999). The metacercariae then undergo encystation into newly excysted juvenile stage in 
the host small intestine and migrate to the liver and to the bile duct system where they 
fully develop into egg laying adults and the life cycle continues.  The pre-patent period 
is approximately 10 to 12 weeks.  Estimation of life-span of adult F. hepatica in humans 
is 9-13 years, in cattle is 1-2 years and in sheep is up to 20 years (Andrews, 1999; Keiser 
and Utzinger, 2009; Robinson and Dalton, 2009). 
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Figure 1.1 The life cycle of Fasciola hepatica (provided by DJL 
Williams).  
 
1.3 Epidemiology and transmission of Fasciola hepatica 
The geographical distribution of F. hepatica is mainly determined by the distribution 
patterns of the snail intermediate hosts (Mas-Coma, 2005), which is tied to suitable snail 
habitats. Moreover, transmission of F. hepatica is influenced by the biology of the 
parasite, the movement of farmed animals, climatic and environmental conditions, and 
herd management (Bennema et al., 2011; McCann et al., 2010a). Few, if any 
comprehensive epidemiological studies on the prevalence of liver fluke infection have 
been conducted in sheep however several studies for cattle include information that is 
directly relevant to transmission of the parasite to sheep and these studies will be 
referred to in the section below. 
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 The role of snail development in the transmission of Fasciola hepatica 1.3.1
In order to understand the epidemiology and transmission patterns of F. hepatica and 
initiate efficient disease control, a comprehensive knowledge of the ecology of the 
intermediate snail host, G. truncatula is very important. Optimum conditions required 
for snail development are suitable temperature, light, soil pH, vegetation, depth of water, 
current of the water, soil moisture, and chemical composition of the soil, which can 
affect snail populations in the ecology system (Ollerenshaw and Rowlands, 1959). 
Attention is given to the suitability and availability of snail habitats on pasture.  F. 
hepatica egg development and larval stages in the snails can take place over a few 
months within a 7 to 9 month period of the year (Boray and Enigk, 1964).  Temperate 
climate affects the prevalence of F. hepatica infection in G. truncatula (Charlier et al., 
2011). In the UK, snail populations have shown seasonal variations in summer and 
winter infection.  In a wet summer, many juvenile snails develop rapidly and they are 
invaded by hatching miracidia from May to July. During July to October, snails shed a 
large numbers of cercariae onto pasture.  During a dry cold summer, small densities of 
snail populations will appear in May, June and July. Exposure of sheep to heavily 
contaminated-pasture in July to October may increase the incidence of acute fasciolosis 
due to ingestion of massive doses of metacercariae. Therefore, levels of pasture 
contamination in autumn can be much lower due to fewer numbers of fluke eggs 
hatching and fewer snails available for fluke infection and subsequent completion of the 
life cycle. Winter infection of snails is less common compared to summer infection.  In 
addition, snails deactivate and hibernate in the winter months and development 
commences again in spring and leads to metacercariae on pasture to challenge sheep in 
May and June. 
The absence of G. truncatula in Northern Bolivian Altiplano have shown that the 
populations of this species inhabited mainly permanent water bodies (Lake Titicaca) for 
the survival of G. truncatula throughout the year (Mas-Coma et al., 1999b). However 
more typically in the UK, the habitat of the intermediate snail host of F. hepatica 
requires comparatively little water as it can breed well in muddy conditions and also 
depending on the type of soil.  Poorly drained pasture also influences the abundance of 
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G. truncatula and may provide suitable habitats for the snails (Charlier et al., 2011; 
Sargison, 2012) thus can make a significant contribution to liver fluke infection in 
sheep. 
 
 The role of Fasciola hepatica biology on parasite transmission 1.3.2
Under favourable circumstances, fully developed miracidia will hatch from the eggs in 
two to three weeks and actively seek and penetrate G. truncatula  or die within 24 hours 
(Andrews, 1999). They generally successfully infect a snail within three hours of 
hatching (Kalbe et al., 1997). The ideal temperature of the development of miracidia in 
the eggs has been reported as a minimum temperature of 9.5 to 10°C (Rowcliffe and 
Ollerenshaw, 1960).  Several studies have been carried out to determine the time of egg 
hatching (Over, 1982; Rowcliffe and Ollerenshaw, 1960).  The eggs were incubated at a 
constant temperature of 15°C and it was found that miracidia were fully developed and 
able to hatch around 40 days and at a higher constant temperature of 25°C, egg hatching 
occurred in 30 days.  The second important factor for the development of the eggs is 
moisture and humidity.  The eggs need to be washed out of the faeces by either rain, 
surrounding water, insects or trampling, and to be constantly surrounded by a surface 
film or moisture (Rowcliffe and Ollerenshaw, 1960).  Eggs can be killed by desiccation, 
but they may survive for months in moist faeces and over the winter season. For 
example, in the UK, F. hepatica eggs can survive up to 10 weeks in the summer and up 
to six months in winter (Ollerenshaw, 1971). Throughout the winter (<10°C), the 
climatic conditions do not allow the development of the eggs but studies have shown 
that overwintering of infection inside snails could occur (Boray, 1969; Gaasenbeek et 
al., 1992).   
Miracidia need light, specific temperatures and cold, fresh water to stimulate the 
hatching process (Torgerson and Claxton, 1999). A previous study on temperature has 
shown that 5 to 6°C is the lowest temperature threshold for miracidia to survive once 
hatched; mean survival time at 8°C was 24 to 30 hours, whereas at 24°C this increased 
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to 13 to 20 hours (Christensen and Nansen, 1976).  A similar experiment has been 
conducted in the UK, to determine the survival temperature for miracidia and the study 
showed that high temperature may reduce the miracidium life-span; 6 hours at 25°C 
(Smith and Grenfell, 1994). The miracidia respond to light (phototropic) and 
chemotactic reactions to locate the snail with a distance of 15 cm increasing their 
chances of encountering G. truncatula (Andrews, 1999; Neuhaus, 1953). 
Not many studies have been carried out for the mollusc stages of development.  It is 
known that the development of mollusc stages of F. hepatica is crucially dependent on 
temperature; the lowest threshold temperature for development to occur being 10°C 
(Kendall and McCullough, 1951; Ollerenshaw, 1959). Other studies have shown that the 
time of infection of the snail until cercarial shedding may decrease from 80 days at 15°C 
to around 20 days at 30°C (Gettinby and Byrom, 1991; Over, 1982).  Laboratory studies 
suggested that G. truncatula infected by a single-miracidium led to production of more 
metacercariae than those infected by two, five, 10 or 20 miracidia (Dreyfuss et al., 
1999). Nevertheless, one snail has the potential to produce multiple metacercariae 
compared to the number of miracidia it was infected with.  This study also showed that 
the numbers of metacercariae produced depends on several factors such as height of the 
snail, amount of food the snail received and survival rate of the infected snails (Dreyfuss 
et al., 1999). 
Studies carried out on the survival of metacercariae, indicated that, about two-thirds of 
the metacercariae were attached to various objects near the water surface (Ueno and 
Yoshihara, 1974) whereas the rest become floating cysts (Dreyfuss and Rondelaud, 
1994).  The floating cysts may flow with the water to find a suitable object to become 
attached to or if not, they may die.  Metacercariae of F. hepatica are relatively resistant 
to unfavourable climatic conditions and remain viable on the pasture for several months, 
particularly in cool and damp environments (Enigk and Hildebrandt, 1964).  Without 
water, survival of metacercariae is dependent on relative humidity of approximately 
70% (Hodasi, 1972).  On the other hand, at a constant temperature of 20°C with a high 
relative humidity of 90% encysted metacercarial survival rates were limited to only 14 
days (Boray and Enigk, 1964).  In tropical countries, if exposed to direct sunlight for 
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more than eight hours, survival of metacercariae is 0% (Suhardono et al., 2006).  
Metacercariae have the ability to survive at temperatures between 0°C to -20°C and are 
able to survive the freezing and thawing processes (Boray and Enigk, 1964).  Previous 
studies in The Netherlands have shown that metacercariae can survive in the winter 
(both mild and wet and dry winters) under natural conditions on commercial farms  
(Gaasenbeek et al., 1992) although this study did not record the exact temperature in 
winter.  The overwintering of metacercariae of F. hepatica has been reported elsewhere 
in the UK and Australia (Anon, 2009; Boray, 1963; Ollerenshaw, 1959). Warm and 
moist soil surface conditions also favour the propagation of the snail and infective stages 
on pasture.   
Historically hay, which is used as animal fodder during winter, has been reported as an 
important source of F. hepatica infection.  Metacercariae successfully encysted on hay 
stalks can persist in moist conditions with a minimum of 70% relative humidity (Hodasi, 
1972) or 90% relative humidity (Boray and Enigk, 1964). Metacercariae can be killed 
within two days or in eight hours times by exposing them to direct sunlight at 37°C and 
above (Suhardono et al., 2006). 
 
 The effect of environment on Fasciola hepatica transmission 1.3.3
Epidemiological studies have found a high prevalence of exposure to F. hepatica 
infections in dairy herds in England and Wales is significantly related to environmental 
factors such as the elevation and slope, soil type and also soil pH (McCann et al., 
2010b). Other studies pointed out soil condition as a risk factor for transmission of 
bovine fasciolosis in Switzerland (Rapsch et al., 2008), specifically the water retention 
capacity and ground water of soils. Clay soils are more water retentive compared to 
sandy soils, and are therefore associated with the presence of G. truncatula. Slope was 
found to be a negative risk factor for fluke in dairy herds (Howell et al., 2015; McCann 
et al., 2010b). Generally, the greater the slope gradient, the better the drainage and hence 
providing poorer snail habitats. Similarly soil pH was identified as a potential protective 
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risk factor (McCann et al., 2010a). Although several risk factors have been identified, it 
is essential to understand why these factors are so important to F. hepatica life cycle and 
habitat for G. truncatula. 
Soil minerals are another factor that influences F. hepatica transmission in farmed 
animals.  Snails grow in soil conditions rich with calcium and magnesium minerals for 
their shell formation, however it has been reported that iron and phosphorus may 
influence the snail biology as well as the parasite life cycle (McCann et al., 2010a). 
Nevertheless, further understanding and investigations are needed since very little 
research has been carried out on the effect of soil mineral contents on the parasite life 
cycle. Soil pH may also have its effect on F. hepatica transmission because a neutral pH 
is essential for propagation of the snail.  Various studies have been carried out on this 
factor in woodlands, for example, in England, Sweden and Finland and suggested that 
snail richness was increased by 2 to 5 species per pH unit (Millar and Waite, 1999; 
Valovirta, 1968; Waldén, 1981). According to Frömming, E. (1956), the essential 
conditions for these snail with the range of pH 5.6 to 8.6 which could have impact on 
the snail richness. Interestingly, Kirk et al. (2010) reported that soil pH across England 
and Wales has increased, for instance, soils became less acid under all land uses (arable, 
managed grass, semi-natural grass and coniferous wood) from 1978 to 2003.  These 
results suggest that the increase in soil pH was due to the decreased sulphur deposition 
from the atmosphere and changes of liming practices on arable land during the survey 
period.  On the other hand, the details of soil pH for grassland in England of 6.0 to 6.5 
were obtained from Department of Agriculture and Rural Development 
(http://www.dardni.gov.uk). Therefore, it is most likely that changing soil pH conditions 
could favour F. hepatica transmission in England and Wales. 
 
 The effect of climate on Fasciola hepatica transmission  1.3.4
British climates are locally influenced by the Atlantic Ocean and latitude.  Regions 
which are closest to the Atlantic i.e. western parts of England, Wales, Scotland and 
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Northern Ireland, are wettest regions of the UK whereas Eastern parts generally have 
drier and cooler weather.  As for Northern parts, the general pattern of the climate is 
cooler and has wetter weather compared to Southern parts. For example, Wales has a 
high rainfall, and North East England has a drier climate (McCann et al., 2010a). Studies 
have shown that climatic-change scenario may be inextricably linked to fasciolosis and 
is particularly relevant in years when summer rainfall is high (Skuce et al., 2014). This 
prediction has now been confirmed in the UK, where fasciolosis patterns have been 
changing for the last 20 years due to the climate change and also the amount and 
frequency of rainfall (Fox et al., 2011). Studies reported in England and Wales (McCann 
et al., 2010a) and in Belgium (Bennema et al., 2011) have provided evidence that 
climatic factors have a large effect on F. hepatica transmission. As prevalence of 
fasciolosis is highest in areas where winters are wetter and parts of the country receiving 
high summer rainfalls in the UK, these conditions favour the F. hepatica life cycle and 
snail development in many parts of the UK (Fox et al., 2011; Kenyon et al., 2009; 
McCann et al., 2010b; Van Dijk et al., 2010).  Risk of infection of fasciolosis in sheep is 
associated with the changeable weather in the UK (Van Dijk et al., 2010) especially if it 
has been a wetter summers that favours the propagation of parasite life cycle and 
support larger snail populations. According to the authors, climate change in south 
eastern Scotland has confirmed that the prevalence of fluke infections in the drier east of 
the country has been reported on most sheep farms. This part of the country has received 
more rainfall than usual.  Hence, it is possible that flooding might have affected the 
development of the intramolluscan and free-living stages of the parasite. However, other 
studies have shown that rainfall has negative association with infection risk of F. 
hepatica due to heavy rainfall or flooding which washed away the free-living stages and 
snails (Bennema et al., 2011; Rapsch et al., 2008). These authors reported the 
development success rate of F. hepatica is not influenced by rainfall but it depends on 
the presence of sufficient humidity. 
There is now a consensus that climate change (warmer winters and wetter summers), 
which are predicted to occur in the UK over the next 50 years may play a significant 
role in the changing epidemiology of fasciolosis (increase the prevalence of F. 
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hepatica), along with growing concerns about drug resistance (Charlier et al., 2012).  
Summer outbreaks of fasciolosis are rare but occur when snails are infected in late 
spring and early summer in any year.  In the UK most infection results from appearance 
of the metacercariae on the pasture in the autumn, as a result of summer infection of 
snails (Ollerenshaw and Rowlands, 1959).  If pastures have poor drainage, it is likely 
that the pasture will be wet for many weeks to come, especially in years when summer 
rainfall is high. Boggy or poached fields will provide suitable snail habitats, increasing 
infection of snails and leading to high infection risk in the autumn. Sheep are also at risk 
when they are forced to graze flukey areas in March-April as metacercariae can survive 
over winter.   It has been predicted that liver fluke infection could extend from being a 
seasonal disease to a year round threat due to predicted temperature increases in the 
winter months, with the greatest rise in exposure in Wales. Furthermore, winter season 
are predicted to become even milder and through the year, the mean temperature will be 
above 10°C development threshold, thus fasciolosis outbreaks can be expected in late 
spring/early autumn. The studies also showed that Scotland and Wales are predicted to 
have serious epidemics of fasciolosis up to 2070 (Fox et al., 2011). The future maps 
have showed that serious epidemics are expected in Scotland by 2020 and by 2050 in 
part of Wales (Fox et al., 2011).  To conclude, high annual rainfall, high soil moisture, 
suitable temperature and rainfall, affecting farming practices and parasites life cycle.  
These factors together with increased of anthelmintic resistance (Charlier et al., 2012) 
creating a really worrying scenario. 
 
 The effect of animal management on Fasciola hepatica transmission  1.3.5
It has been proposed that snail densities and richness on the grassland can be also 
affected due to mowing mechanisms (Martin, 1987; Schmid, 1983).  Mowing 
mechanism or grazing is essential to maintain the soil structure, soil fertility as well as 
the balance and diversity in grassland.  Bennema et al. (2011) suggested that greater 
numbers of metacercariae are found when there are no mowing activities on the pasture; 
a possible reason being that mowing can disturb the snail habitat. Furthermore, other 
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damage of the soil surface that is caused by mowing practise is through fertilizing and 
compacting by farm vehicles  (Martin and Sommer, 2004). A few studies in Belgium 
have reported that farm management may also play an important role in spreading the 
disease (Bennema et al., 2009; Bennema et al., 2011; Charlier et al., 2011).  The type of 
pasture, length of grazing season and proportion of grazed grass in the diet have all been 
shown to influence the transmission of  F. hepatica in farmed animals (Bennema et al., 
2011).  Notable under farm management is the length of grazing season (as mentioned 
above) which can cause high levels of infection in livestock (Bennema et al., 2011). 
This suggests that the longer the grazing season the higher the risk of F. hepatica 
infection at the farm level.  In order to avoid this, livestock are not allowed to graze on 
pastures heavily contaminated with metacecariae as the proportion of grazed grass in the 
diet of the herd has posed an elevated risk for high F. hepatica infection levels 
(Bennema et al., 2011). Thus, restricted grazing area for the herd is likely to minimize 
the disease risk for F. hepatica. By preventing the animals from grazing on the 
contaminated pastures or areas close the river bank this may reduce their risk of 
ingesting the metacercariae. Similarly cleaning out ditches on the farm or fencing off 
wet areas in order to reduce the chances of sheep coming into contact with infective 
metacercariae at these favourable for G. truncatula breeding habitats (Howell et al., 
2015).  
 
1.4 The increasing prevalence of Fasciola hepatica infection in the UK 
Fasciolosis is one of the most common parasitic diseases in the UK as this country has 
wetter summers and warmer winters, suggesting that climate change is partly 
responsible for the increase in the prevalence of F. hepatica in this region.  According to 
the Veterinary Investigation Diagnostic Analysis (VIDA) database submissions made to 
the Animal Health and Veterinary Laboratories Agency (AHVLA) or now known as 
Animal and Plant Health Agency (APHA), diagnoses of fasciolosis have increased 
rapidly from 1999 to 2009 (Anon, 2009a).  The APHA has documented an increase in 
the diagnosis of acute and chronic liver fluke infections in sheep and cattle over the past 
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10 years. Liver fluke infection in sheep has been reported across Great Britain and the 
number of outbreaks was increased from 1995 to 2001 as shown in Figure 1.2 (Mitchell, 
2002). This increase in the number of cases has led to concerns over the increased risk 
of fascioliasis in sheep. Sheep and cattle in western and eastern regions of the UK are 
now being exposed to the liver fluke infection based on the findings of several studies 
conducted. McCann et al. (2010b) indicated that the seroprevalence of F. hepatica 
infection in dairy herds in England was estimated at 72% whereas in Wales it was 84%. 
Changing climate patterns over recent years may explain the different findings between 
these studies to the studies done by Salimi-Bejestani et al. (2005a) in 2003, indicating 
that the prevalence of fasciolosis in dairy herds was found at 48% and 86% in England 
and Wales respectively. Within the UK, F. hepatica appears to have expanded in its 
geographical distribution and transmission range. This parasite was traditionally 
associated with wetter western parts of the UK.  However, evidence of increasing levels 
of subacute fasciolosis was reported in the eastern parts of the UK; East Anglia and 
eastern Scotland (Pritchard et al., 2005). This is supported by studies that have 
documented the emergence of fasciolosis in cattle in East Anglia; this area is among the 
driest in the UK (Pritchard et al., 2005).  However, due to recent high summer rainfall, 
increased sheep movement for seasonal grazing and wetter conditions; these provided an 
ideal climate for the development of free living stages of the life cycle of F. hepatica as 
well as the stages involving the intermediate snail hosts, G. truncatula (Pritchard et al., 
2005). Similarly F. hepatica appears to be successfully completing its life cycle on most 
farms in south east Scotland (Kenyon et al., 2009).  The climate change has favoured the 
intermediate host, G. truncatula and has the potential to alter survival rate of fluke 
stages in the environment (Van Dijk et al., 2010).  These hypotheses agreed with other 
studies, indicating that changing climate, changing farming practices and increased 
livestock movement or introduction of infected sheep or cattle into unaffected areas in 
these regions is another possible way of spreading the disease (Bennema et al., 2011; 
Howell et al., 2015).  Over the next 50 years, climate change forecasts predict warmer 
winters and wetter summers in the UK.  
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Figure 1.2 Acute and chronic cases of fasciolosis in sheep in Great 
Britain from 1977 to 2012. Source: Modified from Animal Health and 
Veterinary Laboratories Agency (AHVLA) /APHA.  
 
 
The risk of infection has increased directly as there has been greater animal movement 
between farms (Fairweather, 2005).  Introduction of newly bought-in sheep and hence 
their parasites, was suggested to have caused the spread of F. hepatica across the UK 
over the past few years.  It is likely that animal movement has spread resistance of F. 
hepatica and may be responsible for the introduction of fluke into new areas or into new 
environments.  Therefore, farmers need to know the health status of new stock before 
they enter their premises.  Farmers are recommended to do a quarantine treatment 
especially if sheep are bought from known fluke endemic areas, e.g: South Wales, North 
West England and West Scotland.   
 
1.5 Detection of Fasciola hepatica infection 
Liver fluke infections can be detected using various diagnostic tools. Under field 
conditions, faecal egg count (FEC) has been considered the most reliable method of 
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diagnosing F. hepatica infection in animals and is often the method of choice to detect 
the efficacy of anthelmintic treatments (Flanagan et al., 2011a).  Liver fluke eggs in 
faeces have been reported to be detected from as early as 7 week post-infection (wpi) 
(Paz-Silva et al., 2002), whilst other studies report eggs found at 9 wpi (Martinez-Perez 
et al., 2012), 8 to 10 wpi (Martinez-Valladares et al., 2010a; O'Neill et al., 2000), 10 and 
12 wpi (Dumenigo and Mezo, 1999) or even later at between 11 to 16 wpi (Zimmerman 
et al., 1982).  The limitation of the test sensitivity of FEC is that it can only detect patent 
infection once adult fluke are producing eggs. This means that the test is not suitable for 
detecting fluke infection prior to 7-8 wpi and represents a major drawback given that 
fasciolosis in sheep is due to the early stages of the parasite migrating through the liver 
1-2 wpi. Even when detecting patent infection various studies have highlighted the 
unreliable and intermittent shedding of fluke eggs in the host faeces which affects the 
FEC and results in under-diagnosis of infection (Conceicao et al., 2002; Rokni et al., 
2002).  
More recently the coproantigen ELISA, cELISA, (Espino et al., 1998; Espino et al., 
1997; Mezo et al., 2004; Valero et al., 2009) has been developed for the early detection 
of F. hepatica infection and a PCR assay has also been used as a diagnostic tool 
(Martinez-Perez et al., 2012; Robles-Pérez et al., 2013).  Coproantigen ELISA, which 
uses F. hepatica antigens in host faeces, allows early detection of infection from 4 wpi 
onwards. Under experimental studies in sheep, it has been proven that this test has 100% 
sensitivity and specificity, even when sheep were only infected with a single fluke 
(Mezo et al., 2004). As is mentioned above, due to the lower sensitivity of FEC, 
(Charlier et al., 2008; Rapsch et al., 2006) compared to cELISA, the latter is potentially 
a convenient tool for the early diagnosis of F. hepatica infection in sheep. Similarly, 
PCR of faecal samples, is also a promising tool for the detection of F. hepatica as early 
as 2 wpi (Robles-Pérez et al., 2013). A comprehensive evaluation of these tests under 
experimental conditions forms the basis of chapter 2 and a more detailed introduction of 
the relative merits of each test is provided there. 
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1.6 Control of Fasciola hepatica 
The control of F. hepatica can be achieved by using various options such as pasture 
management strategies and the use of molluscicides.  Historically molluscicides were 
used by farmers to control snail populations in the short-term (Crossland, 1976), but this 
was both expensive and environmentally unsound  (Urquhart et al., 1970). Due to their 
toxicity and negative effects on biodiversity, the use of molluscicides was made illegal 
in the UK.  Fasciolosis control might be attained with environment approaches such as 
draining or fencing-off wet areas on pasture to reduce access of grazing sheep and cattle 
to snail habits (Charlier et al., 2011; Howell et al., 2015). In reality the use of 
anthelmintic drugs to treat F. hepatica has formed the basis of effective strategies in 
controlling liver fluke infections in sheep as summarised below. 
 
1.7 Anthelmintic control of Fasciola hepatica 
For over 30 years, triclabendazole (TCBZ; 6-chloro-5-(2, 3-dichlorophenoxy)-2-
methylthiobenzimidazole), a benzimidazole derivative, has been the the drug of choice 
for controlling F. hepatica infection in both sheep and cattle due to its efficacy against 
both immature and mature flukes (Boray et al., 1983; Fairweather and Boray, 1999a).  
Currently there are a few fasciolicides on the market that are available for the control of 
liver fluke infections (see Table 1.2 and 1.3).  Closantel and nitroxynil are also available 
to control fasciolosis in livestock but these two anthelmintics have no effect on 
immature fluke less than 6 week old as highlighted below.  
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Table 1.2 Drugs currently available in sheep.  
 
Active Compound Product Type Efficacy 
Triclabendazole Fasinex, 
Tribex 
Fluke only All stages from two-day-old 
immature flukes to adult 
Closantel Flukiver, 
Supaverm, 
 
Fluke 
Haemonchus contortus 
Adult and immature flukes from 
three to four weeks, Haemonchus 
contortus 
Nitroxynil Trodax Fluke 
Haemonchus species 
Adult and immature flukes, 
Haemonchus species and 
gutworms 
Albendazole Valbazen, 
Allverm 
Fluke and worm Adult flukes, gutworms, 
lungworms and tapeworms 
Triclabendazole + 
Levimisole 
Combinex Fluke and worm 
(Combination) 
Adult and immature flukes, 
gutworms and lungworms 
Levimisole+ 
oxyclozanide 
Nilzan Gold Fluke and worm 
(Combination) 
Adult flukes, gutworms and 
lungworms 
Source: Modified from Fairweather and Boray, Fasciolicides: Efficacy, actions, 
resistance and its management (Fairweather and Boray, 1999a). 
 
 
Table 1.3 Percentage efficacy spectrum of drugs at recommended dose 
rates against  Fasciola hepatica  in sheep.  
 
  Age of fluke (weeks) 
Drug 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
Albendazole,  
Oxyclozanide, 
Niclofolan, Bithionol, 
Clorsulon+Ivermectin(inj)                   50 - 70%   80 - 99% 
Clorsulon (oral)                    
 90-
99%       
Nitroxynil, closantel             50 - 90% 91 - 99% 
 
Rafoxanide 
         
50-
90%       
 
                                           
                                                      
          91-99%         
Triclabendazole 
 
90 - 
99%  
                                                                   99- 100% 
Source: Modified from Fairweather and Boray, Chapter 7, Fasciolosis, JP Dalton editor, 
CABI Publishing,1998 (Dalton, 1998). 
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 Triclabendazole (TCBZ) 1.7.1
Triclabendazole demonstrated activity against both mature and immature stages of F. 
hepatica at 10 mg/kg in sheep (Boray et al., 1983). Oral administration of TCBZ by 
dosing in sheep delivers the drug directly into the rumen of the host where TCBZ is 
metabolised into the TCBZ sulphoxide (TCBZ-SO) and the sulphone (TCBZ-SO2) and 
hydroxy derivatives (Virkel et al., 2006).  Evidence of fluke involvement was noted in 
drug metabolism of TCBZ to TCBZ-SO and TCBC-SO2 with the fluke microsomal 
fraction capable of generating the active metabolites from the TCBZ parent drug 
(Mottier et al., 2004; Robinson et al., 2004). Based from these findings, it was 
hypothesised that, in addition to the host species liver, the flukes themselves play an 
important role in metabolising the parent drug. 
It has been proposed that TCBZ displays the same mode of action as other BZs 
involving the binding of the drug to tubulin, which is a constituent protein in 
microtubules and mitochondrial membranes. The BZs have been shown to inhibit the 
polymerization of microtubules and therefore most likely interfere with microtubule-
based processes in helminths (Lacey, 1988).  For F. hepatica, this has led to suggestions 
that TCBZ and its metabolites cause uncoupling of oxidative phosphorylation (Carr et 
al., 1993).  Alternatively, it may result in a failure to form microtubules and disrupt the 
transportation process in the tegument of flukes (Stitt and Fairweather, 1993), leading to 
the loss of the tegument of flukes (Halferty et al., 2009) and death of the fluke (Brennan 
et al., 2007). It has been shown that 48 hours after treating the host with TCBZ, 
morphological changes were observed in fluke (Hanna et al., 2010).  Triclabendazole 
significantly inhibited microtubule polymerization, preventing the production of a 
tegumental secretion layer which covers the surface of the fluke and maintains apical 
membrane function (Halferty et al., 2008; Shareef et al., 2014; Tansatit et al., 2012). 
Therefore, the interruption of this layer may damage the tegument severely by 48 hours 
post treatment (Hanna et al., 2010). The destructive lesions observed on the tegument of 
flukes by SEM following treatments with TCBZ comprised tegument swelling, followed 
by blebbing, loss of spines and tegumental sloughing leading to complete disruption of 
the latter organ. These studies were carried out using in vitro and in vivo experiments on 
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both stages of juveniles and adults F. hepatica and F. gigantica (Halferty et al., 2008; 
Tansatit et al., 2012; Toner et al., 2010). However, other studies on TCBZ-resistance 
have shown that TCBZ does not target the tubulin molecule.  It is believed that TCBZ-
resistant isolates processed TCBZ more rapidly and their may be a role for drug 
detoxification pathways, specifically P-glycoprotein (Fairweather, 2011b).  
 
 Other flukicides 1.7.2
Nitroxynil is a narrow spectrum anthelmintic and it belongs to the halogenated phenol 
group of fasciolicides.  Nitroxynil has been reported to have a high efficiency against 
adult flukes, lower efficacy (50-90%) against fluke aged 6 to 8 weeks and are not 
effective against earlier stages (Boray, 1986; Rapic et al., 1988).  Experimental studies 
have shown that nitroxynil is active against adult TCBZ-resistant F. hepatica, with 
100% efficacy (P< 0.001) by day 14 post treatment (Coles and Stafford, 2001; Mooney 
et al., 2009) and most recently similar results were reported in sheep farms in Northern 
Ireland (Hanna et al., 2015). The mechanism of action of the drug is unclear but the 
mechanism of action of nitroxynil is suggested to be due to uncoupling of oxidative 
phosphorylation, consequently leading to depletion of parasite ATP (Martin, 
1997).  This is based on the similarity of the chemical structure between halogenated 
phenols and 2, 4-dinitrophenol, a known uncoupler of oxidative phosphorylation in 
mammals.  Extensive pharmacokinetics of nitroxynil studies have been undertaken on 
the plasma proteins, especially albumin both in vivo and in vitro (Alvinerie et al., 1991; 
Beretta and Locatelli, 1969).  After drug administration in the sheep, the plasma levels 
increase and remain high for three days, then decreases precipitously although levels of 
two to three parts per million (ppm) can be still be detected after 60 days post treatment 
(Parnell, 1970).  It is suggested that the flukes ingest the drug from the plasma and this 
is probably the primary route of nitroxynil ingestion by the parasites.  In addition, this 
slow rate of elimination and the persistence of nitroxynil in the plasma may affect the 
efficacy of this drug against fluke in sheep. 
21 
 
Closantel and oxyclozanide have similar pharmacologic effects that act by uncoupling 
oxidative phosphorylation.  They belong to the salicylanilide group of fasciolicides. The 
processes involved increasing the glucose uptake (Kane et al., 1980) and a decrease in 
fluke intra-tegumental pH (6.8 to 6.5) (Pax and Bennett, 1989). Because of these 
processes, parasites become paralyzed and starve to death (Skuce and Fairweather, 
1990). Closantel has marked activity against liver flukes (Boray, 1986).  It is highly 
lipophilic compound that extensively bound to plasma protein and is known to shuttle 
protons across membranes, in particular the inner mitochondrial membrane (Alvarez et 
al., 2007).  Studies have been conducted looking at activity of closantel against adult 
TCBZ-resistant F. hepatica (Coles et al., 2000; Hanna et al., 2015). The results 
suggested that closantel works effectively against adult TCBZ-resistant F. hepatica with 
100% efficacy (Coles et al., 2000) and was fully effective against TCBZ-resistant F. 
hepatica on sheep farms in Northern Ireland (Hanna et al., 2015). In a separate 
experiment using oxyclozanide, similar drug efficacy (99.6%) was reported against adult 
TCBZ-resistant F. hepatica (Coles and Stafford, 2001).  
 
1.8 Definition of Anthelmintic resistance 
Resistance is inherited; resistance genes are present in populations of parasites, which 
allow parasites to survive anthelmintic treatment, and when they the reproduce pass 
these anthelmintic resistance genes on to the next generations (Sangster, 1999).  
Resistance is defined as, ‘a greater frequency of individuals within a parasite population 
that have been affected by a dose or a concentration of compound, are no longer 
affected; therefore, a greater concentration of drug will be needed (Prichard et al., 1980).  
Higher doses are needed in order to reach a certain level of drug efficacy.  The World 
Association for the Advancement of Veterinary Parasitology (WAAVP) has drawn up 
specific guidelines for defining resistance, however, presently there is no ‘gold standard’ 
available for defining different isolates of F. hepatica in terms of drug sensitivity either 
in vitro or in vivo.   
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The cause of resistance in parasites is often difficult as many factors are involved in the 
evolution of this process. Since drug resistance is inherited and selective, the survivors 
following drug treatment pass resistance genes to their offspring and whilst it is believed 
that these genes are initially rare, their proportion in the parasite population increases 
under drug selection (Kaplan, 2004). A parasite that is able to respond to selective 
pressure, i.e drug pressure, is likely to carry the resistance alleles in the parasite 
population. This process of selection identifies that the rate of selection of resistant 
parasites is dependent on the frequency of drug use. The reliance on TCBZ as the drug 
of choice due to its high efficacy against immature and mature F. hepatica in sheep has 
inevitably led to TCBZ resistance. Since its introduction in the early 1980s, heavy 
reliance on TCBZ has resulted in resistance in sheep that has become a worldwide 
problem. 
 
1.9 The incidence of triclabendazole resistance in the UK and worldwide in sheep 
Triclabendazole resistance in liver flukes now poses major problems to small ruminant 
farmers throughout the world.  The first case of TCBZ resistance has been documented in 
Australia in the mid 1990s (Overend and Bowen, 1995). Since then there have been several 
reports of TCBZ resistance  on sheep farms in the UK; reviewed by Fairweather et al. 
(2005) and there is a broader concern that over-reliance on TCBZ resulted in increased 
levels of resistance in sheep in the UK (Daniel et al., 2010; Gordon et al., 2012a; 
Mitchell et al., 1998; O'Brien, 1998) and overseas such as The Netherlands (Gaasenbeek 
et al., 2001; Moll et al., 2000), South America (Ortiz et al., 2013) and Spain (Alvarez-
Sanchez et al., 2006) and elsewhere in the world (see Table 1.4 and 1.5).  Evidence from 
preliminary studies in England and Wales showed that TCBZ resistance was found on 
seven out of 25 sheep farms by using  a composite fluke egg count reduction test (Daniel 
et al., 2012).  However we do not know how extensive the problem of TCBZ resistance 
is at the national level.  
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Given the importance of TCBZ resistance a number of TCBZ-resistant (TCBZ-R) and 
susceptible (TCBZ-S) laboratory isolates have been derived and form the basis of 
experimental studies to identify mechanisms of drug resistance and all these F. hepatica 
isolates have been reviewed by Hodgkinson et al. (2013).  In Ireland, the Sligo isolate 
was originally derived from the County of Sligo in 1998 and described as being TCBZ-
R (Coles et al., 2000; Fairweather, 2011a).  Other isolates that are listed; Cullompton 
which originated from Cullompton, Devon has been shown to be TCBZ-S in vivo 
(Halferty et al., 2008; McConville et al., 2009) and Fairhurst is also TCBZ-S (Walker et 
al., 2004). The Oberon isolate was confirmed to be TCBZ-resistant and Walker et al. 
(2004) have reported that the disruption was more severe in the Fairhurst than the 
Oberon isolate, based on in vitro study.  For other TCBZ isolates, Leon, originated from 
North West Spain and studies have confirmed that this is a resistant isolate (Alvarez-
Sanchez et al., 2006; Martinez-Valladares et al., 2010b). However, studies by Flanagan 
et al. (2011a) have shown that results from FECRT and the coproantigen reduction test, 
suggesting that the Leon fluke isolate was in fact susceptible to TCBZ treatment and this 
was confirmed at necropsy.   
Other studies question whether failure of the efficacy of TCBZ to remove a parasite 
population from the liver is due to anthelmintic resistance or the inability of a fluke-
damaged liver to metabolize the drug into its active forms and thus reduces the 
concentration of the active sulphoxide metabolites of TCBZ (Fairweather, 2011a). 
However, Sargison et al. (2011b)  consider that liver function in metabolising TCBZ to 
ensure its efficacy may not be as important as previously assumed given that both TCBZ 
and its sulphoxide (TCBZ-SO2) metabolite are capable of disrupting adult F. hepatica in 
vitro (Halferty et al., 2009). These studies highlight some of the problems of interpreting 
TCBZ resistance studies in F. hepatica populations in sheep. 
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Table 1.4 Reports of triclabendazole resistance in Fasciola hepatica  in the United Kingdom (UK ) and Ireland.    
 
Country 
(region) 
Sheep population 
tested 
Anthelmintic tested Test Used Drug efficacy/result References 
Ireland Not stated TCBZ Not stated Failure of TCBZ treatment (Lane, 1998) 
Ireland Not stated TCBZ Not stated Failure of TCBZ treatment (O'Brien, 1998) 
West of Ireland Naturally infected sheep 
on farms 
 
-TCBZ (Fasinex) 
- Nitroxynil  (Trodax) 
-Closantel (Flukier) 
-Oxyclozanide (Zanil) 
 
FECRT - TCBZ: 49%-66% efficacy 
(7-56 days pt) 
-Nitroxynil: 100% efficacy 
-Closantel: 100% efficacy 
-Oxyclozanide: 100%    
 efficacy 
 
(Mooney et al., 
2009) 
UK Naturally infected sheep 
on farm and 
experimentally infected 
sheep 
TCBZ -FECRT 
-CRT 
Failure of TCBZ treatment (Gordon et al., 
2012a) 
UK (England,  
Wales and 
Scotland) 
Natural infection sheep 
farms 
 
TCBZ (Fasinex) CFECRT -Full validation of   
 cFECRT 
- Loss of efficacy of TCBZ   
  in 6/13 farms in SW Wales  
 and one farm in Scotland 
(Daniel et al., 
2012) 
Northern Ireland Natural infection sheep 
farms 
 
-TCBZ (Fasinex) 
-Nitroxynil (Trodax) 
-Closantel (Flukier) 
-FECRT 
-Coproantigen  
 ELISA 
 
 
-TCBZ was ineffective 
-Nitroxynil and closantel were 
full effective 
 
(Hanna et al., 
2015) 
CRT = Coproantigen reduction test, pt = post treatment, cFECRT = Composite faecal egg count reduction test, TCBZ = Triclabendazole, FECRT = Faecal egg count 
reduction test 
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Table 1.5 Reports of triclabendazole resistance in Fasciola hepatica  outside the United Kingdom.    
 
Country 
(region) 
Sheep population 
tested 
Anthelmintic tested Test Used Drug efficacy/result References 
Australia 
(Victoria) 
Natural infection 
sheep farms/ 
Experimental 
infection 
 
TCBZ -FECRT 
- Fluke recovery 
First case of TCBZ 
resistance reported 
worldwide 
(Overend and 
Bowen, 1995) 
Netherlands Natural infection 
sheep farms 
-TCBZ (Fasinex) 
-Closantel (Flukier) 
FECRT -TCBZ: 15.3% efficacy 
-Closantel: 99.7% efficacy 
(Moll et al., 2000) 
Netherlands Experimental 
infection 
TCBZ (Fasinex) 
 
FECRT TCBZ: 10.8% efficacy (Gaasenbeek et 
al., 2001) 
Spain Sheep farm TCBZ (Fasinex) FECRT TCBZ: 75.7% efficacy  (30 
days pt) 
(Alvarez-Sanchez 
et al., 2006) 
Peru Experimental 
infection 
 
TCBZ (Fasinex) Fluke recovery TCBZ: 25.2% efficacy 
 
(Ortiz et al., 
2013) 
TCBZ = Triclabendazole, FECRT = Faecal egg count reduction test
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1.10 Mechanisms of resistance 
The mechanism of drug resistance is thought to be influenced by genetic changes in 
drug uptake, drug metabolism that inactivates / removes the drug or prevents its 
activation and a change in the distribution of the drug in the target organism that 
prevents the drug from accessing its site of action. In liver fluke, it is suggested that drug 
metabolism is up-regulated in TCBZ-resistant F. hepatica (Alvarez et al., 2005; 
Robinson et al., 2004). The active form of TCBZ-SO, blocks the movement of 
tegumental secretion, leading to widespread sloughing of the tegument. With regard to 
the uptake of drugs (TCBZ to TCBZ-SO); the uptake by TCBZ-R fluke isolates was 
shown to be significantly lower than that of the TCBZ-S isolates (Alvarez et al., 2005; 
Mottier et al., 2006), suggesting that uptake of TCBZ and its metabolites is altered in 
resistant fluke.  Furthermore, the well-known drug transporters, p-glycoprotein-linked 
drug efflux pumps, were suggested to be involved in the resistance mechanism.  It is 
likely that p-glycoprotein expression can have important effects on drug absorption, 
distribution and elimination; this is specific to TCBZ as it is not seen in albendazole 
(Mottier et al., 2006).  In addition, p-glycoprotein inhibitors have potential to lead to a 
‘reversion’ from resistance flukes to susceptible flukes. Similarly, inhibition of p-
glycoprotein by verapamil, appears to enhance TCBZ action in TCBZ-R isolates, but 
such findings were not observed for TCBZ-S isolates (Fairweather, 2009). 
In terms of what is known about genetic changes or mutations responsible for the 
development of resistance this is complicated because the genes involved are not known 
although, extrapolating from the situation of BZ resistance, it was suggested that tubulin 
was involved (Robinson et al., 2002). However, studies on TCBZ have indicated that the 
same mutation does not seem to cause resistance in F. hepatica (Fuchs et al., 2013). 
Mutations in p-glycoprotein genes have been implicated (Wilkinson et al., 2012) but 
again other studies do not support their involvement (Elliott and Spithill, 2014). 
Essentially the mode of action and mechanisms of TCBZ resistance remain unknown 
and remain the focus of research; reviewed by Hodgkinson et al. (2013). 
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1.11 Diagnosing triclabendazole resistance 
As highlighted above diagnosing TCBZ resistance can be challenging, particularly in the 
field. In the absence of WAAVP guidelines there are a number of approaches that can be 
used, for example faecal egg count reduction test (FECRT), controlled efficacy tests and 
the coproantigen ELISA test. These tests rely on accurate methods of detecting F. 
hepatica infection, as highlighted in section 1.5 above. The relative merits of each 
approach are highlighted below along with the ongoing need to evaluate and validate 
these tests. The tests differ in their ability to detect TCBZ resistance in vivo or in vitro. 
 
 In Vivo Diagnostic Tests 1.11.1
 Faecal egg count reduction test  1.11.1.1
The FECRT has become the principle means of diagnosing the efficacy of anthelmintic 
treatments under field conditions. To conduct the test, faecal samples can be collected 
from individual sheep per rectum and then coproscopy examinations performed but this 
procedure is not suitable on commercial farms as the sedimentation technique is time 
consuming when processing a large number of faecal samples and needs trained 
personnel. 
Using a subset of the flock, 10 animals per treatment group, has become a well-
established method to diagnose anthelmintic efficacy of different classes of drugs 
against nematodes in sheep based on the guidelines of the WAAVP (Wood et al., 1995).  
This method has been adapted for detecting TCBZ resistance in experimentally infected 
sheep (Flanagan et al., 2011a). Other studies also suggested that the FECRT is a useful 
diagnostic test to investigate the true anthelmintic failure for use in the field (Gordon et 
al., 2012a; Hanna et al., 2015; Jones et al., 2014). A separate study has validated the use 
of a composite FECRT (cFECRT) in groups of 10 sheep to detect TCBZ resistance 
status on sheep farms (Daniel et al., 2012).  The cFERCT,  requires sampling of faecal 
samples from a group of 20 sheep, followed by flukicide treatment, and 21 days post-
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drenching sampling of the same 20 sheep for assessing TCBZ efficacy (Daniel et al., 
2012).  The cFECRT approach was shown to be just as sensitive as using the traditional 
method, which is the individual counts (Daniel et al., 2012). Both tests have limitations 
in that they may give essentially different results due to egg losses during processing 
and counting stages.  Unlike roundworms, liver flukes do not release eggs consistently 
into faeces as eggs may be retained in the gall bladder, so even after the removal of 
mature flukes from the liver of sheep (i.e. following drug administration) a positive FEC 
can be recorded, however the fate of adult fluke that are killed by the drug is unclear 
(Sargison, 2012). Therefore, for an anthelmintic to be fully effective and to avoid 
misinterpretation of anthelmintic efficacy it is recommended that FECRT be taken 14 
and 21 days post treatment to exclude the problem associated with retention of F. 
hepatica eggs in the bile ducts of sheep (Flanagan et al., 2011a). 
 
 Controlled slaughter test 1.11.1.2
This in vivo test is most reliable for all types of drugs and is the gold standard for 
evaluating anthelmintic efficacy.  However, it is also the most costly test as animals 
have to be sacrificed so that total worm counts (nematode parasites) and liver fluke 
burden (F. hepatica) can be performed, it is therefore not suitable for diagnosing 
resistance in the field but ideal for research work such as dose confirmation studies or 
for confirmation of resistance.  The WAAVP provided the guidelines for conducting this 
test for gastrointestinal nematode parasites (Wood et al., 1995).  The only reliable and 
useful test for TCBZ resistance in F. hepatica is a dose and slaughter study (Coles et al., 
2006).  The controlled slaughter test is conducted when both control and infected groups 
in the trial have been treated with an anthelmintic in which the parasites have reached 
patency in the host.  The percentage efficacy is calculated by comparing the mean of 
parasites recovered in treated and control animals (Wood et al., 1995).  FEC and 
coproantigen reduction tests (CRT) have been validated as tests for diagnosis of TCBZ 
resistance in sheep and cattle by using the WAAVP approved dose and slaughter trials 
for nematodes (as official guidelines for interpretation of the CRT do not exist) 
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(Brockwell et al., 2013; Gordon et al., 2012a). In nematode parasites, resistance is 
confirmed when the reduction in worm burdens is less than 90% or if 1000 or more 
worms survived anthelmintic treatment (Wood et al., 1995). 
 
 Coproantigen ELISA test (BIO K 201) 1.11.1.3
As discussed in section 1.5 above the coproantigen ELISA (cELISA) has been 
developed for the early detection of F. hepatica infection and the levels of coproantigens 
were no longer detected in the faeces within 2 weeks of anthelmintic treatment 
identifying its potential for diagnosing TCBZ resistance (Dumenigo and Mezo, 1999; 
Espino et al., 1997; Gordon et al., 2012b; Mezo et al., 2004). This test has been applied 
in a number of experimental and field studies reporting cases of TCBZ resistance (see 
Table 1.6). However, studies done by Novobilsky et al. (2012)  found that following 
TCBZ and albendazole treatment, fluke eggs appeared in two individual ewes on day 0, 
7 and 24, however the presence of coproantigen were not detected. It may thus be 
concluded that the release of coproantigen by this test may cause false negative results.  
This is also supported by other studies that reported in naturally infected sheep, 2 to 6 
flukes were found in liver of 5 out of 27 slaughtered sheep, however they were found to 
be negative for the cELISA (Gordon et al., 2012b).  Most recently, fluke eggs were 
found in one animal, on day 7 post treatment with TCBZ but negative result was 
reported by using cELISA (Robles-Pérez et al., 2013). The cELISA has not been fully 
validated under field conditions and therefore requires further evaluation. 
 
 Polymerase Chain Reaction (PCR) 1.11.1.4
Molecular and genetic tests are limited and available for detecting benzimidazole 
resistance in Haemonchus contortus in sheep (Taylor et al., 2002). Recently, PCR assay 
is a newly developed molecular technique for diagnosis of F. hepatica infection in sheep 
which may prove a useful method of detecting anthelmintic resistance in naturally and 
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experimentally infected sheep (Martinez-Perez et al., 2012; Robles-Pérez et al., 2013). 
The sensitive and specific detection of F. hepatica DNA by PCR has been investigated 
as a diagnostic tool to monitoring the efficacy of TCBZ treatment and detect cases of 
TCBZ resistance. The assay, claims to detect liver fluke infection as early as 2 wpi, 
which is two weeks earlier than detection using cELISA (Robles-Perez et al., 
2013).  However, this diagnostic tool has limitations and every step in preparing the 
samples must be carefully done to achieve the specificity. DNA extraction and 
amplification reaction from faecal samples is crucial and one limiting factor is the 
presence of PCR inhibitors in faecal samples which can inhibit PCR amplification of 
target DNA. The inhibitors that have been identified are from gut materials, complex 
polysaccharides derived from plants in the diet (Fernando et al., 2003) or food debris 
(Greenfield and White, 1993), the break down products of heme (eg: bilirubin, bile salts) 
(Widjojoatmodjo et al., 1992) and DNA present in the faeces could also inhibit the Taq 
polymerase (Weyant et al., 1990). Some also indicate that inhibitors are from the 
materials and reagents such as KCL, NaCl and other salts, ionic detergents such as 
sodium deoxycholate, sarkosyl and SDS (Weyant et al., 1990), ethanol and isopropanol 
(Loffert, 1997) and phenol (Katcher and Schwartz, 1994) that come into contact with 
DNA samples during processing. There have been reports of other reagents used for 
cultivating microorganisms that could potentially be PCR inhibitors (Rossen et al., 
1992); other inhibitors are still unknown. 
To eliminate the PCR inhibitors, there are several options that can be applied during 
DNA extraction such as dilution of template DNA (1:10) as recommended by Monteiro 
et al. (1997).  QIAamp tissue method extraction is the kit that was proposed in this study 
(Monteiro et al., 1997).  According to Wehausen et al. (2004), the use of magnetic beads 
in DNA extraction was superior compared to other materials.  
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 In Vitro Diagnostic Tests 1.11.2
Another test that is used for gastrointestinal nematodes is the egg hatch assay (EHA) 
that has been developed to detect benzimidazole resistance (Coles et al., 2006; von 
Samson-Himmelstjerna et al., 2009). Although the EHA was originally developed to 
detect anthelmintic resistance in nematode parasites, this test can be also be used in 
fluke. Several studies have been conducted in F. hepatica for validation of EHA 
(Alvarez et al., 2009; Canevari et al., 2014; Fairweather et al., 2012). 
 
 Egg Hatch Assay  1.11.2.1
The egg hatch assay (EHA) is used to detect benzimidazole resistance in sheep 
gastrointestinal nematodes and relies on ovicidal activity of the drugs.  Eggs of resistant 
isolates embryonate and hatch in higher concentrations of the drug than those of a 
susceptible isolates (Coles et al., 2006; Whitlock et al., 1980).  Proof of concept for 
EHA to detect TCBZ resistance in F. hepatica was carried out (Alvarez et al., 2009; 
Fairweather et al., 2012).  In their work, fresh eggs are recovered from the gall bladder 
and the hatch rate compared for eggs at various concentrations of TCBZ, albendazole 
(ABZ) and their sulfoxide metabolites. Most recently, the EHA was developed to detect 
resistance of F. hepatica to ABZ by using eggs from faecal samples of ABZ-susceptible 
and -resistant F. hepatica isolates (Robles-Perez et al., 2014). It has been shown that 
susceptible and resistant isolates can be differentiated at serial dilutions of drug 
(Fairweather et al., 2012; Robles-Perez et al., 2014).  It is a simple diagnostic tool as it 
does not require any expensive equipment, however, the limitation of this technique is 
that its requires large numbers of clean eggs to conduct the test and its validation for 
field diagnosis of anthelmintic using eggs from faeces remains to be performed. 
 
 
32 
 
1.12 Aims and Objectives 
The aim of this study was to:  
1. Evaluate and compare three diagnostic tests, composite faecal egg count 
reduction test (cFECRT), coproantigen ELISA (cELISA) and PCR assay, for their 
ability to detect F. hepatica infection and determine TCBZ efficacy in sheep 
experimentally infected with a TCBZ-S isolate. 
2. Improve the design of the composite FECRT (cFECRT) to detect TCBZ 
resistance in fluke populations.  
3. Determine the prevalence of TCBZ resistance in sheep farms in the UK using the 
Composite Faecal Egg Count Reduction Test (cFECRT). 
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Table 1.6 Summary of coproantigen ELISA studies.  
 
Test used/Antibody Experimental 
procedures 
Faecal sampling Parasite Results References 
 
Coproantigen ELISA 
Mab-ES78, mouse 
IgG2a 
Rats (n=20), 
experimentally 
infected with 25 
metacercariae 
Weekly from day 
of infection until 
16 wpi 
 
F. hepatica  
 
-Coproantigen was first detected at 4wpi in 45% 
of animals. 100% tested positive by 6 wpi. 
 
- Eggs began to appear in faeces at 8 wpi. 
 
 
(Espino et al., 
1997) 
 
Coproantigen ELISA 
Mab-ES78 
Sheep (n=10) 
experimentally 
infected  with 200 
metacercariae 
From day of 
infection until 14 
wpi 
 
F. hepatica  
 
Coproantigen first detected at 4wpi in 5 animals. 
All animals were positive by 6 wpi. 
 
-Eggs began to appear in faeces between 10 and 
12 wpi. 
 
(Dumenigo et 
al., 2000) 
Coproantigen ELISA 
E/S antigens 
-experimental 
infected sheep 
(n=20) with 50 
metacercariae 
(Group 1), 100 
metacercariae 
(Group 2), 200 
metacercariae 
(Group 3) and 
control group  
From day of 
infection until 12 
wpi 
 
F. hepatica  
 
Coproantigen detected from 4wpi and at the 9
th
 
wpi, 14 out of 15 infected animals were positive 
to coproantigens. 
 
The sensitivity was 93.3%. 
 
 
Eggs began to appear in faeces after 8 wpi. 
(Almazan et al., 
2001) 
Coproantigen ELISA 
IgG 
 
Rats (n=36) 
experimentally 
infected  with 20 
metacercariae 
From day of 
infection until 21 
wpi 
 
F. hepatica  
 
- For coproantigen detection, the infection was 
firstly detected 1 or 2 weeks before the 
appreance of F.hepatica eggs in the faeces. 
 
- Eggs began to appear in faeces at 7  
  wpi. 
 
(Paz-Silva et 
al., 2002) 
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Coproantigen 
ELISA  
Mab MM3 
 
 
 
Sheep, 
experimentally 
infected with 5, 
10, 20 and 40 
metacercariae  
-From day of 
infection  until 18 
wpi 
- 6 lambs  were 
treated with TCBZ 
on week 14 pi 
- 15 lambs were 
untreated 
-lambs were 
slaughtered at 18 
wpi to determine 
fluke burden  
F. hepatica  
 
-all treated animals (n=6) had no fluke whereas 
untreated animals (n=15) were found to be 
infected with between1 and36 flukes.  
 
- Comparison of coproantigen levels and egg 
counts indicated that infected sheep had 
detectable amounts of coproantigens 1-5 weeks 
before patency 
 
- in treated animals, coproantigen became 
undetectable from 1 - 3 weeks after treatment; 
however eggs continued to be intermittently 
shed in faeces until 4 weeks after treatment 
 
- in untreated animals, coproantigen remained 
detectable until at least 18 wpi 
(Mezo et al., 
2004) 
 
Coproantigen 
ELISA 
Mab ES78 
Sheep, (n=7) 
experimentally 
infected  with 100 
metacercariae 
From day of 
infection until 25 
wpi 
 
At week 18, sheep 
were drenched 
with TCBZ 
F. gigantica Coproantigen was first detected within 5 to 9 
wpi (57-71% of animals were positive) and 
reached 100% by 11 wpi. 
 
Eggs began to appear in faeces from 15 to 17 
wpi. 
 
 
(Endah 
Estuningsih et 
al., 2004) 
 
Coproantigen 
ELISA  
Mab MM3 
 
Infected sheep 
with 200 
metacercariae 
from day of 
infection and once 
a week, starting at 
5wpi 
- until 32 wpi 
F. hepatica  
F. gigantica 
F. hepatica-infected sheep 
i) Eggs began to appear in faeces from 10 to 14 
wpi. 
ii) coproantigen levels and egg counts indicated 
that sheep had detectable amounts of 
coproantigens 4-7 weeks before patency and 
coproantigen level increased above the cut-off 
value from 6 to 9 wpi 
 
 
(Valero et al., 
2009) 
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F. gigantica-infected sheep 
i) The eggs began to appear in faeces from 
weeks 11 to 16 wpi. 
ii) coproantigen levels and egg count indicated 
that sheep had detectable amounts of 
coproantigens 3-6 weeks before patency and 
coproantigen levels increased above the cut-off 
value between 7 to 11 wpi 
 
  
 
 
Coproantigen 
ELISA  
Mab MM3 
 
 
 
 
Infected sheep 
(n=38) with 250 
metacercariae 
  Faecal samples 
were collected 
twice-weekly 
throughout the 
trial period 
 
-CRT as a 
diagnostic marker 
 
F. hepatica  
 
 
-For coproantigen detection, the infection was 
firstly detected at 5 to 6 wpi and onwards. 
 
-The eggs began to appear in faeces from weeks 
10 wpi. 
(Flanagan et 
al., 2011b) 
 
Coproantigen 
ELISA  
Mab MM3 
 
 
Infected sheep 
(n=49) with 200 
metacercariae of 1 
of 4 F.hepatica 
isolates 
 
  Faecal samples 
were collected 
twice-weekly 
throughout the 
trial period 
 
CRT as a 
diagnostic  marker 
F. hepatica  
 
 
Faecal samples tested positive by coproantigen 
and egg count respectively, at: 
 
i) Cullompton isolates – 50 and 77 dpi  
ii) Leon isolates – 62 and 75 dpi 
iii) Fairhurst isolates – 53 and 70 dpi 
iv) Oberon isolates – 47 and 59 dpi 
 
All sheep, regardless of fluke isolate, were 
positive for coproantigens at 12 wpi. Eggs were 
detected in all the Oberon F. hepatica-infected 
sheep at 12 wpi, but eggs were only detected in 
90% (9/10), 69% (9/13) and 77% (10/13) of the 
(Flanagan et 
al., 2011a) 
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Cullompton, Leon and Fairhurst F. hepatica-
infected 
sheep groups at 12 wpi. 
 
 
Coproantigen 
ELISA  
Mab MM3 
 
 
 
-experimental 
serology positive 
sheep (n=24)  
Faecal samples 
collected on day 0, 
7, 24, 46 and 74. 
 
-CRT as a 
diagnostic marker 
 
- Group A 
(5mg/kg ABZ) 
-Group B 
(10mg/kg TCBZ) 
-Group C (control) 
 
At day 24: 
-Group B 
(10mg/kg TCBZ) 
-Group C 
(10mg/kg TCBZ) 
 
F. hepatica  
 
-In TCBZ treated animals, coproantigen and 
eggs were no longer detected in faeces 7 days 
after application 
-ABZ treatment had no effect on either egg or 
coproantigen detection 
 
-In all groups, a greater number of egg positive 
than coproantigen positive animals were 
detected.   
-all coproantigen positive animals had fluke 
eggs in their faeces 
- False negative results were detected in 2 
animals in Group C (positive for egg count on 
day 0, 7 and 24), but were negative for the 
presence of coproantigen. 
 
(Novobilsky et 
al., 2012) 
 
Coproantigen 
ELISA  
Mab MM3 
 
 
 
 
 
-naturally infected 
sheep (n=45) 
 
-experimental 
infected sheep 
(n=7) with 200 
metacercariae 
Experiment group: 
Faecal samples 
were performed 
weekly from 6wpi 
to 12 wpi. 
 
 
F. hepatica  
 
natural infection 
-only 24 out of 45 sheep had positive egg counts 
-All animals were positive by coproantigen 
detection 
 
 
experimental infection 
-Eggs were detected by 9wpi. 
-Coproantigen was first detected by 4wpi 
(57.1% of animals were positive) and reached 
100% by 8wpi. 
(Martinez-
Perez et al., 
2012) 
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Coproantigen ELISA 
Mab MM3 
 
 
-naturally infected 
sheep (2 farms) 
 
 
CRT as a 
diagnostic marker 
 
Longitudinal study 
from June to 
November 
F. hepatica  
 
 
Coproantigen ELISA and FEC became positive 
at the same time point (in July). 
*The coproantigen ELISA was negative before 
FEC and this could be due to the low fluke 
burdens (5 or lower) in the livers. 
 
 
(Gordon et al., 
2012b) 
Coproantigen ELISA 
Mab MM3 
 
naturally infected 
sheep  
(Northern Ireland) 
Treated: TCBZ, 
nitroxynil and 
closantel, 
(Faeces:  at day 0 
and day 21 
F. hepatica  
 
Nitroxynil and closantel reduced the FECs and 
was supported by the results of CRT.  However, 
results of CRT remained positive after 21 days. 
TCBZ was ineffective; confirmed by FECRT 
and CRT results. 
(Hanna et al., 
2015) 
E/S excretory/secretory; Mab monoclonal antibody
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CHAPTER 2  
 
Evaluation of diagnostic tests for the detection of Fasciola hepatica 
infection and determination of triclabendazole efficacy in sheep 
experimentally infected with a triclabendazole susceptible field 
isolate 
 
2.1 INTRODUCTION 
The availability of effective and sensitive methods for the accurate detection of liver 
fluke infection under field conditions is essential if Fasciola hepatica is to be 
effectively controlled and has an important role in monitoring the efficacy of drug 
treatment. The ability to detect infection at the early stage as parasites migrate 
through the liver is of particular importance. To date a number of different 
techniques for the detection of F. hepatica infection have been described in the 
literature; FEC, coproantigen ELISA (cELISA) and polymerase chain reaction 
(PCR) based assays.  
 
 Detection of Fasciola hepatica infection in sheep 2.1.1
Historically the diagnosis of fasciolosis was made using coprological methods to 
detect fluke eggs in the faeces of infected sheep (Anderson et al., 1999).  FEC has 
become a common diagnostic and research tool worldwide due it being both simple 
to conduct and inexpensive.  However, there is a long timeframe before infections 
become patent approximately 8-12 week (Andrews, 1999) and in experimental 
studies in sheep observation of F. hepatica eggs under the microscope does not occur 
prior to 8 weeks post infection (Zimmerman et al., 1982). Furthermore, poor 
sensitivity of the FEC (estimated to be only 30%) can lead to false negative results 
(Happich and Boray, 1969a).  Therefore, in order to detect early stages of liver fluke 
infection, effort has been made to develop alternative robust and sensitive diagnostic 
tools for F. hepatica infection in sheep. A number of diagnostic tests have been 
developed for detecting infection of liver flukes including the cELISA (Brockwell et 
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al., 2013; Flanagan et al., 2011a; Flanagan et al., 2011b; Gordon et al., 2012b; Hanna 
et al., 2015; Kajugu et al., 2015) and PCR assay (Martinez-Perez et al., 2012; 
Robles-Pérez et al., 2013).   
Traditionally enzyme-linked immunosorbent assay or ELISA has been used to detect 
antibodies that are produced in response to liver fluke infection in blood or milk 
samples (Salimi-Bejestani et al., 2005b). A commercial coproantigen ELISA 
(cELISA, BIO K 201, Bio-X Diagnostics, Jemelle, Belgium) test for fasciolosis, 
based on the use of MM3 monoclonal antibody for antigen capture is available and 
detects fluke coproantigens in faeces.  The test was used as an alternative method to 
FEC for detecting fluke infection in the faeces of cattle and sheep. In the antigen-
capture ELISA, polyclonal antibody is coated on a 96-well microplate and the faecal 
samples added; if the fluke specific coproantigen is present in the faecal samples it 
can bind to the antibody. A first conjugate (MM3 monoclonal, biotin conjugated) is 
added to bind to the antibody to form a Y structure (Fig. 2.1) and then the second 
conjugate (avidin peroxidase) is added. Finally TMB chromogen (3,3',5,5'-
tetramethylbenzidine) is added to form a colour development – yielding a blue 
colour which changes to yellow upon addition of a sulfuric or phosphoric acid stop 
solution. Coproantigen values are expressed as the percentage positivity (PP) 
according to the formula; % = (Mean OD of the sample / Mean OD of positive 
control) x 100.  If the value of PP (%) falls above the threshold (according to the 
manufacturer’s protocol) positive reactions are reported. 
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Figure 2.1 Coproantigen ELISA (BIO K 201, Bio -X Diagnostics,  
Jemelle, Belgium).   
 
In experimental infection in sheep, the early detection of F. hepatica infection has 
been confirmed by cELISA due to coproantigens present in faeces during the pre-
patent period of infection. Infections can be detected as early as 5 weeks post 
infection (wpi); earlier than FEC (Flanagan et al., 2011a; Flanagan et al., 2011b).  
Furthermore, other tests on MM3 capture ELISA have reported 100% sensitivity and 
100 % specificity with the ability to detect infection even when sheep were infected 
with the lowest infective dose of metacercariae (ranging from 10 to 40 
metacercariae, (Mezo et al., 2004). These authors reported that this test can detect 
infection as early as 5 wpi. However, this is somewhat limited by the unpredictable 
release of coproantigen in the faeces and false negative results can be reported 
(Flanagan et al., 2011b).   The cELISA is a rapid, specific and easy diagnostic tool to 
use in the laboratory.  The manufacturers report that it can be used for large number 
of samples in routine diagnosis which can be finished within 5 hours (BIO K 201 
manufacturer’s guidelines).  The assay is therefore considered a sensitive method for 
detecting early diagnosis of liver fluke infections in sheep faeces.  
Recently, PCR assays have showed promise as a sensitive diagnostic tool for the 
detection of liver fluke infection in sheep. Amplification of F. hepatica DNA from 
faecal samples by PCR assay was first achieved by Martinez-Perez et al. (2012).  In 
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that study, they conducted two different PCR assays to detect the cytochrome C 
oxidase 1 gene (Cox-1); standard PCR and nested-PCR.  For standard PCR, specific 
PCR primers were designed based on F. hepatica mitochondrial DNA (mtDNA) 
Cox-1 sequence (Cox1 Forward/Reverse) (Martinez-Perez et al., 2012).  Standard 
PCR analysis from faecal samples was carried out from 0 to 8 wpi and showed that 
the detection of F. hepatica infection was positive from three weeks post infection.  
An alternative nested-PCR utilizes two consecutive PCRs and is carried out the same 
way as the standard PCR but the larger fragment produced by the first reaction is 
used as the template for the second PCR reaction.  Using this method, the sensitivity 
and specificity of DNA amplification was higher than the standard PCR as results 
showed that infection with F. hepatica can be detected as early as 2 wpi (Martinez-
Perez et al., 2012).  Most recently, another PCR assay was developed to detect liver 
fluke infection in faecal samples from sheep.  This PCR was designed to specifically 
amplify the F. hepatica internal transcribed spacer 2 (ITS2) region on faecal samples 
from infected sheep (Robles-Perez et al., 2013). The infection can be detected as 
early as 2 wpi (Robles-Pérez et al., 2013). On the basis of these studies PCR offers 
much higher sensitivity than the other methods (Robles-Perez et al., 2013).   
Further to detecting F. hepatica infection a sensitive, specific diagnostic test is 
needed to confirm the efficacy of triclabendazole (TCBZ) treatment and the presence 
of TCBZ resistance. The use of the simpler and less expensive FEC in which only 
pre- and post-treatment samples are required is a widely used test; however, F. 
hepatica egg shedding is intermittent and infected sheep only consistently shed eggs 
in the faeces from 10 to 12 wpi (Andrews, 1999).  While this is the most technically 
correct procedure for detecting fluke eggs from infected sheep, a particular problem 
with this test is that its low sensitivity can result in false negative post-treatment FEC 
results. Alternatively, fluke eggs can be stored or remain in the gall bladder of the 
animal following drug treatment, even when sheep have been successfully treated, 
which makes interpretation of post treatment counts difficult (Flanagan et al., 2011a; 
Flanagan et al., 2011b; Mitchell et al., 1998).  Furthermore, sedimentation methods 
are laborious techniques and are time consuming, requiring each sample to be 
examined by trained staff, suggesting it is not suitable for analysing samples from 
large flocks. 
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The controlled slaughter test is the ‘gold standard’ to establish anthelmintic 
resistance in liver fluke populations (Gordon et al., 2012a) as suggested by WAAVP 
guideline to obtain full confirmation of true parasite resistance (Coles et al., 2006).  
In this test, animals in both of control and treated groups are slaughtered following 
treatment and sheep fluke burdens counted.  However, this test is expensive and is of 
limited diagnostic value as it requires sacrificing of animals, thus it is not 
recommended for the routine diagnosis of anthelmintic resistance. Other tests are 
used to monitor susceptibility of F. hepatica to TCBZ are post-treatment fluke 
histology (Hanna et al., 2015) and egg hatch assay (Alvarez et al., 2009; Canevari et 
al., 2014; Robles-Perez et al., 2014). 
The cELISA has been applied in a number of experimental and field studies 
reporting cases of TCBZ resistance (see Table 1.5). However, the nature of the 
release of coproantigen may cause this test to give false negative results  
(Novobilsky et al., 2012) and cases of naturally infected sheep recording negative 
cELISA results but positive by FEC raises questions over the performance of the test 
in detecting TCBZ resistance (Gordon et al., 2012b; Robles-Perez et al., 2013).  
Similarly the sensitivity and specificity of detection of F. hepatica DNA by PCR has 
identified this as a diagnostic tool for monitoring the efficacy of TCBZ treatment and 
detect cases of TCBZ resistance, although it remains to be evaluated. 
 
Aim of the study 
A number of diagnostic tools have been developed for detecting F. hepatica 
infection in sheep, but each suffers to some degree from sensitivity, reliability, 
reproducibility and ease of interpretation.  In this section, the research is therefore 
focused on evaluating the currently available diagnostic tests and their ability to 
detect F. hepatica infection in experimentally infected sheep.  The study was carried 
out on sheep infected with 200-215 metacercariae of a TCBZ susceptible field isolate 
of F. hepatica.  Infected sheep were maintained until patent infections were well 
established (until 14 wpi). Faecal samples were taken weekly from 0 to 14 weeks 
wpi and subjected to cELISA, FEC and PCR analysis. At 14 wpi sheep were treated 
with TCBZ at 10 mg/kg bodyweight.  Daily faecal samples were taken from day 0 to 
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day 10 post treatment (pt) and subjected to cELISA and FEC analysis. Ten days post 
treatment (dpt) sheep were slaughtered and the number of fluke present were 
counted. 
  
2.2 MATERIALS AND METHODS 
 
 Experimental design for the infection of sheep with a triclabendazole 2.2.1
susceptible isolate of Fasciola hepatica 
Twelve lambs were infected on day 0 with a range of 200-215 metacercariae using 
an oral dosing syringe. ~Two hundred metacercariae were counted using a 
magnification of 4 x under a dissecting microscope and viability was determined by 
observing movement within the metacercarial cyst. The visking tubing (Sigma-
Aldrich Company Ltd, Dorset, UK) is an artificial permeable membrane and it was 
used in the study. The visking tubing was cut out and inserted into the end of a 
syringe loaded with water, which was then used to flush the sheep’s mouth.  Faecal 
samples were taken per rectum at weekly intervals up to 14 weeks post infection 
(wpi).  Faecal samples were subjected to coproantigen detection, PCR faecal assay 
and egg detection via sedimentation to detect the presence of F. hepatica infection.  
At 14 wpi, sheep were divided into two groups.  Group 1 was allocated as the 
untreated control group whereas Group 2 animals were treated with TCBZ 
(Fasinex
®
; 10 mg/kg) per os.  Faecal samples were collected daily until 10 day post 
treatment (dpt).  Again, individual faecal samples were assessed using sedimentation 
and cELISA.  Faecal egg counts were carried out weekly from week 0 to 14 wpi and 
daily post treatment from day 0 to 10 dpt.  Similarly the cELISA was conducted on 
weekly samples taken from 1 to 14 wpi and daily from day 0 to 10 dpt.  At 10 dpt, 
all sheep were euthanized and post mortem exam was carried out for liver fluke 
recovery and enumeration.  
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Figure 2.2.1  Experimental design for the infection of sheep with a 
triclabendazole susceptible Fasciola hepatica  isolate and comparison 
of diagnostic methods for the detection of F. hepatica  infection and 
triclabendazole efficacy.  
       
 Source of metacercariae 2.2.1.1
The maintenance and infection of snails and production of metacercariae was carried 
out by Katherine Allen, in the Department of Infection Biology, University of 
Liverpool. A field isolate of F. hepatica from an organic farm with no history of 
TCBZ treatment was sourced from naturally infected sheep. Eggs were isolated from 
faecal samples using standard parasitological techniques and used to infect Galba 
truncatula snails from a colony of snails maintained in house on pans of clay mud 
and fed on a diet of Oscillatoria algae. Both the snails and algae were maintained at 
a controlled temperature of 22
o
C. For experimental infection miracidia were released 
from F. hepatica eggs following embryonation at 27
o
C in the dark for 14 days 
followed by exposure to a direct light source to stimulate hatching.  Following 
infection, snails were maintained on mud pans and fed every two to three days until 
 
 
Week 14 
Week 0 
(Infected 200-215  
metacercariae  (Susceptible 
isolates) 
PCR 
FEC 
Coproantigen 
ELISA 
Faecal 
samples:  
Weekly 
from 
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 0- 14  
post 
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(pi) 
Treated group  
(TCBZ: 10 mg/kg)  
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Faecal 
samples:  
Daily 
from Day 
0 - 10   
post 
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(pt) 
FEC 
Controlled 
slaughter study 
Coproantigen 
ELISA 
 
 
45 
 
 
six wpi. Prior to being shed snails were sealed in Visking tubing containing water in 
individual wells of a six well plate. Shedding of cercariae was triggered by exposing 
to a drop in temperature of 8-12
o
C for 30 min followed by a slow return to room 
temperature (RT) under a light source over a period several of hours. Snails were left 
overnight for the emerged cercariae to encyst as metacercariae on the sides of the 
Visking tubing after which they were washed and stored at 4
o
C until use.    
 
 Experimental infection of lambs 2.2.1.2
All experimental procedures described were conducted at the University of 
Liverpool, subject to the Institute’s Experiments and Ethics Committee approval, 
and were conducted under approved British Home Office license no PPL4003621 in 
accordance with the Animals (Scientific Procedures) Act of 1986. Lambs were 
purchased and housed in indoor pens throughout the study and for a minimum period 
of four weeks prior to infection. On housing and immediately prior to infection they 
were subjected to both faecal analysis and serum antibody ELISA testing (Salimi-
Bejestani et al., 2005b) to confirm fluke-free status prior to infection.  Whilst housed 
they were fed with ad libitum access to hay and a 17% protein pellet at 0.5 kilo per 
day and water. 
 
 Parasitology Techniques 2.2.2
 Faecal egg count by sedimentation 2.2.2.1
Faecal egg counts were performed from each animal using 5g of faecal sample 
mixed with water to make a faecal slurry.  The faecal slurry was washed through a 
stack of three difference sized sieves with the 710 μm sieve on top, followed by the 
150 μm and 38 μm mesh size sieves (Figure 2.2.2 a).  The stack of sieves was 
washed under the running tap water until the water ran clear from the bottom sieve. 
At which point the top sieve was removed and the lower two sieves were washed 
through by repeating the same washing procedure as above.  The 150 µm sieve was 
removed and the sediment on the surface of the 38 µm sieve was backwashed into a 
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500 ml beaker.  The beaker was topped up with tap water and allowed to settle for 4 
min (Figure 2.2.2 b). The supernatant was discarded and to leave approximately 100 
ml at the bottom of the beaker which was then refilled with tap water and left to 
stand for another 4 min.  The process was repeated as many times as necessary until 
the supernatant was clear (Figure 2.2.2 c).  The supernatant was then removed until 
~50ml remained in the bottom of the beaker and the entire volume was transferred to 
a viewing chamber petri dish and two drops of methylene blue were added.  The 
petri dish was placed under a microscope (Motic
®
) with a minimum magnification of 
4 x to screen the presence of the fluke eggs. All eggs were counted in the 5 g of 
faeces and adjusted to provide an egg per gram (epg) count. The procedure for 
recovering eggs from faecal samples is described in detail in Appendix 2.1.    
 
 
(a) 
 
(b) 
 
(c) 
 
(d) 
Figure 2.2.2 (a). A stack of three different siz ed sieves (710, 150, and 
38 μm) .  (b) The beaker was fil led with tap water and allowed to 
sediment for 4 min. (c).  The process was repeated several times unti l  
the supernatant was clear of debris. (d) Methylene blue was added and 
the solution was viewed under the dissecting microscope . 
 
710 μm 
150 μm 
38 μm 
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 Liver fluke recovery 2.2.3
At 10 dpt, all 12 sheep were euthanized with a captive bolt and the liver was 
removed soon after slaughter. Approximately 5 g of faecal sample was removed 
from the rectum and stored for subsequent FEC, coproantigen and PCR analysis.  At 
necropsy, all bile ducts were dissected and adult flukes were removed and counted.  
All flukes were collected into a petri dish containing phosphate buffered saline 
(PBS) warmed to 37°C.  The parasites were again rinsed in warm PBS and incubated 
individually in 1 ml of RPMI media (Gibco
®
) at 37°C for 2 hr.  The liver was 
sectioned at 1 cm intervals, soaked in sterile PBS (or saline) and was incubated at 
37°C for 2 hr to allow any immature flukes to emerge.  Prior to counting, liver slices 
and sediment were passed through a 38 µm sieve and examined grossly for immature 
flukes.  The flukes were stored in PBS for transfer to the laboratory.  The parasites 
were then removed from the petri dish and stored frozen ahead of further tests (See 
Appendix 2.2). 
 
 Coproantigen ELISA   2.2.4
The commercially available cELISA kit (BIO K 201, BIO-X Diagnostics, Belgium) 
was developed for the diagnosis of F. hepatica infection in sheep.  The plate has four 
rows (rows A, C, E and G), which include polyclonal antibody specific to F. 
hepatica and another four rows (rows B, D, F and H) that have been sensitised with a 
polyclonal antibody that is not specific for F. hepatica. 
Fresh faecal samples were used.  The faecal samples were weighed out to 0.5 g and 
then mixed up with 2 ml of the dilution buffer in a 15 ml tube.  Each sample was 
homogenized for 10 s using the vortex and the tubes were then centrifuged at 1,000 x 
g for 10 min.  Following centrifugation, the supernatant was collected and stored in 
1.5 ml Eppendorf tubes at -20°C until needed.  The samples were not stored for 
longer than 6 weeks after collection as per recommendation (Gordon et al., 2012b).  
The BIO K 201 cELISA was performed according to the manufacturer’s 
specifications. Briefly, plates were prepared by dispensing 110 μl of the diluted 
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samples into each well in duplicate except in wells G1 and H1 as these two wells 
acts as a controls.  The plate was sealed and placed on a plate agitator at 21ºC for 2 
hours. All the solution was then removed and the plate was washed with the washing 
solution three times. One hundred μl of diluted biotin-linked anti- F. hepatica 
antibody conjugate was dispensed into each well and the plate was sealed and 
incubated at 21ºC for 1 hr.  The plate was again washed three times with the washing 
solution following which 100 μl of diluted avidine-peroxidise-linked conjugate was 
added to each well and the plate was incubated at 21ºC for 1 hr.  At which point, 100 
μl of chromogen solution was pipetted to each well. The plate was then incubated at 
21ºC for 10 min in the dark and followed by adding 50 μl of stop solution to each 
well.  A colour change from blue to yellow was read using an ELISA plate reader set 
to 450 nm (Infinite
®
 F50, Tecan Ltd, Reading, UK) after the stop solution was added 
(See Appendix 2.3). Coproantigen values are expressed as the percentage positivity 
(PP) according to the formula; % = (Mean OD of the sample / Mean OD of positive 
control) x 100. As per the manufacturer’s instructions the cut-off value for and 
percentage positive (PP) value was 6.65 and 9.32%, respectively. 
 
 PCR of faecal samples 2.2.5
 Faecal DNA samples 2.2.5.1
Following collection per rectum, all faecal samples were stored at 4°C until testing. 
DNA was extracted from individual faecal samples using 0.5 g from each sheep.   
 Extraction of DNA from faeces  2.2.5.2
Two commonly used DNA extraction procedures, Qiagen kit (Qiagen Ltd, 
Manchester, UK) and Nucleospin
®
 Tissue (Fisher Scientific UK Ltd, Loughborough, 
UK) kit were used according to manufacturer’s instructions but only the Qiagen kit 
was used for the majority of samples. DNA was extracted from faeces using the 
QIAamp DNA Mini Stool Kit (Qiagen Ltd, Manchester, UK) according to the 
manufacturer’s instructions, with only minor modification.  A total of 0.5 g of fresh 
sheep faeces was placed into a 15 ml tube and 2.8 ml of stool lysis buffer (buffer 
ASL) was added. Each tube was homogenized for 1 min using a vortex, and the 
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suspension was incubated at 95°C for 5 min.  Following incubation, all samples were 
vortexed for 20 s and centrifuged at 2500 x g (MSE Mistral 3000i) for 8 min.  A 1.5 
ml volume of the supernatant was transferred into a new 15 ml tube and the pellet 
was removed.  A tablet of InhibitEX (Qiagen Ltd, Manchester, UK) was added to the 
sample in order to absorb DNA-degrading substances and PCR inhibitors from the 
faecal samples. The mixture was vortexed thoroughly until the tablet was completely 
re-suspended.  The sample was then incubated for 3 min at RT to allow inhibitors to 
adsorb to the InhibitEX
®
 matrix and then centrifuged at 2500 x g for 6 min to pellet 
the inhibitor:InhibitEX
®
 matrix. Four hundred microliters were transferred into a 
new 1.5 ml microcentrifuge tube and the tube was centrifuged at 2500 x g for 3 min.  
Next, 200 µl of the supernatant was transferred into another 1.5 ml microcentrifuge 
tube and 15 µl of proteinase K, was added followed by 200 µl of Buffer AL from the 
QIAamp DNA Mini Stool Kit and the mixture vortexed for 15 s. The suspension was 
processed further by incubation at 70°C for 10 min. To precipitate the DNA, 200 µl 
of absolute ethanol (ABS ethanol) was added and mixed by vortex, followed by 
centrifuging for 1 min at 16 000 x g (microliter centrifudge; Heraeus
®
 Biofuge Pico).  
To complete the purification process, a QIAamp
®
 spin column was used. The spin 
column was placed into a new 2 ml collection tube and the entire sample was 
transferred onto the column and centrifuged for 1 min at 12, 850 x g. The DNA 
bound to the silica membrane of the spin column was washed by adding 500 µl of 
washing buffer (buffer AW1) and then centrifuged at 12, 850 x g for 1 min. The 
column was washed twice by adding 500 µl of washing buffer AW2 buffer to the 
spin column and centrifugation at 12, 850 x g for 3 min, each time. A final 
centrifugation for 1 min at 12, 850 x g was carried out in order to completely remove 
residual traces of washing buffer AW2 and to dry the column.  Bound DNA was 
eluted into a new labelled 1.5 ml microcentrifuge tube by adding 60 µl of Buffer AE 
onto the QIAamp
®
 membrane, incubatation at RT for 5 min and centrifugation for 1 
min at 12,850 x g.  The eluted DNA was stored at -20°C until further use as template 
for PCR (See Appendix 2.4). 
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 Optimizing the PCR assay 2.2.5.3
A list of available PCR assays for F. hepatica is shown in Table 2.2.1.  Comparison 
of the tests was made using DNA extracted from a F. hepatica FEC-positive faecal 
sample from sheep 14 and 18 wpi, collected as part of concurrent experimental 
studies in the Veterinary Parasitology group. Comparison was also performed with 
DNA extracted from adult F. hepatica recovered from the liver of infected sheep and 
DNA extracted from purified F. hepatica eggs recovered from the gall bladder. The 
18 wpi sheep faecal samples were also used to determine the optimal dilution factor 
of the extracted faecal DNA; undiluted; 1:10; 1:20 and 1:50 dilutions were prepared 
and tested by PCR.  For all dilutions, 1 µl of template DNA was added to the PCR 
reaction, except for 1:20 and 1:50 dilution where 4 µl of template DNA was used.  A 
negative control (water) and positive control (adult F. hepatica DNA) was included.  
Based on these PCR results, ITS2 was identified as the most sensitive PCR and was 
used in all subsequent analyses. Following optimisation the PCR conditions used to 
test all 12 experimentally infected sheep were as follows: ITS2 PCR, 1:50 dilution 
and 4 µl template DNA. 
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Table 2.2.1 Published PCR methods for the diagnosis of liver fluke 
infection in sheep.  
 
PCR assay Primer 
name 
Primer sequence        Size of PCR         
            product    
                (bp) 
   Reported   
sensitivity (wpi) 
Reference 
RAPD Fhep F / 
Fhep R 
 
5´-GCG GCCAAA TAT GAG TCA-3´ 
5´-CTG GAGATTCCGGTTACC AA-3´ 
568                 
ND 
(McGarry 
et al., 
2007) 
Cox: 
Standard- 
PCR  
 
Nested-
PCR 
Standard: 
Cox1 F /  
Cox1 R 
 
Nested: 
 
1° 
Primer:  
Cox2 F / 
LrRNA 
R 
 
2° 
Primer: 
Cox1 F / 
Cox1 R 
 
5´-GTTGGCATATTGCGGCTTAG-3´  
5´-AGGGATCTGCACCTCAACTC-3´ 
 
 
 
 
5´-TNTGTTTTTTKCCKATGCAYTA-3´ 
5´--TCYYRGGGTCTTTCCGTC-3´ 
 
 
 
 
5´-GTTGGCATATTGCGGCTTAG-3´  
5´-AGGGATCTGCACCTCAACTC-3´ 
 
423
1 
 
 
 
 
1° PCR 
=1045  
2° PCR 
=423
1
 
 
3 
 
 
 
 
2 
 
(Martinez
-Perez et 
al., 2012) 
ITS2 ITS 2 F / 
ITS 2 R 
5´-GTGCCAGATCTATGGCGTTT-3´ 
5´-ACCGAGGTCAGGAAGACAGA-3´ 
292                2 (Robles-
Pérez et 
al., 2013) 
1
Primers for standard PCR and final product of the nested PCR are identical; ND not determined. 
 
The 292 bp fragment of ribosomal ITS2 was amplified using the forward primer 
ITS2; 5ˈ- GTGCCAGATCTATGGCGTTT-3ˈ and the reverse primer ITS2; 5ˈ-
ACCGAGTCAGGAAGACAGA-3ˈ (Robles-Perez et al., 2013).  These primers were 
based on the ITS2 sequence of F. hepatica (GenBank accession number 
GQ231547.1).  The PCR reaction were performed in a total reaction volume of 25 µl 
containing 12.5 µl of Taq Polymerase Master Mix (2.0 mM MgCl2, 0.4 mM dNTPs 
and 0.05 units/ µl Ampliqon Taq polymerase), 0.5 µl of each ITS2 primer and 4 µl of 
DNA diluted 50 times.   
The following temperature programme was used: after an initial denaturation step for 
2 min at 95°C, a set of 40 cycles was run, each one including 30 s at 95°C, 30 s at 
63°C and 45 s at 72°C followed by a final extension step of 10 min at 72°C.  
Reactions were performed using a thermal cycle (T3 Thermocycler, Biometra
®
, 
Goettingen, Germany). Five microliters of the PCR product were electrophoresed on 
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a 1.2% agarose gel and stained with 10 µl SYBR
®
 Green safe (Roche Diagnostics 
GmbH, Mannheim, Germany) to determine the amplified fragments. The obtained 
PCR product was analysed using agarose gel (1.5%) electrophoresis and a 100 bp 
DNA ladder (Invitrogen, Taastrup, Denmark) was used as a marker. The gel was 
later run at 100V, 120 mA (PowerPac
TM
, Bio-Rad Laboratories Ltd, Hertfordshire, 
UK) for 30 min and then the amplified fragment was visualized into ultraviolet light 
imaging chamber. 
Statistical analysis  
The percentage efficacy of the TCBZ treatment in sheep was calculated using the 
following equation according to the WAAVP guidelines (Wood et al., 1995): 
 
Efficacy =  Mean of F. hepatica in control group – mean of F. hepatica in treated group  x  100                                                    
                                           Mean of F. hepatica in control group 
 
The number of parasites is presented as an arithmetric mean and was analysed using 
a Student’s “t” test.  
All parameters for epg and PP values, means ± SDs are given.  A P value for epg and 
PP were compared with the Mann-Whitney test.  For linear correlation analysis, the 
Spearman rank correlation coefficient R was computed by using SPSS anaylsis 
software (SPSS, release V.20.0; SPSS Inc, USA). A P value of P≥0.05 was 
considered to indicate a statistically significant difference at the 5% level of 
significance.  Tables and graphs of the data were produces using Microsoft Excel 
(Microsoft Office 2010). 
 
2.3 RESULTS 
 Detection of Fasicola hepatica infection by coproantigen ELISA and FEC 2.3.1
Fasciola hepatica infection was first detected by the cELISA at 5 wpi in two animals 
and all sheep tested positive by 8 wpi (Figure 2.3.1). Eggs of F. hepatica were first 
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detected in the faeces of one animal at 7 wpi and all animals had a positive FEC by 
11 wpi (Figure 2.3.1).   For some sheep, there was insufficient faecal sample to allow 
evaluation of FEC at every time point post infection: week 7 (8 out of 12 sheep 
tested), week 8 (9 out of 12 sheep tested), week 10 (11 out of 12 sheep tested), week 
12 (10 out of 12 sheep tested), week 13 (11 out of 12 sheep tested) and week 14 (11 
out of 12 sheep tested).  With the exception of the one animal positive by FEC at 7 
wpi, individual sheep remained positive from the first test-positive result until they 
were divided into control and treatment groups at 14 wpi (Figure 2.3.1).  Results of 
the cELISA for the 12 individual sheep tested weekly until 14 weeks post infection 
showed a steady rise in percentage positivity (PP) over time until ~11 wpi (Figure 
2.3.2). Mean PP values (± SD) for the group of 12 sheep are shown and reflects the 
rise in cELISA values until they plateau at 11-12 wpi (Figure 2.3.3). In Figure 2.3.4, 
the same pattern was shown in the rising of FEC for the 12 individual sheep tested 
weekly until 14 wpi.  Results of mean FEC (± SD) are presented in Figure 2.3.5 and 
reflect that, unlike the cELISA the mean FEC value continues to rise until 14 wpi.  
There was no correlation between the cELISA and FEC values for all sheep, R
2
 = 
0.031 (Spearman’s test p = 0.21) at 14 wpi (Figure 2.3.6).  
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Figure 2.3.1 The total number of individual sheep testing positive for 
infection with Fasciola hepatica  by i) the coproantigen ELISA 
detection kit -BIO-X K 201  (blue bars) and ii) the FEC (red bars).  
 
Note that due to insufficient faecal sample availability for FEC testing 
only a proportion of samples were tested at  the following timepoints:  
W7 (n=8 samples tested),  W8 (n=9 samples tested), W10 (n=11 
samples tested), W12 (n=10 samples tested),  W13 and 14 (n=11 
samples tested). For coproantigen testing, the test  was performed on 
all samples at all  time points expect: W6 (n=11 samples tested).  
 
 
 
 
 
0
2
4
6
8
10
12
W0 W1 W2 W3 W4 W5 W6 W7 W8 W9 W10W11W12W13W14
To
ta
l n
u
m
b
e
r 
o
f 
sh
e
e
p
 t
e
st
in
g 
p
o
si
ti
ve
 f
o
r 
in
fe
ct
io
n
 
Weeks post infection 
Copro
FEC
55 
 
 
 
Figure 2.3.2 Coproantigen ELISA values  (PP, percentage positivity) 
for 12 individual sheep (1-12) tested weekly for 14 weeks post  
infection.  
 
The red dashed line represent the cut -off value (PP > 6.65%) for a 
positive result . Note that the test was not all performed on W6 (n=11 
samples tested).  
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Figure 2.3.3 Mean coproantigen levels (PP, percentage positivity , ± 
SD) for the group of 12 sheep tested weekly for 14 weeks post  
infection. Bars represent the 95 percent confidence interval.  
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Figure 2.3.4 Fluke faecal egg counts in eggs per gram (epg) for 12 
individual sheep (1-12) tested weekly for 14 weeks post  infection.  
 
Note that due to insufficient faecal sample availability for FEC testing 
only a proportion of samples  were tested at the following time points:  
W7 (n=8 samples tested),  W8 (n=9 samples tested), W10 (n=11 
samples tested), W12 (n=10 samples tested),  W13 and 14 (n=11 
samples tested).  
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Figure 2.3.5 Mean fluke faecal egg counts (± SD) in eggs per gram 
(epg) for the group of 12 sheep tested weekly for 14 weeks post 
infection. Bars represent the 95 percent confidence interval.  
 
 
 
 
Figure 2.3.6 The correlation between FEC (epg) and PP (%) values on 
14 wpi (n=11 samples tested).  
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 Evaluation of coproantigen ELISA and FEC to detect efficacy of 2.3.2
triclabendazole 
Following TCBZ treatment, four out of six treated sheep (numbers 2, 3, 7 and 11) 
remained persistently positive by cELISA from 0 to 10 dpt (Table 2.3.1).  At 5 dpt, 
one treated sheep recorded a negative cELISA result and the PP value remained 
below the cut-off value over the remainder of the sampling timeframe (ranged PP = 
0 to 4.21). The remaining treated sheep tested negative by cELISA at 8 dpt recording 
a PP value of 5.67, below the 9.32% cut-off but recorded a PP value of 8.31 at 9 dpt 
prior to recording another negative value of 3.29 at 10 dpt. When the FEC test was 
used to detect infection two out of six treated sheep were negative when sampled on 
7 dpt but one sheep recorded a positive FEC again at 8 dpt and the other at 10 dpt 
(Table 2.3.2). The daily mean PP values and mean FEC (± SD and the 95% CI 
levels) over the 10 dpt sampling timeframe are shown in Table 2.3.3. Comparing 
control and treated groups of sheep revealed statistically significant differences in 
the cELISA PP values from 4 to 9 dpt but no statistically significant difference was 
observed at day 10 post treatment (see Table 2.3.3 and Figure 2.3.7). Although, 
treated sheep continued to shed fluke eggs right up until 10 dpt FEC were 
statistically significantly lower from 5 dpt, when compared to control sheep (see 
Table 2.3.3 and Figure 2.3.8). There was a statistically significant difference between 
the two groups, however, on the first 3 dpt, there was an overlap between the 
standard errors of coproantigen levels for treatment and control groups (Figure 
2.3.8).  
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Table 2.3.1 Fasciola hepatica coproantigen ELISA values (PP, percentage positivity) from 0-10 dpt for sheep treated 
with triclabendazole  (10 mg/kg) per os compared to untreated controls.  The cut -off value (PP > 9.32%) for a positive 
result .  
 
Sheep ID 
Control 
                                                                                    Days post treatment 
                                                                                       PP (%) 
 Day 0 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 Day 9 Day 10 
1 112.6 105.16 111.48 104.19 104.69 109.19 100.51 104.74 97.79 98.26 104.6 
4 93.7 113.77 119.2 * 78.60 110.4 46.77 120.05 154.85 124.91 119.72 
6 122.93 110.68 98.49 105.28 87.08 93.42 92.82 94.99 91.68 89.06 118.63 
8 137.68 113.88 122.30 116.44 119.05 110.53 109.34 119.54 101.67 113.80 83.61 
10 132.49 115.57 113.86 * 98.62 106.81 84.71 104.91 95.95 93.52 71.54 
12 131.08 110.4 124.87 113.13 95.09 101.89 101.2 123.71 107.2 129.42 76.79 
                                                                                          
Treated                                                                                                      PP (%) 
 Day 0 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 Day 9 Day 10 
2 115.74 113.17 120.12 91.30 63.87 61.71 59.92 75.95 46.40 72.48 87.36 
3 115.72 115.97 115.26 78.99 42.49 38.52 55.02 43.34 29.68 25.97 45.85 
5 117.87 94.01 99.07 56.71 26.95 42.44 18.28 17.02 5.67 8.31 3.29 
7 126.06 117.30 120.14 90.84 63.27 72.48 91.74 83.18 66.62 76.23 108.78 
9 98.23 59.67 101.96 48.18 12.49 4.21 1.14 0.57 0 0.62 0.53 
11 124.46 121.86 121.47 88.12 60.92 53.89 52.66 31.70 44.16 19.24 19.12 
* Missing data; Note that bold values are representing positive coproantigen results 
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Table 2.3.2 Fasciola hepatica faecal egg counts (epg) from 0-10 dpt for sheep treated with triclabendazole  (10 mg/kg) 
per os compared to untreated controls.   
 
Sheep ID 
Control 
                                                                                    Days post treatment 
                                                                                       FEC (epg) 
 Day 0 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 Day 9 Day 10 
1 357.5 37.8 79.1 90.6 107.2 309.8 79.0 160.0 325.6 325.4 168.8 
4 814.0 245.3 494.8 * 667.0 343.6 160.5 432.2 460.5 287.6 233.0 
6 282.0 74.0 305.2 90.8 133.2 411.4 54.0 284.3 425.6 290.3 106.4 
8 535.6 * 129.8 97.2 692.8 422.0 388.6 392.0 450.6 276.0 93.2 
10 501.7 200.5 143.0 * 110.8 517.4 129.6 245.0 179.8 527.6 113.8 
12 360.0 39.0 116.0 135.6 140.0 250.0 131.2 285.6 198.8 251.6 48.8 
                                                                                          
Treated                                                                                              FEC (epg) 
 Day 0 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 Day 9 Day 10 
2 712.0 697.2 14.0 99.0 87.6 29.8 16.0 13.2 * 29.2 15.4 
3 397.5 277.2 283.0 79.6 194.2 21.8 13.2 7.2 7.0 1.4 1.2 
5 633.3 336.6 28.3 9.0 * 3.6 0.4 1.5 4.2 1.4 0.8 
7 391.8 84.5 44.8 31.2 * 29.6 45.2 16.6 23.25 17.4 1.2 
9 721.0 277.2 130.6 12.2 5.6 3.4 0.8 0 0 0 0.2 
11 479.0 217.6 93.6 3.0 3.6 1.2 2.0 0 0.6 0.2 0.6 
* Missing data 
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Table 2.3.3  Fluke egg counts (epg) and Fasciola hepatica coproantigen ELISA (PP, percentage positivity) from 0 -10 
dpt for sheep treated with  triclabendazole  (10 mg/kg) per os compared to untreated controls.  
 
Group                                                                               Days post treatment 
                                                                                epg (Mean ± SD) 
 Day 0 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 Day 9 Day 10 
Control 475.1 ± 
191.6 
119.3 ± 
100.0 
211.4 ± 
159.3 
103.6 ± 
21.6 
308. 5 ± 
288.1 
375.7 ± 
94.5 
157.2 ± 
119.8 
299.8 ± 
99.0 
340.2 ± 
126.4 
326.4 ± 
101.4 
127.3 ± 
64.6 
Treated 555.8 ± 
152.0 
315.1 ± 
205.9 
99.1 ± 
100.0 
39.0 ± 
40.6 
72.8 ± 
89.9 
14.9 ± 
13.7 
12.9 ± 
17.2 
6.4 ± 7.2 7.0 ± 9.5 8.3 ± 
12.2 
3.2 ±  
6.0 
p-value p=0.337 p=0.028 p=0.109 p=0.273 p=0.088 p=0.004 p=0.004 p=0.004 p=0.006 p=0.004 p=0.004 
                                                                                          
                                                                                                     PP (Mean ± SD) 
 Day 0 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 Day 9 Day 10 
Control 121.7 ± 
16.3 
111.6± 
3.7 
115.0 ± 
9.5 
109.8 ± 
5.9 
97.2 ± 
14.1 
105.3 ± 
6.7 
89.2 ± 
22.4 
111.3 ± 
11.4 
108.2 ± 
23.5 
108.2 ± 
17.0 
95.8 ± 
21.3 
Treated 116.3 ± 
10.0 
103.7 ± 
23.6 
113.0 ± 
10.0 
75.7 ± 
18.7 
45.0 ± 
21.6 
45.5 ± 
23.8 
46.5 ± 
32.2 
42.0 ± 
32.5 
32.0 ± 
25.6 
33.8 ± 
32.6 
44.1 ± 
45.3 
p-value p=0.423 p=0.631 p=0.873 p=0.201 p=0.004 p=0.004 p=0.037 p=0.004 p=0.004 p=0.004 p=0.078 
The Mann-Whitney test statistics on both fluke egg count and coproantigen level data for each group (n=6). Values shown represent the mean 
and standard deviation.
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Figure 2.3.7 Mean coproantigen ELISA levels (PP, percentage 
positivity) and bars represent the 95 per -cent confidence interval.  
 
 
 
 
Figure 2.3.8 Mean fluke egg counts in eggs per gram (epg)  and bars 
represent the 95 per -cent confidence interval.  
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 Fluke recovery 2.3.3
An infective dose ranging from 200-215 metacercariae was used to infect each of the 
12 sheep (Table 2.3.4). A total of 21 live adult fluke were recovered from the six 
TCBZ-treated sheep (one animal was negative) whereas 760 live adult fluke were 
recovered from the livers of the control F. hepatica-infected sheep (Table 2.3.4).  
This difference was shown to be highly significant by using the T-tests (p < 0.001).  
The efficacy of TCBZ was determined by percentage reduction in live adult fluke 
recovered post mortem in TCBZ-treated sheep compared to untreated controls. This 
represented a significant reduction of 97%.  
   
Table 2.3.4 Fasciola hepatica  cELISA (PP, percentage positivity),  
faecal egg counts (epg) and number of adult fluke recovered post  
mortem on 10 dpt for the six untreated control and six treated sheep.  
 
Sheep 
ID 
               Untreated control Sheep 
 
No. metacercariae 
given 
PP (%) FEC (epg) Fluke recovery 
1 203 104.60 168.8 129 
4 209 119.72 233.0 136 
6 200 118.63 106.4 78 
8 208 83.61 93.20 145 
10 213 71.54 113.8 122 
12 215 76.79 48.8 150 
                 Treated Sheep 
  PP (%) FEC (epg) Fluke recovery 
2 212 87.36 15.4 5 
3 210 45.85 1.2 1 
5 208 3.29 0.8 1 
7 203 108.78 1.2 13 
9 200 0.53 0.2 0 
11 208 19.12 0.6 1 
(Note that bold values are representing positive coproantigen results) 
 
 
65 
 
 Detection of Fasciola hepatica infection by PCR from faeces 2.3.4
A comparison of the three published PCR assays (see Table 2.2.1) was performed.  
All PCR assays reliably detected F. hepatica DNA when the template was extracted 
from adult parasites or purified eggs from the gall bladder, however, only the ITS2 
PCR gave a reliable positive result when DNA from a known F. hepatica positive 
faecal sample was used (Figure 2.3.9). Using DNA extracted from two 18 wpi sheep 
faecal samples the optimal dilution factor of the extracted faecal DNA was identified 
as a 1:50 dilution (Figure 2.3.10), although typically both 1:10 and 1:50 dilutions 
were subjected to PCR.  
When the optimised ITS2 PCR was applied to the faecal samples from the sheep 
experimentally infected with F. hepatica no consistent amplification was seen for 
any individual sheep at each timepoint from 0 to 4 wpi, 8 and 10 wpi (Figure 2.3.11). 
The PCR reaction did appear to amplify a product of the correct size from 
individuals 1, 3, 5, 7, 8 and 11 at 0 wpi (Figure 2.3.11 A) which was prior to 
infection but faeces for these animals did not record a positive result at later 
timepoints (Figure 2.3.11 C and D). The ITS2 PCR recorded a few samples as fluke-
DNA positive at later timepoints (Figure 2.3.11 F and G) but did not detect fluke 
DNA in faecal samples from all sheep at 8 and 10 wpi even though the majority of 
these faecal samples were confirmed positive by FEC and cELISA (Figure 2.3.1).  
 
 
 
66 
 
 
 
Figure 2.3.9 Composite agarose gel showing the products obtained by 
ITS2, Cox-1 (nested) and RAPD PCR using DNA extracted from 
faecal samples from two sheep 18 wpi (duplicate samples  of sheep A 
and sheep B).   
 
PCR methods used: A = ITS2 PCR, B =  Cox -1 nested PCR and C = 
RAPD PCR. Lanes 1-6 –  1. Sheep A1 ,  2. Sheep A2 ,  3. Sheep B1 ,  4. 
Sheep B2 ,  5. positive control and 6. negative  control. A 100bp ladder 
(M) was used as a molecular size marker.   
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Figure 2.3.10 Composite agarose gel showing the products obtained 
by ITS2 PCR using DNA extracted from faecal samples from two 
sheep 18 wpi at three dilutions: undiluted, 1:10 dilution and 1:50 
dilution.  
 
Lanes 1-16 –  1. negative control, 2. positive control, 3. Sheep A 1  
undiluted, 4.  Sheep A 2  undiluted, 5.  Sheep B1  undiluted, 6. Sheep B2  
undiluted, 7.  Sheep A 1  1:10, 8.  Sheep A 2  1:10, 9. Sheep B1  1:10, 10. 
Sheep B2  1:10, 11. Sheep A1  1:50, 12. Sheep A2  1:50, 13. Sheep B1  
1:50, 14. Sheep B2  1:50, 15. positive control  and 16. negative control.  
A 100bp ladder (M) was used as a molecular size marker.  
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Figure 2.3.11 Composite agarose gel showing the products obtained 
by ITS2 PCR using DNA extracted from faecal samples from the 12 
sheep experimentally infected with Fasciola hepatica .   
 
Each of the 12 animals was subjected to faecal sampling and PCR at 
several time-points throughout infection: A = 0 wpi,  B = 1 wpi, C = 2 
wpi, D = 3 wpi, E = 4 wpi, F = 8 wpi, G = 10 wpi. Lanes 1-12. Sheep 
1-12, 13. Positive control and 14. Negative control.  A 100bp ladder 
(M) was used as a molecular size marker.  *denotes samples not run in 
PCR as insufficient faecal material was available.  
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2.4 DISCUSSION 
In vivo and in vitro tests, incorporating both experimental and natural infection 
studies in sheep, have been developed for the detection of F. hepatica infection and 
to test for populations resistant to TCBZ (Flanagan et al., 2011b; Gordon et al., 
2012b; Hanna et al., 2015; Novobilsky et al., 2012; Robles-Pérez et al., 2013). 
Despite their availability few studies compare the three diagnostic tools; FEC, 
cELISA and new PCR assays for detecting early infection of liver fluke in 
experimentally infected sheep, hence the study reported here.  
 
 Sensitivity of the coproantigen ELISA 2.4.1
This experimental study confirmed that the cELISA is sufficiently sensitive to detect 
early fluke infection between 5 wpi to 8 wpi (Figure 2.3.1). Several studies using the 
BIO K 201 cELISA report detection of F. hepatica by 5 wpi (Flanagan et al., 2011b) 
and between 7 to 9 wpi (Flanagan et al., 2011a) in experimentally infected sheep. 
Martinez-Perez et al. (2012) also confirmed that the infection of liver fluke were 
detected by 4 wpi in experimentally infected sheep.  In cattle, infection of liver fluke 
was identified by cELISA between 6 to 8 wpi (Brockwell et al., 2013). Other studies, 
using the same ELISA as in the present experiment, have shown that coproantigen 
were found as early as 5 wpi (Mezo et al., 2004) and after 4 to 7 wpi before fluke 
egg shedding in F. hepatica-infected sheep (Valero et al., 2009). Similar findings 
were observed with naturally infected sheep which show the sensitivity of this 
commercial ELISA kit (Hanna et al., 2015).  
In our study, following metacercarial challenge, the cELISA increased steadily from 
6 wpi and reached a peak for individual animals and as a group mean at 11-12 wpi 
(Figure 2.3.2 and 2.3.3); at which point cELISA values reached a plateau and did not 
continue to rise between 12 and 14 wpi (Figure 2.3.3) suggesting once patency is 
reached the amount of coproantigen released remains relatively stable.  It is 
suggested that immature fluke may produce lower amounts of excretory-secretory 
antigens (Mezo et al., 2004) presumably due to their smaller size but once patency is 
achieved it appears that levels of coproantigen remain the same.  In the present 
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study, the percentage positivity (PP %) cut-off value for a positive result was 
calculated according to the manufacturer’s recommendations but the actual cut off 
value varied between batches of plates, ranging from 6.55% to 9.32%  as 
recommended by the manufacturer.  
Following treatment the cELISA values between TCBZ treated and control groups 
were statistically significantly different (Figure 2.3.7).  This is in agreement with 
results from a cELISA in cattle, infected with a TCBZ-susceptible isolate of F. 
hepatica, where all TCBZ-treated animals produced negative cELISA results by 7 
dpt (Brockwell et al., 2013). Following treatment of this TCBZ susceptible isolate of 
F. hepatica at the recommended dose of TCBZ four out of six treated sheep 
remained positive by cELISA for the duration of the trial (except for sheep 11; 
negative FEC but positive cELISA on day 7 pt). For treated sheep 9 and 5, a negative 
result was reported for cELISA however they were positive for FEC (Table 2.3.3). 
We can conclude from our findings for these two animals that coproantigen negative 
sheep contained fluke eggs in their faeces whilst the other four sheep recorded both 
positive cELISA and FEC values from day 0 to 10 pt (except for treated-sheep 11; 
zero fluke egg but 31.7% PP value on day 7 pt; Table 2.3.3).  This is in agreement to 
previous studies where evidence of false negative results was reported (Gordon et al., 
2012b; Novobilsky et al., 2012). These false negative results probably reflect the 
sensitivity of cELISA when using this test on natural infected sheep. The reason for 
the discrepancy in their findings (Gordon et al., 2012b; Novobilsky et al., 2012) and 
our findings with experimental infected sheep remains to be determined. 
Ten dpt the highest PP value amongst treated sheep was reported for the animal that 
was infected with 13 parasites, which was the general trend through the 0-10 dpt 
timeframe (Table 2.3.1) but  sheep found to have 5 and 1 parasite at post mortem 
also had values well above the PP positive cut-off value. Similar results have been 
reported by other studies (Brockwell et al., 2014; Mezo et al., 2004).  This shows 
that the cELISA is able to detect very low fluke infections even with one fluke 
(Mezo et al., 2004). The present study proved that even as few as one fluke that 
survived drug treatment, as with sheep 3 and 11, can record a high level of 
coproantigen in the faeces. However, one sheep with 1 parasite at slaughter was 
negative by cELISA but positive by FEC, thus indicating that BIO K201 cELISA 
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may give false negative results. Due to inconsistent results found in this study, this 
diagnostic test requires further investigation. Given that a susceptible isolate of F. 
hepatica was used to infect the sheep in this study, it raises questions over how to 
interpret post treatment and cELISA values.  It has been suggested that the reason for 
continued release of coproantigen is due to disintegrating fragments of flukes that 
may still be present by 10 days post TCBZ treatment (Flanagan et al., 2011b). 
Flanagan et al. (2011b) also confirmed that cELISA results remained positive in the 
control Cullompton sheep group and were largely absent at 2 wpt for the TCBZ-
treated Cullompton (TCBZ susceptible) sheep groups whereas for TCBZ-treated 
Sligo (TCBZ resistant) sheep groups, the cELISA results remained positive. In these 
studies live flukes were recovered from animals infected with the Sligo isolate, and 
dead fluke from those sheep infected with the Cullompton isolate (Flanagan et al., 
2011b) which is in contrast to our findings where we recovered liver fluke from the 
host even though a TCBZ susceptible isolate was used. 
 
 Sensitivity of the FEC  2.4.2
Eggs were first recovered from one sheep infected with 200-215 metacercariae as 
early at 7 wpi (Figure 2.3.1). These findings are in agreement with another study, 
which examined fluke eggs at 7 wpi, but this was in rats that have a shorter pre-
patent period (Paz-Silva et al., 2002). By 11 wpi all sheep tested positive, indicating 
the presence of mature liver fluke (Figure 2.3.1). Other studies have shown that F. 
hepatica eggs are first detected a bit later between 8 to 10 wpi in mice (O'Neill et al., 
2000), and in sheep from weeks 10 and 12 pi (Dumenigo and Mezo, 1999) or even 
later, between weeks 11 to 16 pi (Rodriguez-Perez and Hillyer, 1995; Zimmerman et 
al., 1982).  More recent studies reported that sheep were positive for the first time by 
egg count sedimentation method at 10 wpi (Flanagan et al., 2011b), at 9 wpi 
(Martinez-Perez et al., 2012) and 12 wpi (Flanagan et al., 2011a). In the present 
study, after metacercarial challenge, the number of eggs shed in faeces increased 
from 9 or 10 wpi and reached a peak for individual animals and as a group mean at 
14 wpi (Figure 2.3.4 and 2.3.5); reflecting the time taken to reach patency of 
infection as described in other studies (Flanagan et al., 2011b; Mezo et al., 2004) but 
also suggests that, in contrast to coproantigen, the numbers of eggs shed continues to 
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increase even once patency has been reached. Our findings clearly demonstrate the 
relationship between egg shedding in sheep faeces from 7 to 11 wpi and the period 
of development from ingestion of metacercariae by sheep and development to the 
adult fluke that sheds eggs onto the pasture between 10 to 12 weeks (Andrews, 
1999). 
For both treated and control groups, prior to treatment (Week 0 to 14 pi) FEC 
showed variation within individual animals (Figure 2.3.4). Post-treatment, F. 
hepatica egg counts fluctuated greatly in both the treated and control group sheep 
(Table 2.3.2). Fluctuations of FECs were observed in the present study, where 
animals changed from positive to negative to positive again. Two treated sheep 9 and 
11 have shown that at 7 dpt, individual epg was zero count.  No eggs were seen for 
two consecutive days post treatment for sheep 9 but became positive again at 10 dpt.  
As for sheep 11, it consistently became positive again at 8, 9 and 10 dpt. These 
observations are in accordance with the results from other studies as discussed above 
(Brockwell et al., 2013; Flanagan et al., 2011a). Similar results have been confirmed 
by others that natural fluctuations in epg occurred for F. hepatica and identified this 
as a limitation of this test (Honer, 1965; Mezo et al., 2004).  Observation of variation 
in FEC and possible reasons why are discussed in Chapter 3 but this does not detract 
from the overall FECRT result. In this study sheep were slaughtered at 10 dpt which 
is a little earlier than in other studies so there is the possibility that negative FEC 
would have been reported if the experiment was extended and necropsy had taken 
place slightly later. 
Only one out of six of the treated animals was FEC negative at 10 dpt and the 
presence of a total of 21 parasites at 10 dpt is consistent with the shedding of low 
numbers of eggs at this timepoint. These observations are in accordance with the 
results from other studies (Brockwell et al., 2014; Mezo et al., 2004).  
 
 Comparison of the cELISA and FEC 2.4.3
In contrast, the study reported here used an experimental approach involving the 
infection of multiple sheep to determine the TCBZ susceptibility of the isolate 
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because it is known that there can be sheep to sheep variation in drug efficacy and 
that parasites exist as populations of genetically distinct individuals. Results of this 
study confirm that FEC was less sensitive at detecting liver fluke infection compared 
to the cELISA in these 12 individual sheep (Figure 2.3.1).  The first detection of 
fluke eggs in faeces at 7 wpi in one animal is two weeks later than the first positive 
by cELISA.  Several studies in experimentally infected sheep using the cELISA BIO 
K 201 have shown that the infection is detected by 5 wpi, 5 weeks earlier than eggs 
(Flanagan et al., 2011b) and 2.5 and 3 weeks earlier, respectively (Flanagan et al., 
2011a). Martinez-Perez et al. (2012) also confirmed in experimentally infected sheep 
that detection of liver fluke by cELISA was possible at 4 wpi, five weeks earlier than 
detection of eggs by FEC. In the present study, after metacercarial challenge, 
coproantigen levels increased gradually from 6 wpi (Figure 2.3.2) whereas FEC did 
not increase until 9 or 10 wpi (Figure 2.3.4) reflecting that the cELISA detects 
infection in the prepatent period (Flanagan et al., 2011b; Mezo et al., 2004).  Several 
studies have focused on correlation on fluke burden between cELISA and FEC 
(Brockwell et al., 2014; Brockwell et al., 2013). In this study there is a clear lack of 
correlation between FEC (epg) and PP (%) values (Figure 2.3.6) which may be due 
to the fact that the cELISA is less quantitative and that PP levels reach a peak even 
when FEC values continue to rise (Figure 2.3.3 and 2.3.5), probably as peak egg 
production / fertility may not be achieved until a certain age.  It is likely that there is 
variation in the amount of coproantigen released as flukes mature in post infection 
period, alternatively it could be argued that the cELISA gives a better indication of 
the number of adult parasites present as the peak in coproantigen coincides with the 
10-12 week patency window. At a practical level, a limitation of the FEC method is 
that a larger weight of sample is required and it was not always possible to collect a 
sample of sufficient weight which meant that it was not possible to test all animals at 
every timepoint. On the other hand the reduced volume for the cELISA meant that it 
was possible to test every animal at each timepoint. 
 
 Fluke burden in treated and control groups at postmortem 2.4.4
This current study confirmed that the reduction in fluke burden after treatment with 
TCBZ was 97%. Thus confirming that this was a susceptible isolate of F. hepatica 
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according to published criteria (Gordon et al., 2012a). Researchers from The 
Netherlands working on resistant isolates of F. hepatica from mixed cattle and sheep 
farms experimentally infected sheep with susceptible and resistant isolates and found 
high efficacies of TCBZ against these strains; 99.8% whereas 10.8% efficacy was 
reported for resistant strains of F. hepatica (Gaasenbeek et al., 2001). Our results 
showed that treated sheep continued to shed eggs on the day of slaughter and showed 
very low numbers of eggs (range of 0.2 to 15.4 epg) at the end of the trial (Table 
2.3.4). The presence of a positive FEC in all six treated sheep and the presence of 
adult fluke at post mortem reflects that parasite populations have genetic variation 
meaning that some parasites within a drug susceptible population survive treatment 
and that drugs are never 100% effective.  
Correlation between fluke burden at necropsy and cELISA and FEC is shown in the 
Appendix 2.5. Our data showed good correlations between fluke burden when 14 
wpi coproantigen levels were used (R
2
 = 0.642; p = 0.32) but very weak correlation 
for FEC (R
2
 = 0.045; p = 0.39).  However, on the day of slaughter (10 dpt), both 
coproantigen levels and FEC for the six control sheep correlated weakly with fluke 
burden, R
2
 = 0.265 (p=0.70) and R
2
 = 0.001 (p=0.39), respectively. This agrees with 
other studies that confirmed weak correlation was found between FEC and fluke 
burden (Charlier et al., 2008; McConville et al., 2009). Abdel-Rahman et al. (1998) 
also detected low correlation between fluke burden and egg production (R
2
 = 0.39) 
in early studies in cattle.  However, unexpected results were reported by Brockwell 
et al. (2013) that detected strong correlation (R
2
 = 0.8368) between FEC and number 
of flukes recovered at the day of slaughter. A strong correlation between 
coproantigen and fluke burden at slaughter was reported in several studies: in cattle 
(R
2
 = 0.96) (Abdel-Rahman et al., 1998), R
2
 = 0.87 in cattle (Brockwell et al., 2013), 
R
2
 = 0.79 in lambs (Mezo et al., 2004) and R
2
 = 0.69 in cattle (Charlier et al., 2008).  
However this is on contrast to our findings and given the inherent variation in 
cELISA values, even in the same animal over time (Table 2.3.1), it is difficult to 
draw conclusions as the correlation is different depending on which dataset within 
the experiment is used (Appendix 2.5).   
 
75 
 
 PCR  2.4.5
PCR-based technique is an extremely sensitive diagnostic tool that may simplify the 
diagnosis of parasitic infection. This method successfully detects even a very small 
amount of DNA.  However, despite this superior sensitivity, our experiments have 
shown limitations in detecting F. hepatica infection. One main challenge when 
preparing samples is that faecal specimens contain mixtures of host cells, microflora, 
complex polysaccharides, bile salts and other materials which can act of inhibitors to 
PCR (Monteiro et al., 1997; Radstrom et al., 2003) by inactivating Taq polymerase 
and, may also degrade nucleic acids and reduce efficiency of the test (Radstrom et 
al., 2004).   
In the current study, sheep which had been confirmed to have infection with liver 
fluke by cELISA and FEC were negative by PCR, this PCR negative result likely 
indicates unsuccessful amplification of fluke DNA from infected faecal samples with 
the ribosomal ITS2 primers (Robles-Pérez et al., 2013) or inhibition of PCR due to 
chemicals within faeces.  However this finding contradicts the findings of studies 
conducted in Spain (Martinez-Perez et al., 2012; Robles-Pérez et al., 2013).  
Martinez-Perez et al. (2012) showed that PCR to amplify a 423 bp fragment of 
mitochondrial DNA from faecal samples was able to detect F. hepatica infection in 
sheep as early as 2 wpi with a nested-PCR (Cox2_F and LrRNA_R primers) and 
from 3 wpi  using a standard PCR (Cox1_F and Cox1_R primers). This means that 
infection has been detected during the pre-patent period of F. hepatica and so the 
PCR techniques were more sensitive than cELISA and FEC.  Subsequently this 
finding was confirmed by Robles-Pérez et al. (2013) who also detected F. hepatica 
infection in the second wpi in sheep from the faecal samples. This earlier detection, 
using a standard/nested PCR, was based on amplification of a 292 bp fragment of the 
ITS2 rather than a 423 bp fragment of mitochondrial DNA.  
The majority of work conducted for this project was on optimisation of the two PCR 
assays (standard and nested) developed by Martinez-Perez et al. (2012) and later the 
ITS2 PCR by Robles-Pérez et al. (2013). The PCRs were initially trialled using 
known F. hepatica positive samples: adult F. hepatica DNA, DNA recovered from 
infected sheep faecal samples from 14 or 18 wpi and DNA recovered from F. 
hepatica eggs recovered from either the gall bladder or faecal samples. These 
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samples were confirmed positive to F. hepatica using the RAPD PCR (McGarry et 
al., 2007), however results from these trials were inconsistent so troubleshooting and 
further optimisation was performed.   
Four areas of interest were explored: (i) quantity of faeces used for DNA extraction 
(ii) process of DNA extraction – two different commercially available kits – Qiagen 
and Nucleospin (iii) dilution factor of the extracted faecal DNA and (iv) optimization 
of the annealing temperature.  Each variable was taken in turn using the F. hepatica 
positive samples mentioned above.  
i. Quantity of faecal DNA.  In trials conducted by Martinez-Perez et al. 
(2012), DNA extraction appears to have been conducted using 2 g of sheep 
stool samples. However, when we attempted to replicate this we found the 
size of the sample difficult to handle. Therefore we used 250 mg of faeces 
as recommended from the QIAamp DNA Mini Stool Kit.  Attempts to 
quantifying 250 mg from F. hepatica positive samples from infected sheep 
on 14 wpi, however, gave us low yields of DNA and inconsistent bands on 
standard and ITS2 PCR as well as a negative RAPD and nested PCR result 
(data not shown).  Therefore the quantity of DNA was increased to 0.5 g of 
faeces as described by Robles-Perez et al. (2013).  Following quantification 
it was found that by increasing the faecal sample from 250 mg to 0.5 g we 
had increased the quantity of DNA extracted from 1.53 ng/µl to 25.77 
ng/µl; faecal samples from infected sheep on 14 wpi and 18 wpi, 
respectively. On this basis, we might expect to amplify F. hepatica DNA 
during PCR but this was not successful. We suggest that this is due to 
increasing the level of PCR inhibitors in the samples due to the larger 
sample volume.  
ii. DNA extraction kit. DNA extraction was performed using a QIAamp® DNA 
Mini Stool Kit (Qiagen Ltd, UK) and Nucleospin
®
 Tissue (Macherey-
Nagel) and the DNA yield was measured. Based on extraction of DNA from 
250 mg of faeces taken from a sheep 14 wpi that was positive for F. 
hepatica showed that the Qiagen extraction method produced higher DNA 
yields compared to Nucleospin kit (data not shown).  However, all 
extraction samples were negative for F. hepatica using the RAPD PCR. 
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When using the standard PCR as developed by Martinez-Perez et al. (2012) 
positive results were obtained from the Qiagen kit but negative results from 
the Nucleospin kit. Therefore, by using the Qiagen Kit, we increased the 
DNA yield and successfully amplify the target DNA. Moreover, by using 
the QIAamp DNA Mini Stool Kit, it is possible to eliminate PCR inhibitors. 
Previous studies have shown that inhibitors can partly be removed from 
human stool samples by using QIAamp tissue methods (Monteiro et al., 
1997). There are also several options to eliminate the PCR inhibitors during 
extraction.  For example, by using magnetic beads or bead beater methods 
to remove or inactivate PCR inhibitors from faecal samples (Smith et al., 
2011; Wehausen et al., 2004). Therefore future approaches will need to 
carefully design sample preparation and DNA extraction to minimise the 
level of PCR inhibitors. 
iii. In samples where PCR inhibitors persisted, diluting the template DNA (by a 
factor 50) prior to PCR helped remove the inhibiting effects (Monteiro et 
al., 1997).  However, we have difficulty of achieving the right DNA dilution 
in our study as for some samples, a 1:10 dilution was sufficient to eliminate 
the inhibitors.  
iv. Optimization of annealing temperature. Although previous studies used an 
annealing temperature of 63
o
C (Martinez-Perez et al., 2012; Robles-Perez et 
al., 2013) this temperature did not produce a positive result in our 
laboratory. Therefore our approach in this study trialled four different 
annealing temperatures 54°C, 57°C, 63°C and 65°C to optimise the 
annealing temperature for the ITS2, standard and nested PCR  (data not 
shown). An annealing temperature of 54°C cannot be used as this 
temperature resulted in non-specific amplification likely because it was too 
low  the primer could bind imperfectly thus very faint bands were detected.  
Furthermore, if the annealing temperature was too high (65°C), the primers 
are not able to bind to the denatured template DNA (with no bands observed 
in this trial) (Hecker and Roux, 1996).  However since changing the 
annealing temperature did not improve the efficiency of the PCR, the 
annealing temperature of 63°C was maintained, as it had been shown to 
work in previous experiments. Visible results were observed when 
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annealing temperature was lowered to 54°C, 57°C or even higher, the 
annealing temperature of 63°C was maintained in this experiment. 
In summary we attempted to transfer the published PCR method to our laboratory 
and despite extensive optimisation it was not possible to reproduce a PCR test that 
accurately detected F. hepatica infection prior to 8 and 10 weeks post infection and 
even at these later timepoints post infection animals positive by cELISA and FEC 
were negative by PCR. 
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CHAPTER 3  
Improving the Design of the Composite FECRT to Detect 
Triclabendazole Resistance in Fluke Populations 
 
3.1 INTRODUCTION 
Parasitism is one of the most important constraints on farming systems in the United 
Kingdom and other regions of the world. These include gastrointestinal 
trichostrongylid nematodes and liver fluke trematodes.  Their effects on health, 
production and welfare are mainly dependent on the intensity of infection.  Drug 
control strategies have been used by farmers to control the parasites in the livestock 
and due to their extensive use, has resulted in the emergence of anthelmintic-
resistant strains particularly in F. hepatica in sheep.  Thus, reliable assays to detect 
anthelmintic resistance in populations of parasites are required for assessment of 
effective control of parasitic infections.  This detection can be made with several in 
vivo and in vitro tests and there is a need to standardize and validate these tests, 
particularly for F. hepatica in sheep.  Historically, most tests have been developed 
for nematode parasites of livestock, resulting in the guidelines of World Association 
of the Advancement for Veterinary Parasitology (WAAVP).  Therefore, methods for 
detecting resistance in this chapter have been based on the WAAVP guidelines for 
detection of anthelmintic resistance in nematodes (Coles et al., 1992). 
The in vivo method that is most widely used in the field is the faecal egg count 
reduction test (FECRT).  FECRT is the test to estimate anthelmintic efficacy using 
faecal egg counts (FECs).  The test compares the number of parasite eggs recovered 
in faeces taken before and after treatment or by comparing counts in faecal samples 
of treated and untreated sheep, the latter group acts as a control group (Coles et al., 
1992).  Sufficient adult parasites must be present in order to produce enough eggs for 
diagnostic test purposes. The FECRT is also favoured as it can be used with all 
anthelmintic classes. The interval between treatment and post treatment sampling 
should be shorter than the pre-patent period of the parasites for drugs with no 
residual activity and the interval between treatment and post treatment sampling 
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depends on the type of anthelmintic being evaluated. For example, an interval of 3-7 
days is recommended for levamisole, 8-10 days for benzimidazoles and 14-17 days 
for macrocyclic lactones  (Coles et al., 2006). Differences in post treatment sampling 
intervals depend on drug pharmacokinetics, excretion, persistence and their efficacy 
in removing different parasite life stages.  Misinterpretation of anthelmintic efficacy 
whether false negative or false positive results could occur if resampling is done 
outside of these ranges. For example, a study by Grimshaw et al. (1996) falsely 
indicated the presence of levamisole resistance and gave misleading results in the 
FECRT.  This study showed that % FECRT on samples taken 11 and 20 dpt with 
levamisole was 80% and 78%, respectively; however this is due to the maturation of 
immature stages that produce egg in that time period and hence underestimated the 
efficacy of the drug. Therefore, 3–7 days is recommended as this does not allow time 
for maturation and patency of immature infection at the time of resampling, but 
excludes the period of temporary egg suppression in resistant strains; usually up to 3 
days post treatment (Coles et al., 2006), which may lead to a false “susceptible” 
result. 
Anthelmintic resistance in nematode populations affecting sheep, is defined as a 
reduction in FEC of <95% (arithmetic mean) with a minimum pre-treatment count of 
150 egg per gram (epg) for individual FEC according to the WAAVP Guidelines 
(Coles et al., 1992).  In small ruminants, resistance is defined as being present if the 
reduction in FEC (arithmetic mean) is less than 95% and the lower 95% confidence 
level is less than 90% (Coles et al., 1992).  The WAAVP guideline determines that if 
only one of the two criteria is met, anthelmintic resistance is suspected.  However, 
such limits have not been defined for F. hepatica and these thresholds may not be 
applicable for F. hepatica populations or flukicide classes, hence the FECRT has not 
been fully standardised for this worm.  Coles et al. (2001) suggested that suspected 
resistance in trematodes in the field needs confirming by an experimental study; e.g. 
an isolate collected from the field is used to experimentally infect animals, which are 
dosed and then slaughtered and parasites enumerated (Wood et al., 1995). For liver 
fluke, the only reliable test for triclabendazole (TCBZ) resistance in F. hepatica in 
the field is a ‘dose and slaughter controlled study’, as described by Coles et al. 
(2001) and Gordon et al. (2012a).  Suspected TCBZ resistance can be diagnosed by 
using FEC and coproantigen reduction tests and these have been validated using the 
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WAAVP approved ‘dose and slaughter controlled study’ (Gordon et al., 2012a).  
These authors showed that FEC and the coproantigen ELISA (cELISA) were useful 
in detecting resistance. Killing animals is not possible for routine diagnosis of 
resistance, thus the FECRT is one of the few available tests for diagnosing resistance 
in liver fluke in live animals. Other diagnostic tests for detection of TCBZ resistance 
of F. hepatica include PCR (Robles-Perez et al., 2013), but we found in 
experimental infected sheep (chapter 2) that PCR’s evaluated did not detect 
infection.  Therefore, in the present study, we have used the FECRT and, as there are 
no agreed guidelines that define presence of resistance to TCBZ, we have defined 
suspected resistance if the percentage reduction in composite FECs is less than 90% 
based on a previous study (Daniel et al., 2012). In field studies, drug efficacies from 
0 to 60% have been reported when resistant F. hepatica was present (Gordon et al., 
2012b).  Furthermore, drug efficacies from 0 to 21% have been reported when sheep 
were experimentally infected with TCBZ-resistant F. hepatica isolates (Flanagan et 
al., 2011a).   
 
 Distribution of Faecal Fluke Egg Counts within populations of sheep 3.1.1
The first surveys of the distribution of liver fluke infection in sheep took place in the 
1950s in The Netherlands (Honer and Vink, 1963a).  Condemned lambs' livers from 
the slaughter house allowed researchers an insight into the variation in fluke burden 
in sheep. The study modelled parasite distribution as following a negative binomial 
pattern.  A subsequent survey, by the same group of researchers (Honer and Vink, 
1963b) found that the pattern of infection in cattle was similar to that described for in 
sheep in the previous study. The studies also showed that the annual patterns of liver 
fluke infection in sheep and cattle are different; sheep and lambs are exposed to 
continuous infection and may have a different physiological reaction to the infection 
whereas in cattle, exposure is interrupted by different times of housing (Honer and 
Vink, 1963b).  Daily variation of F. hepatica egg counts in individual cattle were 
described in housed cattle in the winters of 1963 to 1964 and 1964 to 1965 (Honer, 
1965). The authors found that marked fluctuations of FECs occurred on five 
different farms, suggesting temporal variation within individual animals and inter-
farm variations may partly explain these differences. The quantity of faeces 
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produced by individual animals on each farm is under the influence of management 
activities; e.g. feeding, milking and other husbandry issues (Honer, 1965).  Other 
available evidence describing the distribution of Fasciola eggs in cattle faeces was 
conducted by Duwel et al. (1990).  The bulls were infected with a varying number of 
metacercariae and the study was carried out for six months.  Daily range of variation 
and distribution of fluke eggs were determined three times a day (morning, noon and 
afternoon). The authors have shown that the distribution of fluke eggs was 
inconsistent within one day and the excretion of the eggs varied widely at each 
timepoint between animals and in each infection group (Duwel and Reisenleiter, 
1990).   
The pattern of nematode egg output in sheep has been described.  Previous work has 
shown that nematode FEC in populations of sheep follow a negative binomial 
distribution (NBD) (Barger, 1985; Stear et al., 2006; Stear et al., 1995).  A majority 
of individual hosts carry low numbers of parasites whereas a small number of hosts 
tend to have higher FEC (Gregory and Woolhouse, 1993). Other factors which will 
affect the overdispersion are the intensity of infection; heavily infected flocks tend to 
show less overdispersion (Daniel et al., 2012).  An estimate of the NBD is defined 
by two parameters; the mean and k, an inverse index of overdispersion.  Studies in 
fluke infected animals have shown high values of k at high mean FECs, suggesting a 
lower degree of overdispersion (Daniel et al., 2012). For example, if sheep are 
sampled in late autumn, this is when animals have been exposed to infection; a 
composite FECRT would give reliable results even though fewer samples are used 
whereas it is challenging to conduct this test during summer as fluke burdens maybe 
lower. It has been suggested that time and size of last infection could affect the 
observed degree of overdispersion in gastrointestinal nematodes (Morgan et al., 
2005), but it is not known how this may affect distribution of fluke eggs.  
A fundamental question has been to determine what affects the distribution of 
parasites within and between hosts.  Age, sex, grazing history etc. are likely to affect 
FEC aggregation. For example, males tend to be more heavily infected than females, 
the reason for which may be differences in immune system.  Also, FECs tend to 
increase with age, then may plateau in older animals, possibly again as a result of the 
deterioration of immune function, although egg counts may decline again, thus 
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reducing the degree of parasite aggregation (Hayward et al., 2009).  Other factors for 
variation of parasite load among sheep populations may include genetic differences 
in susceptibility to infection, condition of the host, behaviour, seasonality and 
geographical area. 
The success of TCBZ treatment can be evaluated by measuring the reduction in fluke 
FEC following treatment.  This is usually based on the detection of F. hepatica eggs 
in individual sheep in experimental infections or under natural infection in the field 
(Flanagan et al., 2011a; Flanagan et al., 2011b; Hanna et al., 2015). Individual FEC 
can be uneconomical, labour intensive and time consuming.  Hence there is a move 
to use composite faecal egg counts to reduce costs for farmers (Daniel et al., 2012).  
However egg counts vary over time within animals and between animals and these 
factors should be taken into account when developing both a FECRT and a 
composite FECRT. Overdispersion of individual FEC within a population has been 
described in nematodes, but less is known about overdispersion of F. hepatica FEC 
within populations of sheep naturally exposed to infection. Furthermore, there are 
several limitations for FECRT including animal-related and farm-related variability 
in FEC data. For example, differences in grazing management between farms will 
impact parasite infection intensities in sheep.  When sheep are grazed in marshy 
areas or farms have fields with poor drainage, this may result in heavy infection of 
fluke in sheep, whereas other farms may have very light infection pressure, thus 
causing large differences in the distribution of pre-treatment FECs between farms. 
Spatial differences due to geographical location of the farms as well as temporal 
differences, including year to year variation in rainfall and the season in which 
sampling is conducted can also play important role in the variability in FECs. 
Furthermore, the non-uniform distribution of eggs in faeces from individual sheep, 
combined with variation in daily egg output may all impact on FEC.  Other factors 
include the inability to measure drug efficacy in the pre-patent phase of infection 
leading to false negative counts and false positive FECs might occur due to the 
release of fluke eggs stored in the host’s gall bladder, even though the flukes have 
been successfully eliminated following drug treatment.  
Recently, for the practical purposes, a composite FECRT (cFECRT) has been 
developed and this test was validated for use in the field for detecting TCBZ 
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resistance in sheep (Daniel et al., 2012). With the cFECRT, pooled faeces from two 
groups consisting of 10 sheep each are tested; 5g of faeces are used from each sheep 
to create a composite sample of 50g and the total egg count for each composite is 
recorded. A particularly challenging issue when developing cFECRT is how 
overdispersion of fluke egg counts can affect the accuracy of this method and the 
sensitivity of a composite test as opposed to conducting counts on each individual 
sheep. There may be a larger degree of overdispersion of fluke eggs in composite 
samples associated with a large variance in egg counts between the 10 sheep which 
make up the composite.  But it has been shown that composite samples from 2 
groups of 10 individual sheep per sample are adequate to detect the reduced efficacy 
of TCBZ in the field (Daniel et al., 2012).   
Other factors can limit the accuracy of cFECRT in the laboratory.  First, it is difficult 
to thoroughly mix the composite samples and eggs may be trapped in higher fibre 
densities. If more fibre is present due to the larger quantities of faeces used, the more 
difficult it is to count the eggs in the Petri dish under the microscope. Secondly, if a 
large number of fluke eggs are present, it is hard to do an accurate count compared to 
counting smaller numbers of well-distributed eggs. However, regardless of these 
issues, when equal amounts of faeces from 10 sheep are mixed together compared to 
a single individual sample, the assumption is that the mean egg density in the 
composite faecal sample equals the sum of the egg density in individual sheep. 
Daniel et al. (2012) showed that the number of sheep required for the cFECRT was 
20.  If the total composite pre-treatment count is 100 or greater, a second set of 
samples from the same animals is collected 21 days after treatment.  However, in 
practise, gathering the same 20 sheep for resampling is often difficult, therefore the 
first aim in this chapter was to determine if the same sheep had to be sampled both 
pre- and post treatment. By using data from two sheep farms, we determined if the 
same 20 sheep required sampling pre- and post treatment, or if a random sample 
from the population could be sampled on the two different occasions.  
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 Identifying an optimal time-point for resampling   3.1.2
The detection of F. hepatica infection is based on the observation of fluke eggs in 
faeces. For the diagnosis of drug efficacy, the cFECRT has been evaluated, which 
measures composite counts at day 0 pre-treatment and 3 weeks post treatment with 
TCBZ.  The reason for using the timepoint, 21 days post treatment was based on 
studies in the literature which showed fluke eggs can be retained in the gall bladder 
after successful treatment with flukicidal drugs (Flanagan et al., 2011a).  Therefore 
the 3-week interval was selected to ensure that residual eggs had been flushed out of 
the gall bladder.  Other studies have shown good results for a FECRT with a 7 day 
period between pre- and post-drench (Brockwell et al., 2013; Gordon et al., 2012b).  
For practical purposes, asking farmers to wait 3 weeks for the results of the FECRT 
leads to some non-compliance and also welfare issues if a resistant population of 
fluke are present, so providing data on drug efficacy in a timely manner is important.  
Hence the second aim of this study was to evaluate an earlier time point (7 days) for 
collection of post treatment samples.  In addition, the cELISA which proved to be 
more sensitive in detecting early infections in sheep in Chapter 2 was evaluated with 
field samples alongside the FECRT.  
 
3.2 MATERIALS AND METHODS 
 Study 1 3.2.1
 FEC distributions on two farms  3.2.1.1
Two farms (farm 1 and farm 2) were recruited to the study in order to investigate the 
distribution of FEC within a population of sheep.  Faecal samples were collected 
from all 44 sheep from farm 1 and all 105 sheep from farm 2 and individual faecal 
counts conducted using the sedimentation method (2.2.2). Farm 1 was sampled in 
June 2012 whereas for farm 2 faecal samples were collected in October 2012. 
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 Study 2 3.2.2
 Comparisons of two time points post-treatment for resampling  3.2.2.1
A total of five farms (farm A, B, C, D and E) from Wales participated in this study 
which was collaboration between the University of Liverpool (Department of 
Veterinary Parasitology) and Farming Connect, Wales.  Pre- and post treatment 
samples from five farms were collected by the farmer or a representative from 
Farming Connect, Wales.  On each farm, 20 sheep were identified at random, 
divided into two groups of 10; Group 1 and Group 2, and each group colour-coded. 
Individual faecal samples from Group 1 and Group 2 were then mixed together for 
composite counts.  Faecal samples were collected on day 0 pre-treatment and then 
sheep were treated with TCBZ at 10 mg/kg
 
at a dose set to the heaviest sheep within 
the group.  Faecal samples were collected from all sheep from Group 1 and Group 2 
at day 7 and day 21 post treatment using the same procedure.  Samples were sent to 
the University of Liverpool for testing individual and composite FECs and cELISA. 
 
 Parasitology Techniques 3.2.3
 Individual Fluke Egg Counts (FECs)  3.2.3.1
FECs were performed using the sedimentation technique as described in Section 
2.2.2 (chapter 2) and in Appendix 2.1 (Anon, 2007).   
 Composite Fluke Egg Counts (cFECs)  3.2.3.2
Five grams of each faecal sample was pooled with the other samples from same 
group to make a total of 50 g to form the composite sample, which was then mixed 
thoroughly with water in a 500 ml beaker and sequentially passed through 710 μm, 
150 μm and 38 μm sieves.  The material retained by the 38 μm sieve was then 
transferred to a large square petri dish and a drop of methylene blue was added. The 
total numbers of eggs were counted under a dissecting microscope and eggs per 50 
gram (ep50g) were calculated.   
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 Coproantigen ELISA 3.2.3.3
The cELISA (BIO K 201, Bio-X Diagnostics, Jemelle, Belgium) was conducted 
according to the manufacturer’s recommendations on individual faecal samples as 
described in previous chapter (Section 2.2.2 in chapter 2 and Appendix 2.3).  For 
composite faecal samples, 0.5 g of faeces from each of the 10 sheep per group were 
used to make the 5 g composite, and then  mixed up with 20 ml of the dilution buffer 
in a 50 ml tube.  Each sample was homogenized for 10 s using the vortex and the 
tubes were then centrifuged at 1,000 x g for 10 min.  Following centrifugation, the 
supernatant was collected and stored in 1.5 ml Eppendorf tubes at -20°C until 
needed.  A full Standard Operating Procedure (SOP) for this procedure is given in 
Appendix 2.3.   
Coproantigen values were expressed as the percentage positivity according to the 
formula; % = (Mean OD of the sample / Mean OD of positive control) x 100.  The 
cut-off of the percentage positive (PP) value was 6.65% as supplied by the BIO K 
201 kit manufacturer. 
Statistical analysis  
The percentage FEC reduction was calculated based on the WAAVP 
recommendation for nematodes.  For the composite counts, the %FECR was 
calculated as (1[-post-treatment count/pre-treatment count]) x 100. Faecal egg counts 
were compared using the Kruskal-Wallis test (SPSS statistical software, release 20.0; 
SPSS Inc., USA) with results applied at the 5% level of significance. With the SPSS 
program, the Spearman rank correlation coefficient R was computed for linear 
correlation analysis.  A P value of .05 or less was considered to indicate a 
statistically significant difference by using R. Basic descriptive statistics (mean, 
standard deviations and median) were computed for each variable and table and 
graphs of the data were produced using Microsoft Excel (Microsoft Office 2010). 
Bootstrapping analysis was conducted by Ms Christina Gill, the mean FEC 
calculated 10,000 times by using a function in R (version 2.10.0 2010, R).  The mean 
estimate and 95% confidence intervals were then calculated and the entire process 
was iterated 10,000 times.   
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3.3 RESULTS 
 Does the distribution of egg counts within populations of sheep from two 3.3.1
different farms follow a negative binomial distribution? 
Table 3.3.1 gives the mean, median and range of Fasciola FEC values on farm 1 and 
farm 2.  Eggs from Paramphistomum spp. were detected in samples obtained from 
both farms but were not counted in this study.  The mean FEC was higher on farm 1 
compared to farm 2 (Table 3.3.1). The distribution of egg counts for farm 1 and farm 
2 is illustrated in Figure 3.3.1, showing that the distribution of FECs are 
overdispersed, with most sheep having low counts but a small number having high 
counts.  Figure 3.3.2 shows three common statistical distributions fitted to the FECs 
from farm 1.  The negative binomial distribution fitted the data best.  The results 
were similar for farm 2.  By using chi-squared goodness of fit test, the NBD 
provided a significantly better fit than the Poisson distribution.  Due to the high 
number of individuals with zero counts, a zero-inflated model was also tested but did 
not improve the fit to the data.   
 
 
Table 3.3.1 Mean, median and range of egg counts per 5 g (ep5g) of 
faeces sampled on two different farms.  
 
Farm  No. of 
sheep 
Mean  Median  Range  
1 44 30.41  9 0 – 259 
2 105 5.90  0 0 – 115 
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Figure 3.3.1 Observed faecal egg counts frequency distributions for 
two different farms i) Farm 1 and ii) Farm 2.  
 
i) 
ii) 
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Figure 3.3.2 The FEC data for farm 1 was analysed to identify the 
model which best fi tted the distribution, either a normal distribution 
(black l ine), a negative binomial distribution (red line) or a Poisson 
distribution (blue line).  The results showed that the negative binomial  
distribution fit ted the data best.     
 
 
 For the FECRT do we need to sample the same 20 sheep pre-treatment 3.3.2
and post-treatment? 
We used a bootstrap analysis to simulate sampling 20 sheep from our two 
populations (farm 1 and farm 2) 10,000 times.  Analysis for farm 2, with 105 sheep, 
showed that the calculated mean FEC after 10,000 re-iterations was within the range 
of the true mean ± 5% in 5.3% of cases and in 10.5% of cases for farm 1 with 44 
sheep.  On both farms the spread of the mean FECs for different random samples 
was large, with 95% being between 11.7-55.6 and 0.6-15.25 eggs per 5g for farm 1 
and 2, respectively. These results suggest that to detect a 90% reduction in faecal egg 
counts, the same 20 sheep should be sampled pre- and post treatment (see appendix 
3.1 for analysis summary).   
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 Can the post-treatment samples be collected at day 7 or day 21? 3.3.3
Five farms submitted samples for the FECRT.  Samples from two groups of the same 
10 sheep were taken at the time of treatment (day 0), day 7 and 21 post treatment.  
Composite FECs were carried out for each group at each timepoint.  The composite 
samples were also tested by cELISA.  In addition, individual counts for each of the 
20 sheep were conducted and individual samples were also tested in the cELISA. 
Four of the farms had pre-treatment composite counts of less than 100 eggs and were 
excluded from this analysis.  The cut-off of 100 eggs in composite count is required 
due to potential underestimation of pre-drench faecal egg count (Daniel et al., 2012). 
Table 3.3.2 summarises the data for the composite FECs taken pre-treatment, 7 and 
21 days post treatment.  The total composite FEC on day 7 post treatment was 115 
eggs compared to 69 on day 21 post treatment.  The percentage reduction in FEC on 
day 7 was 21% compared to 52% on day 21.  These results suggest that sampling on 
day 7 would over estimate the level of resistance on this farm. Table 3.3.3 
summarises the composite cELISA PP values and composite counts recovered at day 
0 (pre-treatment) and day 7 and 21 post treatment for groups 1 and 2.  In group 1, 
there was an increase of composite FEC from 48 eggs to 110 eggs on day 0 and day 
7, respectively and decreased to 37 eggs on day 21.  The results for composite FEC 
for group 2, give a lower number of eggs recovered from day 7 (5 eggs) and rose to 
32 eggs on day 21; on day 0, 97 eggs were detected.  These results were illustrated in 
Figure 3.3.3 together with the composite cELISA at each of the three timepoints.  
Composite coproantigen results were positive at each sampling point.  Overall, the 
samples collected 7 days after treatment with TCBZ, showed a large increase in PP 
values in both groups, thus indicating that sampling at day 7 potentially 
overestimated the resistance on this farm. For day 21, both tests showed a reduction, 
indicating that sampling on day 21 was a better time point to assess treatment 
efficacy.  This was determined further by calculating the correlation between the 
composite FEC and cELISA (Figure 3.3.4). Weak correlation was found (R = 
0.0365) indicating there was no correlation between composite FEC and cELISA, 
thus suggesting that cFECRT is more effective at detecting resistance to TCBZ 
compared to the composite cELISA.    
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Table 3.3.2 The composite faecal egg counts,  carried out using 2 
composite samples from 10 individual sheep (n = 2 x 10) on different 
sampling timepoints from farm A.  
 
Sampling Total composite FEC % FECR 
Day 0 145 - 
Day 7 115 21% 
Day 21 69 52% 
 
 
Table 3.3.3 The composite faecal egg counts and coproantigen ELISA 
(PP), carried out from 2 composite samples from 10 individual sheep 
(n = 2 x 10) on different sampling timepoints from farm A.  
 
Sampling Composite 
FEC 
Composite  
    PP 
Composite 
    FEC 
Composite  
    PP 
 Group 1 Group 1 Group 2 Group 2 
Day 0 48 15.3   97   61.92 
Day 7 110 76.42   5   96.59 
Day 21 37 14.88   32   8.51 
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i)                                                     
 
 
ii) 
 
 
Figure 3.3.3 Composite counts (eggs/50 g) (blue dashed -dots line) 
and coproantigen ELISA (PP, %) level (red dots  line) from farm A for 
i) Group 1 and ii) Group 2.   The coproantigen ELISA positive cut -off 
value is 6.55% (green dashed line).  
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Figure 3.3.4 Correlation between composite counts (eggs/50 g) for 
two groups of 10 sheep sampled on day 0, 7 and 21. The positive cut -
off value is 6.55% (red dashed line).  
 
 
 Is there a correlation between individual FEC and Coproantigen results? 3.3.4
Figure 3.3.5 summaries FEC from 20 individual sheep from all five farms.  For farm 
A the individual FECs remained positive after treatment on 7 and day 21. The total 
numbers of eggs found was 1311 on day 7 post treatment compared to pre-treatment 
samples was 2359 eggs and treated sheep continued to shed fluke eggs 21 days 
following treatment, at which point 869 eggs were detected.  Low or zero fluke egg 
counts were recorded on the other four farms and they were excluded from the study.  
However, on farm C, eggs were recovered on day 21 post treatment, despite the zero 
pre-drench FEC values.  The composite FEC also detected eggs (128 eggs) at day 21 
but was zero count on day 0 and 7 (data not shown).  
There was no significant difference by using the Kruskal-Wallis test (p > 0.348) in 
total egg counts of 20 individual sheep FECs between day 0 pre-treatment and day 7 
and day 21 post treatment on farm A (Figure 3.3.6). Furthermore, a visual inspection 
of their histogram and normal Q-Q plots (data not shown) showed that the 
distribution of FEC was not normally distributed either on day 7 or 21 post 
treatment, with a skewness of 3.319 (SE = 0.512) and a kurtosis of 12.231 (SE = 
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0.992) for day 7 post treatment and a skewness of 1.856 (SE = 0.512) and a kurtosis 
of 3.713 (SE = 0.992) for day 21 post treatment.   
The mean epg results of both groups on farm A at all sampling points (mean ± 
standard deviation) and median (min-max) are shown in Table 3.3.4. Faecal egg 
counts and cELISA were carried out on 20 individual sheep at each timepoint on 
farm A, the results are shown in Table 3.3.5.  Number of eggs recovered from each 
individual sheep varied widely.  The results show one animal with negative FEC on 
day 0, and three and two sheep were negative on day 7 and 21 post treatment 
respectively. For the cELISA, of these 20 animals, 9 sheep were positive for 
coproantigen on day 0 and number of positive animals increased to 13 on day 7. 
Only 8 animals had positive cELISA results by day 21. One sheep whose cELISA 
was positive had a FEC of 8.6 epg, however one sheep with 10 epg had a negative 
coproantigen result.  
The correlations of the FECs and cELISA (PP) values for individual animals over 
the 3-time point sampling period are shown in Figure 3.3.6.  The correlation between 
the two tests varied between days of sampling, with R
2
 values of 0.0468 (p = 0.360), 
0.5492 (p > 0.0001) and 0.0923 (p = 0.1926), respectively, for day 0, 7 and 21. 
These results show that there is a highly significant relationship between FEC and 
cELISA on day 7 post treatment but not at the other two timepoints. 
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Figure 3.3.5 Results of total fluke egg counts (sum of ep5g for each 
individual sheep) for 20 sheep tested on day 0 pre -treatment, day 7 
and day 21 post treatment for the five farms . 
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Figure 3.3.6 Fluke egg counts for 20 sheep from farm A sampled on 
0, 7 and 21 days post  treatment.   
 
Whiskers indicate minimum and maximum values, boxes indicate 25
t h
 
and 75
t h
 percentile values and the dash indicates the median values.  
Note that  the outliers for ‘out’ values (small circle) and ‘far out’ 
(marked with a star).  
 
 
Table 3.3.4 Mean fluke egg counts (epg) and PP values on day 0, 7 
and 21 for sheep from farm A, treated w ith triclabendazole on day 0.  
Values shown represent the mean, median and standard deviation.  
 
Day of 
sampling 
Epg 
(Mean ± SD) 
PP 
(Mean ± SD) 
epg 
Median  
(min-max) 
PP 
Median  
(min-max) 
Day 0  23.6 ±32.3 11.8 ± 19.3 10.5 (0.2-119)   5.8 (0-87.4) 
Day 7 13.1 ± 24.0 23.3±27.6 6.0 (0-105.2)   11.1 (0-88.0) 
Day 21 10.5 ± 12.6 10.9 ±16.0 6.3 (0-42.4)   3.2 (0.33-65.9) 
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Table 3.3.5 Individual counts, both on FEC (epg) and coproantigen 
ELISA (PP, %) were taken from 20 sheep at day 0 pre -treatment, day 
7 and 21 post treatment. The positive cut -off value for coproantigen 
ELISA is 6.55%.  
 
 
Sheep  Day 0  Day 7  Day 21  
 FEC PP FEC PP FEC PP 
1 2 0.16 42.4 57.56 0 1.07 
2 3 5.93 1.0 2.61 3.4 2.36 
3 0.8 27.84 22.2 46.13 10.0 2.95 
4 7 9.35 13.0 34.47 8.2 2.04 
5 70.4 6.77 0.4 13.96 24.8 19.99 
6 1.4 3.38 0 0.23 24.4 18.15 
7 0.2 4.97 0 0 0.2 21.75 
8 0.8 0 6.6 23.19 1 21.37 
9 14 0.77 0.2 11.87 0 0.84 
10 0.8 3.85 11.4 39.27 42.4 33.13 
11 49 87.36 105.2 88.00 18.0 8.44 
12 0 0 1.0 10.48 4.4 1.58 
13 5 5.62 5.4 5.77 2.3 0.33 
14 21.2 11.61 1.0 8.51 0.4 1.60 
15 14.6 11.73 16.0 1.96 36.0 6.79 
16 44.0 24.66 7.4 17.21 8.6 65.89 
17 119.0 2.79 15.0 88.69 10.0 2.36 
18 24.0 3.98 12.0 8.81 0.2 0.96 
19 75.0 14.45 0 1.23 15.8 3.53 
20 19.6 10.87 2 6.46 0.6 3.82 
NB: bold values  represent positive coproantigen results; i ndividual  
sheep were not eartagged, so sample 1,  day 0 does not correspond to 
the same sheep as sample 1,  day 7 or day 21. 
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Figure 3.3.7 Faecal egg counts (epg) and 
coproantigen ELISA (PP, %) levels for i) Day 0 
pre-treatment ii)  Day 7 and iii)  Day 21 day post  
treatment. The posit ive cut-off value is  6.55% 
(red dashed line).  
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3.4 DISCUSSION 
 Study 1 3.4.1
The variability of egg distribution patterns of F. hepatica in sheep has not previously 
been fully addressed. Due to this lack of information, results in this study provide a 
baseline of information regarding patterns of egg distribution in naturally infected 
sheep and highlight the degree of variability in fluke egg output between individual 
sheep and between farms.  
The analysis of the FEC from a total of 149 sheep on two farms, with different levels 
of exposure showed that a high number of zero counts were detected and the pattern 
of egg output followed a negative binomial distribution.  However, the results on 
these farms were limited to FEC data, the location of the farm and the season when 
the samples were collected.  No data were collected on animal signalment such as 
age, date of birth, sex and breed, all of which have been shown to be significantly 
associated with egg count variation in nematodes (Stear et al., 1995).  Those 
variables were influenced by the time of sampling and size of last infection (Morgan 
et al., 2005).  This finding is in agreement with our study.  In our study, farm 1 was 
sampled in June (summer) whereas for farm 2, samples were collected in October 
(autumn).  Different stages of the parasite would have been present in the sheep at 
these times of year.  In the summer, it is likely that adult parasites are present, either 
a residual burden acquired the previous autumn, or derived from metacercariae 
picked up from the pasture in spring. In contrast, in October, the majority of the 
fluke burden would most likely be juvenile flukes, derived from metacercariae 
released as a result of the summer infection of snails.  These parasites would not be 
sufficiently mature to be shedding eggs.  The FEC was higher for farm 1, sampled in 
June. However other factors can also influence egg ouput such as  differences in 
exposure on sheep farms in different regions, depending on the farm environment 
and management practices (Vercruysse and Claerebout, 2001).  Studies of F. 
hepatica have shown that the excretion of fluke eggs varies at different timepoints 
and their distribution is inconsistent at the individual level and within animals over 
time (Duwel and Reisenleiter, 1990).  Similarly, FECs following natural nematode 
infection are very variable both within and between animals (Stear et al., 2006).  Our 
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results confirmed that fluke egg output is best described by a negative binomial 
distribution but we did not obtain any further data on variation in egg output within 
individual animals over time.   
The general principles of infection patterns were applied in the present study with 
the understanding that parasite count data is often overdispersed and this can be 
defined by a NBD (Stear et al., 2006; Stear et al., 1995).  Helminth infections are 
often characterised by being overdispersed with a large proportion of the population 
having low egg count (e.g. high number of zero counts as seen in our data).  A study 
by Barger et al. (1985) revealed that, in nematodes, a NBD provided a good 
description of the distribution of four trichostrongylid species; Haemonchus, 
Ostertagia, Trichostrongylus and Nematodirus.  In contrast, not all FECs in sheep 
population or parasite distributions amongst hosts showed a good fit to the NBD 
(Bliss and Fisher, 1953; Stear et al., 1995).  Studies conducted in natural nematode 
infected sheep have reported that the dominant species is T. circumcincta, and these 
data show that due to the presence of other species (Cooperia spp., Trichostrongylus 
axei and vitrinus) a poor fit of the NBD was observed. In this regard, it is 
complicated because these other species can all contribute to the egg count and their 
eggs are morphologically indistinguishable and the biotic potential differs between 
different nematode species. In the present study, we also detected eggs of 
Paramphistomum spp. on both farms, suggesting that this species can also be 
involved in egg count in sheep, however we specifically excluded paramphistome 
eggs in our counts and our data followed a good fit of NBD.   
The concept of bootstrapping was introduced by Efron (1979). Using this approach 
is useful to estimate the population distribution using information based on re-
sampling from a known sample. Bootstrapping has been used extensively with 
equine FECRT data (Denwood et al., 2010; Kaplan, 2002) and were also applied to 
fluke FECRT data on sheep farms to evaluate the method used in the current study 
(Daniel et al., 2012).  In the present study, our results convincingly showed by using 
bootstrapping methodology, resampling the same 20 sheep gave us the most reliable 
method of estimating the FEC reduction rather than sampling another randomly 
identified 20 sheep on the second sampling visit.  This is supported by the 
recommendation provided by the WAAVP and also from other recent studies (Hanna 
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et al., 2015).  In the cFECRT method, in which 20 sheep are sampled before and 
after administration of drug, this number of sheep was validated taking into 
consideration the variation in FEC due to differences in FEC across individual sheep, 
time of sampling etc (Daniel et al 2012).  Other parasites and other systems also 
show heterogeneities in parasite loads and exhibit a highly aggregated distribution 
and this leads to some individuals that harbour low egg counts and interestingly, one 
host can excessively contribute to high egg count (Anderson and May, 1991).  This 
was also apparent from our data, when individual counts were done, in several 
groups, one sheep of the 20 sampled, had excessively high counts compared to the 
other sheep (Table 3.3.5). The second factor affecting the sampling method used is 
the number of sheep in the flock.  In a small flock, if they are resampled at random, 
it is more likely that sheep that were sampled on the first occasion will be resampled. 
In contrast in a large flock, it is likely that different sheep will be sampled. 
Increasing the number of samples taken is another option, however, the analysis 
conducted by Daniel et al. (2012) showed that increasing the sample size up to 60 
sheep, did not improve the power of the method.   
We have used a threshold of a reduction of less than 90% to indicate evidence of 
resistance.  However it remains unclear whether this indicates true reduced efficacy 
for fluke infections in sheep.  Different cut-off values have been used; for nematodes 
< 95% reduction is used based on WAAVP guidelines and other studies in horses 
have used < 90% reduction to detect BZ resistance (Kaplan and Nielsen, 2010).  
Using a reduction threshold of < 90% to determine efficacy is an arbitrary value and 
until we know the exact variation in FECs as well as the genetics of resistance and 
the flow of genes in a population of fluke, it is difficult to define a definitive cut-off. 
Experimental infections with F. hepatica susceptible isolates have shown FEC 
reductions of between 95 and 100% by 14 to 28 days dpt, supporting our choice of 
90% as a conservative estimate of susceptibility (Flanagan et al., 2001a).  
In conclusion, this study highlights that FECs vary in naturally infected sheep within 
a population and between different populations and sampled at different times.  In 
order to avoid making erroneous conclusions regarding the final interpretation of 
drug efficacy in the field, we propose to examine the same 20 sheep for pre- and post 
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treatment egg counts per farm but suggest that more information is required before a 
reduction of < 90% can be used definitively to indicate true resistance.  
 Study 2 3.4.2
This study sought to determine if the post treatment sample could be taken on day 7 
pt rather than on day 21 pt, which is the current recommended time interval. The 21 
day period between treatment and resampling is based on the suggestion that eggs 
can be trapped in the gall bladder even after the death of the parasites (Fairweather, 
2011b; Flanagan et al., 2011a; Gordon et al., 2012b; Mitchell et al., 1998).  Data 
from the experimentally infected sheep described in Chapter 2, showed that the FEC 
had declined by 98% by 7 days post treatment.  Hence we compared day 7 and day 
21 pt in a field situation. 
Of the five farms which participated in this study, only one had sufficiently high pre-
treatment counts to complete the study. Our findings showed that on both day 7 and 
day 21 pt the %FECR was < 90% indicating that resistance was present on this farm. 
However the %FECR was 21% on day 7 and 52% on day 21, suggesting that by 
waiting until day 21 pt is likely to reduce the risk of over estimating resistance.  This 
interval will allow ample time for the disintegration of susceptible adult fluke 
following treatment and allow for the clearance of any fluke eggs potentially stored 
in the gall bladder.  In experimental studies in which a FECRT was used, a reduction 
in the efficacy of TCBZ was calculated at 14 dpt although this period of sampling 
was not tested in the present study (Flanagan et al., 2011a).  In comparison, other 
studies have used a 21 days period following treatment for the diagnosis of drug 
efficacy in sheep (Daniel et al., 2012; Hanna et al., 2015). From our experimental 
trial (chapter 2), FECs and cELISA were still positive on day 10 pt using a 
susceptible isolate.  In that study 4/6 treated sheep still had a positive egg count but 
the %FECR was 98% on day 7 pt.  However the results from farm A in this study 
suggest that waiting 21 days may be more accurate, especially if resistant parasites 
are present. Variation in the shedding of fluke eggs after treatment with TCBZ has 
been reported in the literature (Flanagan et al., 2011b) which discusses the issues of 
the late immature fluke migratory stages, which mature during the 3 week period 
between treatment and resampling and can potentially lead to an increase in the FEC 
if the fluke are resistant to the drug used. In contrast, experimental study in cattle 
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have shown good results for FECRT at 7 dpt; all six treated animals had returned to 
FEC negative (Brockwell et al., 2013) and in naturally infected sheep, treatment 
success was recorded within one week of treatment with TCBZ (Gordon et al., 
2012b).  Re-sampling at day 14 pt also showed good results which suggest that it is a 
suitable interval between pre and post treatment sampling to calculate the drug 
efficacy. Studies have shown that in naturally infected sheep, treated with closantel, 
oxyclozanide and nitroxynil, FEC was reduced by 100% by 14 dpt but not in the 
case of TCBZ-treated sheep (Mooney et al., 2009), in the study performed by 
Flanagan et al. (2011a) a 95% FEC reduction at day 14 pt were reported for TCBZ-
susceptible F. hepatica infected sheep. Based on our study, a 3 week interval 
between treatment and sampling is needed to detect loss of TCBZ efficacy in the 
field.     
The FECRT currently used in the field to detect evidence of drug failure is based on 
composite FECs (Daniel et al., 2012). However data from the experimental infection 
in chapter 2 suggested that the cELISA was more sensitive at detecting early 
infections.  Hence we evaluated the coproantigen test for its ability to detect 
infection and resistance in the field. The results for farm A showed that the 
composite cELISA increased on day 7 pt and then declined, but remained above the 
positive threshold on day 21 pt.  There was no correlation between the composite 
cELISA and the CFEC. Nevertheless the cELISA supported the conclusion that 
resistance was present on this farm, but the % reduction in PP value was not 
calculated.  Other studies have used the criteria of the PP value declining to negative 
by day 14 pt as assurance that treatment was successful (Flanagan et al., 2011b; 
Gordon et al., 2012b). 
The cELISA was evaluated in the present study using individual samples.  Results 
from farm A showed that positive coproantigen (PP values) were detected from 
13/20 sheep at 7 dpt compared to 9/20 sheep on day 0 (Table 3.3.5).  By day 21, 8/20 
sheep remained positive by cELISA.  Fluke eggs were detected in these animals.  
False positive and false negative results of FEC and cELISA are discussed in the 
previous chapter. In the present study, the discrepancy between FEC and cELISA is 
difficult to clarify, due to an absence of information about the actual fluke burden in 
these animals which could only be ascertained at post-mortem.  Similarly others 
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have shown that in the field, animals with low FEC, had negative cELISA values 
(Hanna et al., 2015).  However, results 21 dpt showed that many more animals give 
positive FEC than cELISA. Studies by Flanagan et al. (2011b) used 14 dpt as the 
resampling time-point and the authors reported that all sheep that were infected with 
TCBZ-susceptible F. hepatica and following TCBZ-treated sheep had zero 
coproantigen levels by 14 pt.  In practice, the coproantigen detection method will be 
useless if the test fails to meet the required level of sensitivity when applied on a 
large scale in a field-based study.   
The coproantigen values increased at day 7 pt in this study before declining on day 
21 pt.  Following drug treatment, for a sensitive population, adult fluke have been 
shown to die within 48 hours (Hanna et al., 2010), however all the fragments of the 
parasites are unlikely to be completely cleared before 7 dpt, hence the coproantigen 
levels detected at day 7 could be due to dead flukes that are releasing the F. hepatica 
coproantigen.  This highlights the importance of a pre- and post-drench time window 
in order to remove the dead fluke.  To avoid this problem, even though three weeks 
is a long time, the results from the present study validate resampling at 21 dpt.  
Moreover, the data from this field study taken together with the data from the 
experimental trial described in chapter 2, suggest that the cELISA requires further 
validation before it could be used to replace the cFECRT in the field. 
In conclusion, this study shows the sensitivity of cFECRT after drug treatment, 
comparing two different resampling time-points in naturally individual infected 
sheep.  Day 21 was identified as the optimum time point to collect the post-treatment 
sample to avoid the danger of over estimating resistance.  The commercial BIO K 
201 ELISA is a sensitive test, however in the present study, inconsistent results 
comparing the cELISA and FECs were obtained.  Evaluating the cFECRT in this 
chapter, has led to the conclusion that it is the optimum test to use in a wider field 
study to determine the prevalence of TCBZ resistance in the UK. 
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CHAPTER 4  
The Prevalence of TCBZ Resistance in Sheep Farms in the UK 
Using the Composite Faecal Egg Count Reduction Test 
 
4.1 INTRODUCTION 
Liver fluke infection caused by the trematode parasite Fasciola hepatica affects 
sheep and cattle in many parts of the world.  It is a common cause of morbidity and 
mortality in sheep and can cause acute, sub-acute or chronic disease.  In sheep, acute 
infection with liver fluke has a negative impact on their welfare, productivity and 
results in significant financial losses, costing the sheep farming industry millions of 
pounds every year.  Chronic fluke infection in sheep results in poor condition, 
reduced wool quality, submandibular oedema, apparent pneumonia (panting due to 
pain) and infertility (low scanning rates) (Sargison and Scott, 2011b). 
In the past, liver fluke disease (fasciolosis) in the UK has been a problem mainly 
during the late autumn and the late winter.  However, climate change is affecting the 
life cycle of F. hepatica and the distribution of the intermediate snail host, which has 
resulted in changes to the seasonal pattern of disease in the UK over the last few 
years (Charlier et al., 2011; Van Dijk et al., 2010).  Between 1995 and 2013, the 
incidence of fasciolosis rose in England and Wales as reported by The Animal and 
Plant Health Agency (APHA) (Anon, 2013).  Apart from changes in temperature, 
rainfall patterns and rising water levels caused by global warming , the spread of 
fasciolosis is also greatly influenced by the introduction of infected sheep to 
previously negative farms and regions (Mitchell, 2002), changes in farming practices 
associated with climate change and environmental regulations (Kenyon et al., 2009; 
Pritchard et al., 2005). 
The pro-benzimidazole anthelmintic, triclabendazole (TCBZ) is the drug of choice 
for acute fasciolosis in sheep due to its high efficacy against immature stages of F. 
hepatica (Fairweather and Boray, 1999a).  In sheep, clinical disease due to early 
immature liver fluke is a major problem and only TCBZ drug can kill this stage of 
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liver fluke from two days post infection.  Studies have found that at a dose rate of 10 
mg/kg, the efficacy was 93 to 98% against this age of fluke (Boray et al., 1983).  The 
authors also reported that at the dose rate of 5 mg/kg, the TCBZ had 92 to 98% 
efficacy against liver flukes aged four to eight weeks, respectively and 100% 
efficacy was achieved against 12 week old flukes.  A list of commercially available 
anthelmintics on the market for treatment of liver fluke infections is shown in Table 
1.2 and 1.3.  In the absence of vaccines for F. hepatica, these anthelmintics have 
historically been used in the control of fasciolosis.  However, there is evidence that 
TCBZ is losing its effectiveness due to the reliance on repeated TCBZ treatment to 
prevent acute disease.  It is now 30 years since the discovery and licencing of 
triclabendazole for prophylactic and chemotherapeutic use (Boray et al., 1983). As a 
result TCBZ resistance in F. hepatica populations in both sheep and cattle has 
emerged.  A major concern now has been raised over the extent of resistance to 
TCBZ in fluke populations.  The impact of not detecting the presence of TCBZ 
resistance on sheep farms can result in serious economic losses as well as affecting 
animal welfare (Sargison and Scott, 2011b).   
The first case of resistance was documented in naturally infected sheep in Australia 
(Overend and Bowen, 1995) and more recently resistance was reported in Great 
Britain (Daniel et al., 2010), Ireland (Mooney et al., 2009), Scotland (Gordon et al., 
2012b; Kenyon et al., 2009; Sargison and Scott, 2011b), Wales (Thomas et al., 2000) 
and a number of  other European countries (Alvarez-Sanchez et al., 2006; Brennan et 
al., 2007; Gaasenbeek et al., 2001).  The summary of resistance cases in the UK and 
worldwide are listed in Table 1.4 and 1.5.  Therefore, there are great concerns that if 
the resistance level to TCBZ in fluke populations has increased, sheep farmers may 
have limited alternatives to choose from. The resistance level will always be 
different on each farm and as such there is no single right answer to fluke control for 
everyone. 
There is pressing a need to identify factors that significantly influence drug 
resistance on farms.  Over reliance and repeated use of TCBZ is one of the factors 
that may result in drug resistance. However, there is a school of thought which states 
that anthelmintic resistance is over-diagnosed; if this is true, rather than perpetuating 
misinformation, this may actually lead to a heightened awareness of the issue and a 
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subsequent change to more sustainable drug use and parasite control management 
strategies, before overt resistance develops (Sargison and Scott, 2011a). Farm 
management also plays an important part in the development of drug resistance.  
Therefore, it is necessary to identify the risk factors associated with presence of 
resistance on farms in order to investigate any links with the development of 
anthelmintic resistance.  Fluke management practices such as pasture management, 
the drenching programme and choice of anthelmintics for the flock is very important 
for sustainable parasite control.  These factors also relate to climate change in the 
UK and this influences F. hepatica life cycle and survival of intermediate host snails 
(Charlier et al., 2011; Sargison, 2012). 
 
Aim of study 
The aim of this chapter was to investigate prevalence of resistance to TCBZ in fluke 
populations infecting sheep in the UK. Two studies were conducted: 1) sheep farms 
in the county of Cumbria in the North West of England, and 2) sheep farms located 
in three areas of Britain: South West England, Wales and North East England. The 
composite faecal egg count reduction test (cFECRT) was used to evaluate the TCBZ 
efficacy on these sheep farms. In study 2, questionnaires were sent out to the farmers 
to investigate anthelmintic utilization practices and on-farm sheep management to 
identify risk factors for drug resistance.  
 
4.2  MATERIALS AND METHODS 
 Study 1 4.2.1
This study was conducted in collaboration with a farmer’s co-operative group, the 
Cumbria Farmers Network (CFN).  The CFN was set up in October 2005 and has 
over 500 members in Cumbria (http://www.thefarmernetwork.co.uk/about-us/).  The 
farms that participated in this study were selected by the CFN such that selected 
farms were evenly distributed throughout Cumbria and were representative of all 
local farm types (hill or lowland) and soil types in the region.  Twenty farms were 
109 
 
initially included in the study, but only sixteen farms subsequently submitted 
samples. Of the sixteen farms, three had pre-treatment FEC below 100 eggs per gram 
(epg) and were therefore not included in the study.  Of the 13 remaining farms, 
samples were collected pre-treatment (day 0) and post treatment (on day 21). The 
field work was conducted from August to November 2013. 
 
 Study 2 4.2.2
On submission of a proposal and a confidentiality agreement and their subsequent 
approval, RADAR (Rapid Analysis and Detection of Animal-related Risks) provided 
details of 750 sheep holdings from the Agriculture census data in from three 
geographical areas of Britain, South West England, Wales and North East England. 
The details provided included name, address and flock size and included flocks with 
more than 200 adult breeding sheep.  A sampling strategy, stratified according to 
county and number of sheep farms according to the database, showed that 126 farms 
(sample size based on a prevalence of 20%, with 7% precision and 95% confidence) 
was required.  This estimate was based on two previous studies which showed that 
the prevalence of fluke infection in dairy herds in Britain was 76% (McCann et al., 
2010b) and prevalence of TCBZ resistance on sheep farms was 28% (Daniel et al., 
2012). In addition 12 study farms from the APHA’s SCOPS project also participated 
in the study.  The field work was conducted from December 2014 until April 2015. 
Ethical approval for both these studies was obtained through the University of 
Liverpool’s ethical review process (VREC82). 
The address list of sheep farmers, obtained from RADAR, was used in order to make 
primary contact and issue an invitation to join this study. Two hundred and fifty 
farms in the three areas were selected randomly from the list.  Each farmer was sent 
a pack containing an invitation letter to participate in the study (see Appendix 4.1), a 
consent form (see Appendix 4.2) and participant information sheet (see Appendix 
4.3).  Respondents were given the opportunity to read the participant information 
sheet that explain the purpose of the study and their participation in this survey was 
voluntary and anonymous.  It was also explained that there were no risk and harm to 
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completing a survey.  Respondents were requested to send back the consent form and 
sign the form as the confirmation that the farmer would like to participate in the 
study.   
It was also requested that samples should not be collected from sheep that had been 
treated with an anthelmintic for fluke within the past 3 months.  Once a farmer sent 
back the consent form agreeing to participate in the study, their details were given to 
APHA, York.  Staff from APHA then contacted and visited the farm to collect the 
faecal samples.  
 
 Questionnaire  4.2.2.1
The questionnaire was divided into six sections and consisted of 51 questions over 
nine pages.  See Appendix 4.4 for a copy of the questionnaire.  The questionnaire 
was comprised of six sections:  
i) The first section included the general information such as names, 
addresses and had to provide the background details of their respective 
farms.   
ii) The second section was entitled ‘About your sheep management’. This 
part was designed to understand participants’ management practices on 
various elements of farm and flock.  There were twenty questions 
comprised on both close-ended and open-ended questions for participants 
to describe all the aspect in their farm management that are undertaken to 
prevent the introduction of liver fluke infection. 
iii) The third section focused on liver fluke status of the farm (two close-
ended questions and one open-ended question). 
iv) The fourth section covered fluke control in regard to the use of 
anthelmintic product and drenching practices.  This part was designed to 
identify deworming history of the farm as well as investigating how the 
farmer handled their newly purchased sheep in particular deworming, 
before being turned out to the pasture. 
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v) The fifth section of the questionnaire asked about sheep fluke FEC. 
Participants were asked to describe their fluke control programme by 
response to: a) the frequency of using FEC, b) conducting any drug 
resistance test on the sheep, c) if yes, provided results of the test. 
vi) In the last section of the questionnaire, questions enquired about fluke 
control advice that was received by the participants.      
To increase the reliability and validity of the questions, the questionnaire was 
reviewed by three supervisors. They were asked to review the survey design and 
contents. Further work of developing the questionnaire evolved around the idea of 
one question for one minute and making the question as clear, short and not time 
consuming to the farmer.   
 
 Data collection 4.2.2.2
Questionnaires were distributed on the first visit to the farm.  Staff from APHA left 
the questionnaire with the farmer and collected it on the second visit 21 days post 
treatment. Data collection from the completed questionnaire survey were entered 
into an Excel database (Microsoft 2010) and for each individual farmer record, a 
numeric farm ID was created. Results of FECs were entered into the same spread 
sheets.  The originals of the completed questionnaires were kept confidentially at the 
Department of Veterinary Parasitology Office at University of Liverpool. 
 
 Parasitology techniques 4.2.3
 Composite Faecal Egg Count Reduction Test (cFECRT) 4.2.3.1
The cFECRT was used to establish drug efficacy. Floor faecal samples were 
collected from 2 groups of 10 sheep on day 0 and immediately afterwards animals 
were treated with TCBZ (Fasinex) using the recommended sheep dose.  Dosage was 
set for the weight of the heaviest animal in the group; on some farms, sheep were 
divided into groups according to weight to ensure the correct dose was used.  The 
dosing gun and Fasinex was provided by the project to ensure correct dosing 
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procedure and was supervised by APHA staff (Sargison and Scott, 2011a).  The 
faecal samples were sent to the University of Liverpool for processing. In the 
laboratory, the faeces were mixed up with plenty of water to make a faecal slurry.  
The faecal slurry was then washed through a sieve stack with sequentially smaller 
aperture sizes mesh (710, 150 and 38 μm).  Extra care was taken to prevent overflow 
through the series of sieves which can result when a large amount of sediment is 
retained on either of the bottom two meshes. Under running tap water, the faecal 
slurry was washed until the water running through the sieves was clean. The retained 
particulate matter containing eggs and debris on the 38 μm sieve was then rinsed into 
the 500 ml beaker. A simple sedimentation technique was performed. Fifty ml of the 
sediment was transfer to a petri dish and one drop of methylene blue was added. 
Eggs were counted under the dissecting microscope using 4 x magnifications. 
Twenty one days after the first sampling, faecal samples were collected from the 
same two groups of sheep. 
Statistical analysis  
The reduction in FECs was estimated on samples obtained before and after treatment 
with TCBZ by using the following equation: 
 
Reduction (%) = 100 -    post treatment counts   x 100 
                                         pre treatment counts 
 
Resistance, or TCBZ treatment failure, is declared when the percentage of reduction 
is less than 90%.  A reduction of FEC was calculated using the Microsoft Excel 
2010. 
Questionnaire survey results were analysed using descriptive statistics (Minitab 17.0 
statistical software).   
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4.3 RESULTS 
 Prevalence of Resistance to Triclabendazole in Cumbria, North West 4.3.1
England. 
Twenty farms were identified to take part in the study, four farms did not send 
samples for analysis and an additional three farms were excluded from the study 
because their pre-treatment FEC were below 100 epg.   
 For the remaining 13 farms, the percentage reductions in cFECRT ranged from 0-
79% and are presented in Table 4.3.1.  Resistance or drug failure, as defined as less 
than 90% reduction in FEC, was present on all farms with farms G to M, showing a 
0% reduction in egg output at 21 dpt.  The geographical location of each farm is 
shown in Figure 4.3.1. 
 
Table 4.3.1 Summary of pre-treatment, post -treatment and reduction 
(%) in composite faecal egg counts (in 50 gram of faecal samples) in  
sheep treated with 10mg/kg (Fasinex
®
;  Novartis) for 13 farms.  
 
Farm ID     Total eggs                               Total eggs 
                          Pre- treatment   Post treatment       %Reduction 
A   2991    640   79 
B   5316    1764   67 
C   4492    2380   47 
D   4062    2394   41 
E   6380    4793   25 
F   676    661   2 
G   218    497   0 
H   391    419   0 
I   243    406   0 
J   1545    3315   0 
K   4376    7947   0 
L   6954    13137   0 
M   21664    65000+  0 
 
 
 
114 
 
 
 
Figure 4.3.1  Map of the North of England showing the location of F. 
hepatica  resistance study farms in Cumbria (Red: 13 sheep farms).  
 
 Prevalence of Resistance to Triclabendazole in England and Wales. 4.3.2
A total of 250 farms were contacted from three different geographical regions areas 
of Britain; South West England (100 participant letters), Wales (50 participant 
letters) and North East England (100 participant letters) to ask if they would 
participate in the study. Thirty four farmers replied (13.6%) of which 30 agreed to 
participate in the study (South West England: 16, Wales: 5 and North East England: 
13), giving a total response rate of 12%.   
Pre-treatment samples were collected from 30 farms and a questionnaire survey 
conducted to obtain information on historical drug use and other risk factors. In 
addition, 12 farms participating in a SCOPS project were also sampled.  Of the 42 
farms, the composite counts were too low to conduct the FECRT on 35 farms.  
Hence seven farms, 16.7% (95% CI 8-31%) of the sampled farms were used in the 
drug efficacy study.  Of these 7 farms, two were SCOPS farms, one was from Wales 
Yorkshire 
WALES 
SCOTLAND 
Cumbria 
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and the remainder were all in North East England.  All 7 farms received treatment 
and second samples were submitted at 21 days post treatment. The pre- and post 
treatment egg counts and the percentage of reduction for all seven farms are 
presented in Table 4.3.2. TCBZ resistance was considered as present when the FEC 
reduction was less than 90%. Figure 4.3.2 shows the location of study farms. 
 
 Questionnaire survey responses 4.3.3
All 7 farms returned questionnaires on the second sampling visit (day 21 pt) having 
met our requirements of pre-treatment FEC above 100 epg.  These farms were in 
lowland areas (1 farm), upland areas (2 farms), hill sheep farms (2 farms) and 2 
farms in the upland marginal/hill areas of England (Table 4.3.3). One of the 
conditions of entry into the trial was that the sheep had not been treated with an 
anthelmintic for at least 12 weeks before faecal collection. This requirement was 
important to ensure that the sheep were infected with sufficient liver fluke parasites 
for the purpose of this study.  
The total number of ewes ranged from 350 to 900 on the 7 farms.  Among the 
sampled farms, 57% had cattle on the farm, 14% had cattle and goats whereas 
another two farms had only sheep (Table 4.3.3).  Analysis showed that there was no 
significant difference (T-test p = 0.82) between resistance status and total number of 
ewes.  Due to the small number of farms further analysis on differences between 
resistance status and farm characteristics was not performed.  
Results of management practices for all 7 farms are presented in Appendix 4.5.  The 
survey indicates that sheep were either moved to the current pasture within the last 
month (farm 1 and 4) or in the last 1 to 3 months (farm 3, 5, 6 and 7).  Cattle were 
reared with sheep on 5 farms and with horses on farm 1.  The majority of farmers (6 
out of 7) sent their sheep away for winter grazing, and all farms produced their own 
forage; for example hay, silage and straw. All farmers used several types of fertilizer 
including commercial fertiliser, manure, lime, slurry and slag. The questionnaire 
asked respondents to rate the drainage of the grazing field by observation and the 
results showed that 2 out of 7 rated the drainage as poor, although all farmers except 
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for farm 1 reported problems with boggy fields. Most farmers except farm 6 and 7 
had tried to improve the drainage on their farms.  The water sources present on each 
farm can be seen in appendix 4.5. 
The questionnaire survey indicated that Flukiver (closantel) was the most commonly 
used drugs to treat fluke.  Fasinex and Endofluke (both triclabendazole) were also 
used (Table 4.3.4).  Most of the respondents indicated that when calculating the dose 
of anthelmintic, the weight of the sheep was important. The reasons provided for 
choosing these products included veterinarian’s advice, recommendation by the shop 
and, less frequently, based on information in magazines or television. The factors 
that influenced the farmers to use anthelmintics for treating liver fluke included 
because they were following a fluke programme advised by the vet or animal health 
officer. It appeared that farmers had their own specific time of treatment as they 
responded that ‘I always fluke at the same times of year’; e.g. after lambing period, 
September/October/November or December/January, when animals show symptoms 
such as poor body condition and after scanning. Of these 7 farms, 2 of the 
respondent farmers reported that the frequency of treatment with anthelmintics was 
twice per year and 2 other farms applied treatment four times annually. Quarantine 
drenching to treat new stock against liver fluke, was not applied on these studied 
farms.   
Six farms (85.7%) stated that FECs were never used and one farm used this test to 
monitor liver fluke infection (Table 4.3.5). The results also showed that no 
investigations had been conducted on drug resistance previously (based on FECRT 
and coproantigen diagnostic test) on six farms (85.7%), however the other farm had 
used FECRT. 
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Table 4.3.2 Summary of pre-treatment, post treatment and reduction 
(%) in composite faecal egg counts (in 50 gram of faecal samples) in 
sheep treated with 10 mg/kg (Fasinex
®
;  Novartis) for 7 farms.  
 
Farm ID          Total eggs                         Total eggs 
                               Pre- treatment   Post treatment                 %Reduction 
1 (Wales)  2518    13   99 
2 (North East)  258    0   100 
3 (North East)  1000    107   89* 
4 (North East)  2284    1   100 
5 (North East)  12155    8947   26* 
6 (North East)  210    32   85* 
7 (North East)  2552    2008   21* 
*indicates farms where resistance is suspected. 
 
 
Figure 4.3.2  Map of the Great Britain showing the location of F. 
hepatica  resistance study farms (Red: Resistant  farm; Blue: 
Susceptible farm) .   
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Table 4.3.3 Responses of farmers to questionnaire survey on farm 
descriptors (n=7).  
 
Variable Level of variable Resistant (n) Susceptible (n) 
Type of farm 1 = Lowland 
2 = Upland 
3 = Hill 
4 = Upland + hill 
 
1 
1 
1 
1 
0 
1 
1 
1 
Farm size (acres) 1 = 0-250  
2 = 251-500  
3 = 501-750  
 
1 
2 
1 
2 
1 
0 
sheep numbers (range) 1 = 301-600 
2 = 601-1000 
2 
2 
 
 
2 
1 
 
Cattle 1 = Yes 
2 = No 
3 = Cattle + goats 
 
           3 
           1 
           0 
             1 
             1 
             1 
Sampling times 
 
1 = January  
2 = February 
3 = March 
 
           1 
           2 
           1 
0 
3 
0 
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Table 4.3.4 Responses of farmers  to questionnaire survey on sheep fluke control on anthelmintic usage practice on each 
farm. 
Variable Level of variable Count/farm Responses 
When last treated 0 = Missing responses  
1 = By October 2014 
2 = By November 2014  
3 = By December 2014  
4 = By January 2014 
 
0 = 1/7 
1 = 1/7 
2 = 1/7 
3 = 3/7 
4 = 1/7 
 
14.3% 
14.3% 
14.3% 
42.8% 
14.3% 
 
Product used when last treated 1 = Endofluke  
2 = Flukiver  
3 =Triclafas  
4 = Flukanide 
 
1 = 2/7 
2 = 3/7 
3 = 1/7 
4 = 1/7 
 
28.6% 
42.8% 
14.3% 
14.3% 
 
Commonly used drench 0 = Missing responses  
1 = Flukiver + Fasinex  
2 = Flukiver + Supaverm + Endofluke 
3 = Flukiver + Fasinex + Combined cattle/sheep  
4 = Endofluke + Fasimec Duo 
5 = Flukiver + Fasinex + Albensure + Endofluke +   
      combined cattle/sheep 
6 = Flukiver + Fasinex + Trodax + Alverm + Tribex +  
      Supaverm + Rycoben + + combined cattle/sheep 
 
0 = 1/7 
1 = 1/7 
2 = 1/7 
3 = 1/7 
4 = 1/7 
5 = 1/7 
  
6 = 1/7 
 
14.3% 
14.3% 
           14.3% 
14.3% 
14.3% 
14.3% 
 
14.3% 
 
 
Treatment frequency (per year) 0 = Missing responses  
1 = 1  
2 = 2  
3 = 3 
0 = 1/7 
1 = 1/7 
2 = 2/7 
    3 = 1/7 
14.3% 
14.3% 
28.6% 
14.3% 
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4 = 4 
 
 4 = 2/7 
 
28.6% 
 
Quarantine drench 0 = Missing responses  
1 = Yes 
2 = No 
 
0 = 1/7 
 1 = 0/7 
 2 = 6/7 
 
14.3% 
0% 
85.7% 
 
 
 
 
Table 4.3.5 Responses of farmers to questionnaire survey on sheep fluke control  on faecal egg count (FEC) on each 
farm. 
 
Variable Level of variable Count/farm Responses 
FEC used to monitor fluke 1 = Yes 
2 = No 
1 = 1/7 
2 = 6/7 
 
14.3% 
85.7% 
 
Previous investigation of 
drench resistance study 
1 = FECRT 
2 = No 
3 = Coproantigen Test 
1 = 1/7 
    2 = 6/7 
    3 = 0/7 
14.3% 
85.7% 
0% 
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4.4 DISCUSSION 
 Study 1 4.4.1
The key aim of this study was to generate some pilot data on the prevalence of 
TCBZ resistance on sheep farms, as there is only limited information available for 
England and Wales. Our data confirms the presence of TCBZ resistance on sheep 
farms in Cumbria, which was detected on each of the 13 farms included in the study, 
8 of which failed to show any reduction in egg counts, demonstrating a high level of 
resistance to this anthelmintic. This finding supports the results of drug efficacy 
trials in sheep conducted by Daniel et al. (2010), who confirmed TCBZ resistance on 
6/13 farms in South West Wales and one farm in South West Scotland. These results 
are in agreement with anecdotal evidence from farmers and the APHA suggesting 
that TCBZ resistance is present on sheep farms in the UK. 
Treatment of susceptible isolates of liver fluke with TCBZ in experimentally and 
naturally infected sheep can result in reductions in FECs of between 96.5% and 
100% (Rapic et al., 1984; Turner et al., 1984; Wolff et al., 1983).  These findings are 
supported by field trials which demonstrated that the drug was fully effective with 
100% reduction in egg output after treatment (Maes et al., 1990; Stansfield et al., 
1987).  This is in contrast to the situation seen in the field when TCBZ resistance in 
sheep was detected years later- the first case was reported in Australia in 1995 
(Overend and Bowen, 1995) and was followed by further reports of drug failure in 
several other countries (Gordon et al., 2012b; Mooney et al., 2009; Sargison and 
Scott, 2011b). Recently, cases of TCBZ-resistant F. hepatica were recorded in South 
West Wales and South Wales Scotland, with egg count reductions of <95% (Daniel 
et al., 2010), suggesting that TCBZ resistance may be wide spread in Great Britain.  
This agrees with our results since TCBZ resistance was also detected on all 13 sheep 
farms tested in Cumbria. However, study by Daniel et al. (2012) failed to find TCBZ 
resistance in England, where ten farms were sampled, including one in the Cumbria 
area.  In the present study, the most important finding is the high prevalence of 
TCBZ resistance, with a degree of resistance evident on all farms. On seven of these, 
there was an increase in egg numbers after treatment indicating that TCBZ was 
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ineffective at controlling neither adults nor immature F. hepatica was removed.  As 
for other farms, the drug was not fully effective against all stages of flukes.  
The cFECRT was used in the present study as a diagnostic tool and this test has been 
validated in a previous study by Daniel et al. (2012).  The cFECRT estimates TBCZ 
efficacy by comparing FECs from animals before and 21 dpt by using two groups of 
10 animals each.  It has been suggested that <95% reduction in FEC is indicative of 
resistance (Daniel et al., 2010; Flanagan et al., 2011a) and this figure is also 
suggested by the WAAVP guidelines for the determination of drug resistance in 
nematodes (Coles et al., 1992).  In this study, we chose to use a less stringent cut-off 
of <90% reduction in cFECRT as the threshold for TCBZ resistance. 
In estimating TCBZ efficacy in F. hepatica, a threshold of 100 epg was identified as 
a pre-requisite for the test to be conducted (Daniel et al., 2012). In WAAVP 
guidelines, they recommend that for nematode infection in sheep, only animals with 
pre-treatment egg count > 150 epg, using the modified McMaster method, should be 
included in the study (Coles et al., 2006). Using the McMaster method, a 
multiplication factor is applied, so 1 egg counted is equivalent to 50 epg.  In the 
TCBZ FECRT used here, actual eggs are counted to give the final count. For the 
CFN study, three farms had counts below the 100 epg threshold and were excluded 
from the study.  In comparison for the second study, only 7/42 farms had counts of 
above 100 epg.   
The biggest challenge in controlling fasciolosis is that TCBZ is the only drug on the 
market that has a high efficacy against young immature flukes (Fairweather and 
Boray, 1999b).  Excessive use of TCBZ has led to an increase in the incidence of 
anthelmintic resistance and results from this study highlight the severity of the 
problem we are facing now.  It is not surprising that the widespread use of this drug 
appears to have selected for TCBZ resistant fluke populations on the farms sampled 
in this study.  There are a number of factors that are likely to have contributed to this 
occurring.   
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 Study 2 4.4.2
Of major concern, TCBZ resistance has now been reported in the UK (Gordon et al., 
2012a; Hanna et al., 2015; Mooney et al., 2009; Sargison and Scott, 2011b) and 
other cases confirmed worldwide (Moll et al., 2000; Ortiz et al., 2013). The 
Department of Veterinary Parasitology at University of Liverpool has monitored the 
anthelmintic resistance status of F. hepatica on sheep farms for many years by 
comparing pre- and post- TCBZ treatment FECs and is revealing the growing 
development of resistance of F. hepatica to TBCZ across the UK. Most flukicidal 
drugs on the market (e.g. closantel, nitroxynil) are effective in treating chronic 
fasciolosis, however TCBZ remains the drug of choice due to its activity towards 
immature flukes (which cause acute fasciolosis) in sheep. Any evidence of TCBZ 
resistance in liver fluke populations on farm would make TCBZ treatment 
inadvisable and would remove one of the key anthelmintics available to control acute 
fasciolosis.  Therefore, estimation of anthelmintic efficacy using cFECRT was 
conducted in this study to document the anthelmintic resistance status of sheep 
farming in three different regions of Britain. These regions were selected as 
representing sheep rearing areas of the country, but where the prevalence of infection 
is likely to vary due to the prevailing climatic conditions. Thus Wales has a high 
rainfall and is known to have a high prevalence of F. hepatica infection, South West 
England has a moderate prevalence of infection and North East England has a drier 
climate and a lower prevalence (McCann et al., 2010a). 
Results of the present study showed that compliance in participating in the study was 
relatively low (12%) and 35/42 farms sampled had fluke egg counts below the 100 
egg threshold. This was much lower compared to Study 1 (Cumbria sheep 
farms). This may be due to the warmer, drier summer of 2014 
(http://www.nadis.org.uk/), leading to a lower fluke challenge (Skuce et al., 2014) or 
because awareness of fluke is high as a result of the massive losses associated with 
fasciolosis following the wet year of 2012 (SCOPS, 2012). 
The evaluation of CFECRT showed that TCBZ was ineffective against F. hepatica 
infection on four out of seven farms that had FEC of 100 or above. Two farms (farm 
5 and 7) had %FECR of 26% and 21% respectively whereas the other two farms had 
%FECR of 89% and 85%, suggesting that the population of parasites showed partial 
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resistance.  These findings suggest that even in an area where the fluke challenge is 
comparatively low, resistance is still a threat.     
In the present study, results of the questions on use of drenches confirmed that six 
out of seven farms used TCBZ to treat liver fluke in sheep.  The use of closantel 
(Flukiver) and nitroxynil (Trodax) are other treatment options for sheep.  Closantel 
and nitroxynil have 91 to 99% efficacy against the adult flukes and were fully 
effective against TCBZ-resistant flukes with the high fluke burden in sheep flocks in 
Northern Ireland (Hanna et al., 2015). Another study also showed that these drugs 
have 100% efficacy against F. hepatica in a naturally infected hill sheep flock in the 
west of Ireland (Mooney et al., 2009).  Our survey also confirmed that the farmers 
have used more than one different type of drug on each studied farm.  Typically each 
farm uses specific brands of anthelmintic drugs (see Table 4.3.4). Whilst TCBZ 
should be reserved for the treatment of immature fluke in sheep, it is likely that 
farmers used various brands of drug without realizing it is the same active compound 
(TCBZ). Over reliance or repeated TCBZ treatment may occur due to this confusion; 
farmer may change one brand to another, thinking that they are alternating the active 
product. This means that the emergence of drug resistance in F. hepatica in sheep 
may occur due to farmers’ lack of knowledge about the active ingredient in different 
products.  Our study has confirmed that 4 out of 7 farms studied showed resistance 
to TCBZ treatment; however, several studies have reported that lack of efficacy of 
the drug is not necessarily associated with the actual resistance.  It is appears that the 
problem may be related to, for example, underdosing or dependent on the efficacy of 
the various brands of TCBZ drug available (Fairweather, 2011a; Sargison, 2012; 
Sargison and Scott, 2011a; van Dijk et al., 2015).  It is highly recommended that 
these drugs should be used strategically to combat infection, by knowing the status 
of the farm; e.g stage of infection present and resistance status.  TCBZ is used for its 
high efficacy against both immature and mature flukes, however if over used for 
long period of time there is a strong potential for the development of resistance to the 
drug within the fluke population on a farm. Our survey also showed that 
veterinarians are an important source of information for farmers regarding fluke 
control strategies and are usually involved in the decision of the product use. 
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Time after last drench is very important in determining when to collect faecal 
samples.  In our study, we requested farmers should only send sheep faecal samples 
that were taken at least 12 weeks after the last drench. However, two farms 
confirmed that the pre-treatment faecal samples were collected at 5 and 9 weeks after 
the sheep were last treated for farm 3 and 5, respectively.  Egg production capacity 
of F. hepatica is very high and an individual fluke may produce 5,000 to 20,000 
eggs per day (Happich and Boray, 1969b).  The pre-patent period for F. hepatica is 
about 8 to 12 weeks (Andrews, 1999).  These parasites need this period of time to be 
at full egg laying capacity and by this time young fluke will have matured.  In a 
previous study, groups of Wistar rats were infected with 20 metacercariae by 
stomach tube (Valero et al., 2006). The authors demonstrated that the pre-patent 
period depended on the infection level and the pre-patent period decreased when the 
burden of flukes increased.  In contrast, experimental studies on sheep infected with 
200 metacercariae have shown that the pre-patent period was 63 days and by 
increasing number of metacercariae (infected with 2000 metacercariae) the pre-
patent period was prolonged, reported at 13 to 15 weeks after ingestion (Boray, 
1969). Therefore, 12 weeks after treatment is the time to get a more meaningful 
interpretation of parasite burden from FECs. Selection bias can be minimize by 
ensuring this period of time of last drenched for the parasites to mature and produce 
eggs.  Other factors include time of year, climate and grazing strategy.  Interestingly 
for farms 3 and 5, despite the treatment 4 and 9 weeks previously, both had an egg 
count above the threshold and both had evidence of resistance in the FECRT. 
Identification of risk factors for F. hepatica infection may help in developing control 
strategies in sheep and these can be assessed through the questionnaire survey.  
However, major problem that we faced is the limited sample size.  The sample size 
was too small because we only received back seven completed questionnaires from 
those farms that had the second sample collected.  Questionnaires were not obtained 
from farms who had FEC below the 100 egg threshold.  Our aim at the outset was to 
obtain data from 126 sheep farms around the UK, but we did not achieve this and 
therefore it is difficult to detect statistical differences between the interaction 
between TCBZ resistance status and various variable responses.  However, with the 
seven replies were adequate to give an overview of fluke farm practices.     
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This survey showed that 5 out of 7 farms grazed cattle on a pasture, before and after 
sheep were grazed. Such a practice could potentially facilitate poorer liver fluke 
control since the same parasite can infect both sheep and cattle.  Whilst for nematode 
infections it is good to rotate with other susceptible livestock such as cattle and 
horses, this is not the case for fluke. Sharing grazing with sheep at the same is 
potentially hazardous as cross infection is likely to happen and is associated with a 
risk of transferring resistant strains of F. hepatica. Other studies have also identified 
co-grazing sheep is a risk factor for infection in cattle and vice versa and wild life 
has been implicated in acting as a reservoir of infection (Bennema et al., 2009; 
Charlier et al., 2011).  
Results from the survey indicate that 85.7% (6/7) of the respondents let the sheep to 
go to other farms for winter grazing.  This approach has been practised by farmers 
for many years and allows sheep to graze lowland pasture protected from extreme 
winter weather. Of these six responses, three of the farms demonstrated resistance to 
TCBZ.   Infective stages of F. hepatica, metacercariae, remain viable on the pasture 
for several months and can survive over winter   (Boray and Enigk, 1964).  However, 
milder conditions may increase the risk of F. hepatica metacercariae surviving on 
pasture, meaning that sheep which are transferred to lowland pastures during winter 
may be at higher risk of picking up infection.  Also, sheep which graze on other 
farms may be exposed to a more diverse population of F. hepatica than those sheep 
which remain on a single farm, and may potentially bring these parasites, some of 
which may be TCBZ resistant, back to their own farm. In a study in Northern 
Ireland, all flocks with high levels of fluke burden were found from lowland areas, 
whereas all the farms in upland areas had lower burden (Hanna et al., 2015). 
Our survey showed that only one farm used FEC to monitor fluke on their property 
and this farm had previously had a FECRT done, but evidence suggested that the 
fluke population on this farm was susceptible (farm 2).  
Other factors should be taken into account when controlling F. hepatica infections 
on sheep farms including optimal use of anthelmintics. It has been suggested that 
development of anthelmintic resistance can be slowed, if the frequency of 
anthelmintic treatment in sheep is minimized (Taylor and Hunt, 1989). Our results 
have shown that sheep on farm 1 were drenched once per year, farm 3 and 6 twice 
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per year, farm 4 three times per year and farm 5 and 7 four times in a year.  Based on 
the resistance status of these farms, farm 5 and 7 drenched the flock more frequently 
compared to other farms and showed the highest level of resistance.  However, 
anthelmintic resistance can also be selected at lower treatment frequencies if the 
same drug is used for over many years. To control infection and delay the 
development of resistance, choosing the right drug product and the times of year to 
treat treatment should depend on the disease pressure on the farm especially if a 
flock continues to graze on heavy contamination pasture.  Strategic treatment times 
may also be given according to the weather conditions and the advent of milder, 
wetter weather. TCBZ can be used for autumn treatment if there is no evidence of 
resistance whereas for farms with evidence of TCBZ resistance, farmers are advised 
to use closantel and nitroxynil to treat the flock.  This strategic control programme 
based on fluke forecast - closantel is used during the high risk autumn treatment 
whereas nitroxynil or albendazole is used when predominantly adult flukes are 
present. 
Underdosing due to body weight estimation is a critical issue that needs to be 
addressed in farm livestock (Sargison, 2012; van Dijk et al., 2015).  Lack of proper 
body weight estimation during drenching may lead to under dosing and hence 
emergence of anthelmintic resistance. Results from the questionnaires have shown 
that nearly 2/3
rd
 of the farmers used scales to estimate body weight.  Results from 
this survey indicate that underdosing of sheep may not occur and that farmers are 
well educated about weighing before drenching. Furthermore, farmers also need to 
monitor the dosing gun as faulty equipment can cause incorrect dosage given to the 
sheep.  Underdosing may also arise following incorrect storage of the drugs; when 
drug are not stored properly, this may impact the efficacy of the drug, thus should 
not be used in sheep (Sargison and Scott, 2011a). These factors were not an issue in 
our study as we provided the drug and the dosing gun and the dose was given under 
the supervision of APHA staff.  However, the survey only considers a single time-
point snap-shot of practices; correctly calibrated dosing guns and properly stored 
drugs were provided and dosing was supervised, no observation of dosing or 
examination of equipment previously used for anthelmintic treatments was available 
and so the accuracy of these drug administration’s cannot be commented on. 
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Therefore, it must be kept in mind that underdosing could easily have occurred in 
previous years and would therefore have selected for resistance. 
The present study investigated farm practice after the introduction of new stock 
which may affect the spread of anthelmintic resistance.  Giving a quarantine drench 
to all new stock could prevent the introduction of resistance F. hepatica isolates onto 
a sheep farm (Sargison, 2012).  Farmers are given advice that they should purchase 
sheep from the flocks of known liver fluke status when restocking.  All of the 
respondent farmers said they did buy in new stock for their properties which 
included ewes and tups.  However, none of the respondents performed quarantine 
drenching to these newly purchased sheep within 48 hours of arrival on the farm.  
This indicated that these farms were at risk of importing sheep carrying resistant 
populations of fluke. There are several recommendations available to farmers to 
reduce the risk of introducing in resistance strains of liver fluke to the farm: the 
paddock used as quarantine should be rested for a year; e.g. not be grazed until 
pastures have been cut for silage or hay or the land ploughed. It has been suggested 
that sheep introduced onto a farm should be treated using a sequentially administered 
combination of a benzimidazole and a salicylanilide derivative drug (Sargison, 
2012). Given the acknowledgement of development of TCBZ resistance around the 
UK, this is likely to be effective way preventing TCBZ resistance to build up. 
Quarantine drenching is an important aspect of an effective parasite management 
plan and failure to practice this may increase the emergence of resistance on the 
sheep properties. 
Results from our survey showed that all the respondents produced their own forage.  
There was a variety type of forage including hay, silage and straw.  However, there 
is uncertainty about the survival of the metacercariae of F. hepatica, on forage, 
particularly silage or hay.  Work by Boray et al. (1964), suggested that metacercariae 
will survive on hay with the relative humidity of >90% when stored at a low 
temperature. Another study, however, found that metacercariae survived for two to 
three months when placed in hay at low temperature and low relative humidity 
(Enigk and Hildebrandt, 1964). Other studies in the UK also demonstrated that 
approximately 50% of metacercariae encysting on herbage in September will survive 
in winter conditions (Ollerenshaw, 1967).  However, it is not clear if metacercariae 
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will survive in hay under normal farm conditions in the UK.  Therefore, feeding the 
animals with hay or silage during winter is probably not a potential source of liver 
fluke infection. In contrast, freshly cut grass from the high risk-flukey pasture is not 
recommended. 
Fertilisers were commonly used on fields grazed by sheep (commercial fertilizer, 
manure, slurry, lime and slag), which can have an effect on soil nutrients, as well the 
vegetation. This could provide better habitats for the snail, providing the water plants 
and mud required by the snail that are rich in organic matter, due to application of 
the fertilisers and calcium which is needed for shell development.  Work from 
Rondelaud et al. (2004) have demonstrated that lower calcium ion concentration 
(723 mg/l) present in waters induces slower growth of infected snails, and limits 
shell height to 8 mm. The authors also concluded that lower calcium ion content 
would create less favourable conditions for the development of redia within the 
snails.  This means that calcium in snail habitat is needed and is a very important 
factor for the development of the liver fluke life cycle. In addition, our survey 
indicates that 6 out of 7 farms (except for farm 7) were under the Environmental 
schemes; therefore have strict guidelines for fertiliser policies. The schemes also 
encourage the creation of wetlands, important for migratory birds and invertebrates, 
but which can increase the risk of F. hepatica (Pritchard et al., 2005). This also 
includes the introduction of G. truncatula to the ecosystem (van Leeuwen, 2012). 
It is of great importance that the flock is moved to the lower risk pasture in order to 
not to exposure the sheep to F. hepatica infections.  This survey showed that 85.7% 
(6/7) of the farms had a boggy field at some part of the year on their properties.  This 
means that using a temporary fencing around the high flukey-risk areas is highly 
recommended. Our results also showed that all the farms bordered wet areas 
including ponds, rivers, streams and marshy areas. These conditions will also favour 
the life cycle of the liver fluke through propagation of intermediate snail host, G. 
truncatula (Charlier et al., 2011).  By controlling the snail habitat (wet areas) and 
reducing numbers of snails through effective drainage could reduce fluke risk on the 
farm but is not possible for those farms in Environmental schemes (Charlier et al., 
2011; Sargison, 2012).  Studies have shown that snails located at the extremity of 
drainage furrows in meadows had a higher prevalence of F. hepatica infections 
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compared to snails colonizing lower parts of the drainage ditches or river bank 
(Rondelaud and Dreyfuss, 1996).  Farms 5 and 7 rated their properties as having a 
poor drainage where the sheep were currently grazing.  The survey results indicated 
that methods used to improve the drainage were harrowing, rolling, sub-soiling, 
aeration and maintenance the existing drains.  It is likely that the life cycle of F. 
hepatica can be disrupted if drainage is improved.  However, on farms 6 and 7 no 
drainage improvement methods were applied.  Installation of water troughs also play 
an important factor to reduce the exposure of infections of sheep on the farm 
(Charlier et al., 2011). The main purpose of this approach is to avoid wet areas 
building up round the watering places.  Majority of the farmers had several main 
water sources on their farms including troughs, piped, stream and spring.  It is the 
best for the flock to graze fluke free areas as snail intermediate hosts can breed 
around water contaminated by infected sheep faeces. Clearly, water resources, 
particularly irrigation systems, can contribute to the introduction and spread of liver 
fluke infections.  
Last but not least is regarding the surveys in this study.  It is believed that giving 
feedback and useful information to the participants will encourage them to 
participate further in future projects and other research related activities.  Data for 
each farm was fed back to the farmers as soon as the egg counts had been completed 
and an advice sheet sent with the results. 
In conclusion, the present study has provided evidence of TCBZ resistance in F. 
hepatica in sheep in the UK.  The cFECRT is useful diagnostic tool in detecting 
resistance.  Although, this is small scale study, and insufficient data was collected to 
ascertain the prevalence of triclabendazole in different regions of Britain, the survey 
findings highlighted the fluke control measures and fluke management adopted by 
farmers at the present time. The worrying sign of TCBZ resistance is now more 
severe than is commonly recognized.  In future, farmers should put a hand together 
with the veterinarians, meetings and training to gain more knowledge on various 
aspects of stock management and control strategies for the flock. A better 
understanding of the best use of anthelmintics can effectively slow down the spread 
of anthelmintic resistance.   
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CHAPTER 5  
General Discussion 
 
The chapter summarises the research objectives and the significant findings and 
conclusions of the study. Recommendations related to this study and future research 
regarding the issue are also addressed. 
Liver fluke infection is typically highly prevalent in sheep in the UK and recently 
there has been a significant rise in both acute and chronic fasciolosis cases.  It is a 
serious production-limiting disease in sheep and cattle due to mortality, reduction in 
milk and meat production, secondary bacterial infection, high-cost of anthelmintic 
treatment and condemnation of livers at slaughter (Garcia et al., 2008; McKenna et 
al., 2002; Sargison and Scott, 2011b; Schmidt and Roberts, 2005).  Previously, East 
Anglia and South-East Scotland were regarded as low-risk areas for fasciolosis, 
however due to changing climatic conditions, specifically warmer and wetter springs 
and summers and milder winters, there has been an increased fluke prevalence in 
livestock throughout the UK (Kenyon et al., 2009; Pritchard et al., 2005; Van Dijk et 
al., 2010).  Over the past 10 to 15 years a number of cases of liver fluke infection 
were reported (see Figure 1.2) with evidence of geographical distribution (from west 
to the east) and different temperature and rainfall patterns (Fox et al., 2011).  
Unusually wet summers between 2007 and 2012 have led to the 2012/2013 liver 
fluke season with high fluke burdens on pasture which resulted in outbreaks of acute 
fasciolosis (SCOPS, 2012). The fasciolosis risk depends on the distribution and 
numbers of the intermediate mud snail hosts (Galba truncatula).  These snails 
survive well in shallow water, ditches, boggy field, marshy environment and banks 
of slowly-moving streams but not in the standing water (Frömming, 1956).  In 
addition, larger bodies of semi-permanent water can provide suitable habitats for 
other lymnaeid snails, e.g. Radix peregra, Lymnaea stagnalis and Galba glabra that 
can also act as intermediate hosts for liver fluke (Relf et al., 2009). In years of high-
fluke risk with the changing weather patterns favourable for snail development and 
establishment of snail habitats the number of snails on pasture in the UK has the 
potential to rapidly increase; increasing the risk of fasciolosis.  
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The epidemiology of fasciolosis continues to evolve in the UK in response to the 
changes in the patterns of anthelmintic usage and the development of anthelmintic 
resistance (Kenyon et al., 2009; Pritchard et al., 2005; Sargison, 2012). One of the 
most effective fluckicide drugs in controlling fasciolosis is TCBZ, which belongs to 
the benzimidazole family; TCBZ has high efficacy against immature (from as early 
as 2 dpi) and mature adult fluke (Fairweather and Boray, 1999a). However, reports 
of TCBZ resistance in fluke populations have been reported in a number of countries 
due to over-reliance on this drug (Alvarez-Sanchez et al., 2006; Daniel et al., 2012; 
Gordon et al., 2012a; Moll et al., 2000; Mooney et al., 2009; Ortiz et al., 2013; 
Overend and Bowen, 1995).  Furthermore, infections of liver fluke in humans are a 
significant problem in both tropical and subtropical regions, even including 
developed countries (Mas-Coma et al., 2009). Recently, a case of TCBZ-resistant F. 
hepatica in humans was reported in The Netherlands (Winkelhagen et al., 2012).  
Despite several treatments with TCBZ, the drug showed no efficacy in the patient, 
thus highlighting a serious zoonotic threat posed by liver fluke infection, particularly 
with resistant parasites (Winkelhagen et al., 2012).  Other cases in humans also have 
been reported in Peru, Bolivia, Egypt, Iran, Puerto Rico and Portugal (Mas-Coma et 
al., 1999a). 
Given these circumstances, it is important to monitor changes in the prevalence of 
this disease and to study the important issue of TCBZ resistance. There are numerous 
anecdotal and a smaller number of confirmed reports of poor TCBZ efficacy in both 
sheep and cattle. This PhD study has therefore focused on an evaluation of 
diagnostic tests that are available to detect early infection of F. hepatica in sheep and 
to identify the most appropriate diagnostic test for detecting TCBZ efficacy.  In the 
second part of the study, we explored ways of making the composite FECRT 
(cFECRT) method for detecting TCBZ resistance in the field, more user friendly.  
The final aim of our study was to determine the current status of TCBZ resistance in 
F. hepatica on sheep farms in Britain using the cFECRT. 
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5.1 Sensitivity of coproantigen ELISA compared with FEC and PCR assay 
At present, methods for detecting infection with liver fluke and monitoring the 
efficacy of anthelmintic drugs, at the farm-level comprise FEC/FECRT, 
coproantigen ELISA and PCR. The cELISA in particular, developed by Mezo et al. 
(2004) may be very promising as this test can detect pre-patent infections and has 
been shown to be highly specific and sensitive for the diagnosis of acute and chronic 
F. hepatica infections in sheep. 
In Chapter 2, we compared these three diagnostic tests, ITS2 PCR, cELISA and FEC 
for their ability to detect F. hepatica infection in experimentally infected sheep and 
to determine drug efficacy in a controlled efficacy test. Comparison of the 
performance of the cELISA, FEC and PCR following TCBZ treatment of sheep 
experimentally infected with a TCBZ susceptible isolate of F. hepatica provided a 
great opportunity to identify their relative merits.  The results from the present study 
have confirmed findings by others, that cELISA (BIO K 201, BIO-X Diagnostics, 
Belgium) is more sensitive than FEC at early detection of liver fluke infection in 
sheep. Coproantigens were first detected at 5 weeks of infection, and all sheep were 
positive by 8 wpi. In contrast, eggs were first detected in faeces at 7 weeks of 
infection, two weeks later than Fasciola coproantigens. Previous studies have found 
similar results in experimentally infected sheep (Flanagan et al., 2011a; Flanagan et 
al., 2011b; Mezo et al., 2004).  In terms of detecting infection the cELISA is the 
most sensitive and is capable of detecting immature fluke around 5-6 weeks of age 
(see Figure 2.3.1). Although a number of PCR protocols claim a greater sensitivity 
(Martinez-Perez et al., 2012; Robles-Perez et al., 2013) it was not possible to 
reproduce these published results. It is difficult to provide an explanation for this 
failure as even faecal samples late in infection, where eggs were clearly visible as a 
source of fluke DNA, did not produce a positive PCR reaction. Similar observations 
have been made by other research groups (Skuce et al., personal communication) and 
it suggests that if the PCR is not capable of detecting fluke DNA in an experimental 
system it is of little value as a diagnostic in a field setting. The FEC performed 
largely as expected in the experimental trial and highlighted its value as a diagnostic 
for patent fluke infection. 
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These experimental infections highlight that the cELISA may be a better indicator of 
TCBZ failure. However, in natural infections, the cELISA does not always perform 
quite as well. This was seen in Chapter 3 in field study with naturally infected sheep. 
This study showed the sensitivity the commercial BIO K 201 ELISA after drug 
treatment is a sensitive test, however inconsistent results comparing the cELISA and 
FECs were obtained. Similarly under field conditions, Kajugu et al. (2015) showed 
that animals that had low but positive FEC results (1-7 epg) were not always positive 
for cELISA; only 10 of 36 animals were positive.   
In contrast, other studies demonstrated that many more animals gave positive 
cELISA results than FECs (Hanna et al., 2015).  It could be that the cELISA may be 
able to detect the presence of immature flukes in the bile ducts, or that the cELISA 
continues to detect coproantigen released from disintegrating fluke (Flanagan et al., 
2011a; Flanagan et al., 2011b). The results in chapter 3 clearly showed a big 
discrepancy between FEC and cELISA compared to chapter 2. It would be 
interesting to have liver fluke burden of naturally infected sheep, to better understand 
the sensitivity of cELISA and support the findings of the present study. One of 
factors that might explain the difference between experimental studies and natural 
infection is that experimentally infected sheep are given a single high dose of 
metacercariae; for example, in our study 200-215 metacercariae were used to infect 
the sheep. In comparison, sheep that are exposed to continuous low levels of 
infection in the field may give a different diagnostic value, both on cELISA and the 
FEC. Another reason may be that experimental sheep were housed indoors 
throughout the study and were therefore not exposed to infection with other parasites 
e.g paramphistomes whereas naturally infected sheep are at pasture and are exposed 
to numerous potential parasitic infections. The FEC is highly specific as distinction 
can be made between different species of egg.  However the cELISA (MM3 assay) is 
also reported as highly sensitive (100%; Mezo et al., 2004) and specific for F. 
hepatica infections: studies have confirmed that there was no cross-reactivity to 
paramphistomum, coccidian and/or gastrointestinal nematodes (strongyle-type and 
Nematodirus spp.) under field conditions (Gordon et al., 2013; Kajugu et al., 2015).  
This suggests it may be more of a sensitivity issue. What is evident is that the 
coproantigen detection method will be useless if the test fails to meet the required 
level of sensitivity in field-based studies and much further evaluation is required. 
135 
 
The cELISA was not tested on a large scale here and it would be beneficial to 
compare the coproantigen detection methodology to the cFECRT in a large scale 
field-based study.  
After TCBZ treatment we observed a significant reduction in egg counts even when 
liver fluke survived TCBZ treatment. Live fluke (ranged from 1-13) were recovered 
from five out of six sheep at 10 dpt. The presence of flukes which had survived the 
treatment suggests variability within this population, which was a recent field isolate. 
The efficacy of TCBZ against this isolate of F. hepatica was 97% with p<0.001 with 
reference to the untreated group. It has been claimed that cELISA BIO K201 has a 
very high sensitivity that can detect as few as one adult fluke (Mezo et al., 2004), 
this result was not supported in the present study. One fluke was recovered from 2 
sheep but only one sheep positive by cELISA and the other was sheep not. Both 
sheep were positive by FEC. These observations may suggest that capture of 
coproantigen by this diagnostic test may give false negative results. Similarly, 
Gordon et al. (2012b) found false negative coproantigen results with naturally 
infected sheep in Scotland, 5 sheep with 2-6 fluke burdens. One possible reason is 
that the presence of coproantigen level in faeces may be irregular, e.g in sheep 
harbouring one fluke burden and this is not necessary coinciding with FEC 
positivity.  This scenario just like FECs, variation in daily egg output of sheep.  
Several issues have been raised concerning fluke eggs which may remain trapped in 
the gall bladder of the sheep after adult F. hepatica is eliminated after treatment 
(Fairweather, 2011b) or the disintegration of dead flukes which continue to produce 
coproantigen and release it to the faeces (Hanna et al., 2010). However our study and 
that of others (Flanagan et al., 2011b; Hanna et al., 2015; Hutchinson et al., 2009)  
have all shown that, despite the presence of low numbers of eggs, that the %FECR 
for a susceptible isolate is >95%, although for field studies, several authors suggest 
that complimentary methods, both FEC and cELISA should be used (Hanna et al., 
2015; Kajugu et al., 2015). Finally it would have been interesting to note what 
difference it would have made if the experimental study in chapter 2 had been 
performed at >14 days post TCBZ treatment, as the effect of retained eggs or 
coproantigen should have been reduced at this timepoint.  
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5.2 Improving the design of cFECRT and evaluating the interval between 
treatment and post treatment sampling 
Undoubtedly improving the delivery of timely and efficient diagnostics for TCBZ 
resistance to farmers would result in greater success in treatment of infected animals 
using effective drugs. Hence in chapter 3, we conducted a study to improve the 
design of the cFECRT to question the need to re-sample the same sheep and 
retaining a 21 day post treatment interval.  Firstly, we determined whether it was 
necessary to sample the same 20 sheep pre- and post treatment, or if two random 
groups of 20 sheep could be sampled for the two counts.  The bootstrap analysis 
showed that the same 20 sheep had to be sampled pre-treatment and at 21 dpt 
because of the variation in egg counts within a population of sheep.  Secondly, the 
cELISA and FEC were compared on individual samples and composite samples 
from 20 sheep on five farms. Faecal samples were collected prior to treatment, 7 and 
21 dpt to determine the optimum time of collecting the post treatment sample. A 
comparison revealed that the individual cELISA values were more informative than 
the composite cELISA values for the detection of infected sheep (see Table 3.3.3 and 
3.3.5). The cFECRT test provides more information about the extent of resistance 
within a population by giving a %FECR; the cELISA, both individual results and 
composite result, could only be considered positive or negative. This study also 
showed that the cFECRT was more accurate if the second sample is collected at 21 
dpt, and can help avoid false positive results compared to FEC reduction at day 7 pt.  
This is due to the issue of fluke eggs that trapped in the gall bladder after successful 
drug treatment and removal of fluke from bile ducts (Flanagan et al., 2011a; 
Flanagan et al., 2011b; Sargison, 2012). 
Only one of the five farms that participated in this study had FECs that were high 
enough to conduct the analysis.  Also the results suggested that the fluke on this farm 
were resistant.  This limited the amount of analysis that could be done, a bigger 
study on more farms would strengthen the conclusions from this study, that the 
cFECRT is a useful field test to detect drug failure. 
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5.3 TCBZ resistance prevalence studies 
Evaluating the cFECRT in this chapter, has led to the conclusion that it is the 
optimum test to use in a wider field study to determine the prevalence of TCBZ 
resistance in the UK. Given that we do not have a clear picture of TCBZ resistant in 
England and Wales Chapter 4, describes a study to establish the prevalence of TCBZ 
resistance in sheep in England and Wales. This was conducted with a view to 
identifying factors influencing the development of TCBZ resistance. Preliminary 
studies in England and Wales showed that TCBZ resistance was evident on 7 out of 
25 farms analysed (Daniel et al., 2012), however those farms were not randomly 
selected for that study. Therefore we set out to conduct a study to ascertain the 
prevalence of TCBZ resistance in sheep in England and Wales, and the study was 
performed in 2 phases. In the first phase, all 13 farms, in the county of Cumbria 
showed evidence of drug failure.  In addition, on 8 of these 13 farms, there was no 
reduction in egg output post treatment, thus indicating a high level of drug failure on 
those farms.  Even given this small number of farms, the findings are disturbing and 
particularly concerning as F. hepatica infection pressure is high.  Despite several 
flock health plans to reduce the spread of anthelmintic resistance in sheep, these 
efforts do not seem to be very effective. Therefore, it is very important for the 
farmers to follow advice from veterinarians including avoiding frequent usage of 
TCBZ. 
In the second phase, a survey of TCBZ resistance was conducted in three regions of 
Britain; North East England, South West England and South Wales. A questionnaire 
was included to identify risk factors associated with drug failure.  This study had a 
poor response rate; although 250 farms were contacted, only 30 farms took part in 
the study.  Of those 30 farms, together with 12 from the APHA’s SCOPS study, only 
7 farms had pre-treatment counts of 100 epg or higher.  Evidence of TCBZ failure 
was observed in 4 of those 7 farms, all from North East England. There were too few 
results from the questionnaire to identify risk factors for resistance. We can conclude 
from these results that TCBZ resistance is common on sheep farms in some parts of 
the UK.  This study identified hotspots of resistance in Cumbria and North East 
England, and other studies showed extensive resistance in Wales.  However further 
investigation is needed to establish a national prevalence.   
138 
 
In an effort to maintain a healthy sheep flock, together with controlling economic 
losses due to fasciolosis (Sargison and Scott, 2011b)  farm management strategies 
might help farmers to have a highly effective long-term control programme for liver 
fluke infection in sheep and in the emergence of anthelmintic resistance.  These 
include the frequency of drenching and the choice of product.   
Whilst TCBZ should be reserved for the treatment of acute infection in sheep, 
farmers are advised to avoid using the same class of anthelmintic drugs every year so 
that the longevity of the compounds will be prolonged.  Another important factor 
which is considered to increase the selection for anthelmintic resistance is the 
administration of correct drug dose (Sargison, 2012).  In this survey, nearly 2/3
rd
 of 
the farmers used scales for estimation of body weight, thus suggesting that 
underdosing due to inaccurate judgement of sheep bodyweight did not occur.  
However, farmers also need to monitor the dosing gun as faulty equipment can cause 
incorrect dosage given to the sheep.  Underdosing may also arise if drugs are not 
stored properly or if they go out of date.  There are extensive industry guidelines 
from organisations such as SCOPS (sustainable control of parasites of sheep) which 
are there to advise farmers on how to best use anthelmintics (Sargison and Scott, 
2011a).   
Other recommendations include quarantine treatments of newly introduced sheep 
using a sequentially administrated combination of a benzimidazole and a 
salicylanilide anthelmintic drug to reduce the spread of resistant F. hepatica into new 
areas or farms (Sargison, 2012). Farm management can have a big effect on level of 
infection. For example by improving drainage systems, or fencing off wet and boggy 
areas that contain snail habitats and grazing sheep on low-risk pastures at high risk 
times of year, can all reduce risk of infection (Pritchard et al., 2005) whilst reducing 
reliance on drugs to control infection.  
In summary, although cFECRT is the most practical and validated test to diagnosis 
liver fluke infection better methods for reliable detection at an early stage of 
infection in sheep are urgently needed. The F. hepatica cELISA, according to our 
results, is useful for detecting immature fluke infections but more work is required to 
establish how useful this test is for diagnosing TCBZ resistance in the field.  In order 
to developed more sensitive cELISA, first, we need to revive the cut-off value for 
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positivity percentage that recommended by the manufacturer.  We noted a high rate 
of false negative results in cELISA on field study and could be explained by the facts 
that high PP (%) of cut-off value (6.65% and 9.32%) resulted in insensitivity of this 
test.  For example, field study in beef and dairy cattle by Brockwell et al. (2014) was 
able to improve the sensitivity of cELISA by using lower cut-off value, 1.3%, and 
thus they removed the false negative results.  Therefore, further testing is required to 
establish lower custom cut-off PP (%) to improve sensitivity. Secondly, the 
manufacturer’s protocol for faecal processing prior to testing can be altered to 
optimise the availability of the faecal antigen and further improve sensitivity. In the 
protocol, faecal sample was diluted in the dilution buffer, centrifuged for 10 min and 
the supernatant were stored at -20 °C until used.  Recent work has shown that they 
leave the solution for overnight so that the faecal antigen will be more dissolved and 
increase the level of coproantigen for further use (Novobilsky A, personal 
communication). The ITS2 PCR used in the present study may hold significant 
promise as Fasciola DNA can be detected from as early as 2 wpi in experimentally 
study (Robles-Pérez et al., 2013).  However, improve developed method needs to be 
further optimised as this assay failed to detect liver fluke infection in our laboratory.  
It is important to be forethoughtful, what is the source of the Fasciola DNA, whether 
it will ever be possible to detect DNA related to infection status, particularly in field 
naturally infected sheep and how does the DNA signal respond to TCBZ treatment, 
therefore, suggestions are made for further validation and investigation of the 
potential molecular based method in our laboratory. Furthermore, the prospect for 
loop mediated isothermal amplication (LAMP) testing to detect fasciolosis and 
TCBZ resistance in the laboratory are discussed.    
Liver fluke is becoming increasingly common in sheep and poses a very real threat 
to livestock production of sheep in the UK and worldwide.  Other major issues 
include resistance to TCBZ. Since anthelmintic resistance is inheritable and 
irreversible once fully fixed within a population, it is important to detect TCBZ 
resistance at early stage in the field so that we can maintain the efficacy of currently 
available drug as long as possible. At the moment there does not appear to be 
resistance to the other drugs that are used to treat F. hepatica, namely closantel and 
nitroxynil. However by reducing the use of TCBZ, greater pressure will be applied to 
these other drugs. There is a lack of effective diagnostic tools to detect infection and 
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the efficacy of TCBZ for the treatment and tests to measure efficacy of closantel and 
nitroxynil are urgently needed. Finally a large scale of TCBZ prevalence study needs 
to be conducted that would help to confirm our findings and provide a solid 
information to indicate options for sustainable liver fluke control in sheep livestock 
industry in the UK. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
141 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
STANDARD OPERATING PROCEDURE (SOP) 
FOR CHAPTER 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
142 
 
APPENDIX 2.1 
 
Modified sedimentation technique for counting of eggs  
 
Equipment/chemical 
Bowl (500ml capacity) 
Coarse sieve (38µm, 150µm and 710µm) 
Counter (Clay Adams) 
Weighing balance (accuracy ±0.1g) 
Glove 
Microscope 
Petri dish (90ml) 
Tap water 
Wooden tongue depressor 
 
Procedure 
1. Bowl was place on the balance and adjusts the weight to zero.  
2. Five grams of faeces were weighed.  
3. The faeces were mixed manually with tap water in a bowl.  Allowed pelleted 
faecal samples to soak and soften before the next step.  
4. The faeces were mixed well and ensure that no spilled for liquid faecal 
samples as the eggs can settle out. 
5. The sieves were stacked according to the size of aperture which is the sieve 
with the smallest aperture should be at the bottom and the largest at the top. 
6. The faecal slurry were poured thorough the sieves under the running tapped 
water. Wash it through with plenty of water until water runs clear from the 
bottom sieve. 
7. The top sieve was removed and repeats again Step 6 for the two remaining 
sieves. 
8. The 150µm sieve was removed and gently washed through the sediment on 
the surface of the 38µm sieve.  The sediments in the sieve were then 
backwash into a 500ml beaker. 
9. Topped up with clean tap water in the beaker and allowed to settle for 4 
minutes. 
10. The supernatant were discarded leaving approximately 100ml at the bottom 
of the beaker and topped up again with water for another 4 minutes. 
11. Step 10 was repeated until the water was clean. 
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12. The clear sediments were poured off down to 50ml or less if possible without 
losing the contents and transferred it to a large square petri dish. 
13. The petri dish was placed on microscope and all eggs were counted when 
seen within the ruled or squared areas that was sit the dish on top. 
14. If the eggs were not need for further testing, added a couple of drops of 
methylene blue as this will help the eggs to stand out (yellowish colour) 
under the microscope. 
15. One egg represent 1 eggs per gram.  
 
 
As for composite FEC, 5g of individual sample was pooled with the other samples 
from same group to make a total of 50g to form the composite sample.  All the steps 
above were applied to give eggs per 50g. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
144 
 
APPENDIX 2.2 
 
Fluke recovery  
 
Equipment/chemical 
String  
Scalpels 
Forceps 
Scissors  
Faecal pots  
Tray 
RPMI media; warmed to 37
 o
C 
PBS; warmed to 37
 o
C 
Petri dishes 
Gloves 
 
Procedure 
1. Before removal of the liver, the duodenum was ligated with string either side of 
the point of entry of the bile duct, this to prevent any loss of flukes. Ensure that 
when removed from the carcass, the gall bladder remains attached and intact. 
Sample of faeces were taken from the spiral colon and stored in the refrigerator 
(Day 10 post-treatment).   
2. The gall bladder was dissected away from the liver using forceps and scalpel 
blade. The whole gall bladder and contents were stored into the faecal pot for 
later examination.  
3. The main bile duct was cut using sharp scissor to recover the adult flukes. Firm 
but gentle pressure was applied along the route of the ducts in order to bring the 
flukes out. The flukes were collected into a Petri dish with PBS warmed to 37
o
C.  
4. The portion of duodenum closest to the liver was squeezed in case any fluke had 
travelled down the common bile duct. 
5. All adult flukes were rinsed in warm PBS and then incubated in 1ml of RPMI 
media at 37
 o 
C for 2 hours in order for the parasite to purge any eggs and 
stomach contents. 
6. The liver was sliced in approximately 1cm thick portions and then transferred 
into tray of warmed PBS (or saline) to 37
o
C.  Each slice was squeezed to reveal 
any hidden flukes.  The liver content was incubated at 37
o
C for 2 hours to allow 
any immature fluke to emerge.  
145 
 
7. After 2 hours, the content was removed and discarded, then washed through a 38 
µm mesh sieve to remove excess blood. The liver parenchyma was examined for 
immature fluke.  Any flukes recovered were transferred into a container of PBS 
at 37
 o
C (or saline).  
8. The inner surface of the gall bladder was washed to detect any remaining eggs 
(likely in heavy burdens some adult fluke may be found in the gall bladder or 
even the duodenum). The bile was washed through a 38 µm with plenty of water; 
eggs that retained in the sieve were then transferred into a faecal pot and stored 
in the fridge in clean tap water. 
9. In the laboratory: 
 
 The adult flukes from the petri dish were removed and counted.  For partial 
flukes recovered, the numbers of posterior and anterior ends were counted as 
well to determine the liver burden. All the flukes were stored frozen in the 
Eppendorf (1 per adult) for further use. 
 Eggs remaining in the wells were transferred into Eppendorf and washed with 
tap water followed by centrifuging for 30 s. The supernatant was discarded and 
replaced with clean water.  This step was repeated until the water is clear and 
there are no debris left in with the eggs. The solution was stored in the fridge for 
later processing.  
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APPENDIX 2.3 
 
Coproantigen: Bio-X Fasciola hepatica  antigenic ELISA Kit (BIO 
K 201)  
 
Composition of the Kit 
Two 96 well Bio-X K201 microplates 
50x avidine (500μl) 
1x chrome solution (2ml) 
50x conjugate (500μl) 
5x dilution buffer (50ml) 
2 vials of positive reference antigen 
1x stopping solution (15ml) 
1x substrate solution (30ml) 
20x washing solution (100ml) 
 
Equipment 
Adhesive for microplates 
Beakers (50ml) 
Distilled water 
Dispenser tips 
Gloves 
Graduated automatic (mono- and multichannel) pipettes 
Graduated cylinders 
Lid 
Microplate reader 
Microplate shaker 
Microplate washer 
Plastic tubes 
Tube rack 
Reagent reservoir for multichannel pipettes 
 
Procedure 
The reagents were removed from the fridge and must be kept at 21°C before use (at 
least half an hour before use). For microplates, removed it from the fridge and then 
followed by its packaging. 
(a) Faecal material 
1. The faecal samples were diluted in the dilution buffer. 0.5 grams of faecal 
material were mixed up with 2ml of the dilution buffer. 
2. All samples were vortexed for 10 s prior to centrifugation.  
3. The tube was centrifuged at 1000g for 10 minutes to concentrate the 
solutions.    
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4. The supernatants were collected and stored in 1.5 ml Eppendorf tubes at -
20°C until testing.   
 
(b) Bio-X Diagnostics microplates preparation 
1. The diluted faecal samples of 110μl were dispended into the wells as 
followed:  sample 1 in wells A1 and B1, sample 2 in wells C1 and D1 and the 
same goes with sample 3 and sample 4. 
2. The plates were incubated at 21ºC or were placed on a plate agitator at room 
temperature for 2 hours. 
3. The plates then were rinsed with the washing solution, prepared as instructed 
in ‘Composition of the Kit’ as follows: 
a. The contents in the microplates were poured off sharply over a sink 
until it gets empty. 
b. The plates were then dried out by tapping the plate upside down with 
clean absorbent paper towels to ensure no liquid in the wells left. 
c. The plates were filled once more with the washing solution using a 
spray bottle and empty the wells again by flipping the plate over a 
sink.  
d. Step ‘c’ was repeated at least two more times, and proceeds to the 
next process.  Avoid the formation of bubbles in the wells to ensure it 
was washed properly by the solution. 
4. 100μl of diluted anti- Fasciola hepatica conjugate was added to each well.  
5. The plates were covered with the lid/cling film and incubated at 21ºC for 1 
hour. 
6. The lid/cling film was removed and then the plates were again washed at 
least three times with the washing solution as described in Step 3. 
7. 100μl of diluted peroxidise-linked conjugate solution was added to each well. 
8. The plates were covered with the lid/cling film and incubated at 21ºC or for 1 
hour. 
9. The lid/cling film was removed and then the plates were again washed for 
three times with the washing solution as described in Step 3. 
10. 100μl of the chromogen solution was added to each well. 
11. The plates were then incubated at 21ºC and away from light for 10 minute. 
12. 50μl of stop solution was added to each well. 
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13. The net optical density of each well was calculated using a plate reader and a 
450nm filter. 
14. Coproantigen values are expressed as the percentage positivity (PP) 
according to the formula; % = (Mean OD of the sample / Mean OD of 
positive control) x 100. The cut-off value for percentage positive (PP) 
provided by manufacturer’s guidelines. 
 
(c) Kit antigens preparation 
    (i) anti-Fasciola hepatica conjugate solution 
20μl of the biotin-linked anti-Fasciola hepatica conjugate was added with 0.98 
ml of the reagent dilution buffer (per strip). 
 
   (ii) avidine-peroxidise conjugate solution 
     20μl of avidine-peroxide conjugate was added with 980μl of the reagent dilution   
     buffer (per  strip). 
 
  (iii) chromogen solution 
     500μl of chromogen was added with 9.5ml of the substrate solution      
     (approximately for 1 plate preparation). The solution must be absolutely  
     colourless when used. Any change of colour or when its turned into blue colour in  
     the pipette, the solution is already contaminated. 
 
 (iv) positive reference 
    0.5ml of distilled or demineralised water was added to reconstitute the antigen. 
 
  (v) stopping solution 
     1 M phosphoric acid stop solution. 
 
(vi) substrate solution 
     Hydrogen peroxide substrate solution must be kept at 4°C. 
 
(vii) washing solution 
     The concentrated washing solution was diluted 20 fold in distilled water. 
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APPENDIX 2.4 
 
QIAamp DNA Stool mini kit – Faecal DNA extraction protocol 
 
Composition of the Kit 
QIAamp Mini Spin Columns 
Collection Tubes (2 ml)  
InhibitEX
® 
Tablets  
Buffer ASL (140 ml) 
Buffer AL (33 ml) 
Buffer AW1 (19 ml)  
Buffer AW2 (13 ml)  
Buffer AE (15 ml)  
 
1. The faecal samples were diluted in the lysis buffer.  A total of 0.5 grams of 
faecal material were mixed up with 2.8 ml of buffer ASL in a 15 ml tube. 
2. All samples were vortexed for 1 min prior to centrifugation until sample 
properly homogenized, then heat the sample in the water bath for 5 min at 
95
o
C. 
3. The sample was centrifuged at full speed @2500g for 8 min to concentrate 
the solutions.    
4. A 1.5 ml volume of the supernatants were collected and transferred into 15 
ml tube with an InhibitEX tablet.  Vortex until the tablet is completely 
suspended, then leaves the samples for 3 min at room temperature and then 
centrifuges at full speed @2500g for 6 min. 
5. A total of 400 μl was transferred into a new 1.5 ml tube and centrifuge at 
@2500g for 3 min.  
6. A total of 200 μl supernatant into the 1.5 ml tube and 15 µl of proteinase K 
were added and then added 200μl Buffer AL and vortex for 15 s. The sample 
must be mixed very well. 
7.  The samples were incubated in water bath at 70oC for 10 min.  
8.  200 μl of ABS ethanol was added and mixed by vortex followed by 
centrifuging for 1 min at 16 000 x g. 
9.  Entire sample was transferred onto the QIAmp spin column (plus the 2 ml 
collection tube) without moistening the rim, label the lid and then 
centrifuged for 1 min at 12 850 x g. 
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10.  500μl of buffer AW1 was added to the column and centrifuged at 12 850 x 
g for 1 min. The spin column was discarded from the tube and placed it in 
another collection tube. 
11.  500μl of buffer AW2 was added to the spin column and centrifuged at 12 
850 x g for 3 min.  This step was repeated and the spin column was 
transferred into a new collection tube and centrifuged at 12 850 x g for 1 min 
to eliminate traces of AW2. 
12.  The column was transferred into a new 1.5 ml tube and 60μl of buffer AE 
was added directly onto the QIAamp
®
 membrane, incubated at room 
temperature for 5 min, and centrifuged at 12 850 x g for 1 min. The eluted 
DNA was store at -20
o
C until analysis. 
 
PCR 
 
PCR reaction was based on a 25 µl volume containing:  
 
 PCR mix Volume (µl) 
1 DNA template (1:50 diluted) 4 
2 H20 6 
3 Primer  ITS2 F 10 µm 1.25 
4 Primer ITS2 R 10 µm 1.25 
5 2 x Biomix Red* 12.5 
*Biomix™ Red (Bioline Reagents Limited, London, UK) 
 
1. Master mix was mixed up for 14 tubes (12 samples and positive and 
negative samples).  
2. 21 µl of the master mix was added to each tube. 
3. 4 µl of DNA templates was added into the tubes.   
4. The thermocycyler was set as followed: 
 
PCR cycling conditions: 
      95
◦
C for 2 min 
   95
◦
C for 30 sec 
63 
◦
C for 30 sec 
72
◦
C for 45 sec 
72
◦
C for 10 min 
 
5. The amplification products were analysed by electrophoresis. 
 
 
 
 
40 cycles 
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DNA Gel Electrophoresis 
This is used to separate macromolecules based upon their size. Nucleic acid 
molecules are separated by applying an electric field to move the negatively charged 
molecules through an agarose matrix. Agarose gel electrophoresis can be used for 
the separation of DNA fragments ranging from 50 base pair to several megabases 
using specialized apparatus. The distance between DNA bands of a given length is 
determined by the percent agarose in the gel. The PCR mix requires a dye front to 
observe movement through the gel and to ensure that the DNA doesn’t run off the 
ends.  However, the Biomix red contains a dye in the master mix so it is not 
necessary to add any dye. 
1. Make up agarose gel at 1.5%- 1.5g agarose was added to 100ml TAE and 
heat in the microwave (take care as the agarose will boil over).  
The large frames should take 100ml agarose, whilst 50 ml of agarose should 
be sufficient for the small casting frames. 
2. Once the agarose is melted and cooled (enough to be handled) 10 ul of Sybr 
Safe was added (for a 100 ml, or 5µl for 50 ml) and mixed by swirling the 
agarose. 
3. Once mix, poured into the gel tank and leave to set (check that there are no 
leaks). 
4. 5 µl of 100 bp ladder was added into the first lane of the gel. 
5. 5 µl of PCR product was added into each well.   
6. Run gel for 30 minutes at 100V- check to see if it has run through.   
7. Gel was placed into G:Box Syngene to visualise bands. 
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APPENDIX 2.5 
i)                                                        ii) 
 
    iii)                                                               iv) 
 
 
Figure 2.5. i) The correlation between fluke burden and 
PP (%) on 14 wpi; ii) The correlation between fluke 
burden and FEC on 14 wpi; iii) The correlation between 
fluke burden and PP (%) on 10 dpt; iv) The correlation 
between fluke burden and FEC on 10 dpt. 
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APPENDIX 3.1 
 
Letter from Ms Christina Gill 
 
Finding the best model for your data 
The negative binomial distribution is often used to describe count data (for example 
FEC). Originally the NBD was designed to work out the probability of an event 
occurring. The NBD is not suitable for all count data, so you have to either show that 
works for your data, or otherwise assume it works based on the results of previous 
studies. Another distribution sometimes used to model count data is the Poisson 
distribution. However, parasite count data is often overdispersed (this means that the 
spread of your data is greater than the mean) and this can be modelled with the NBD 
(unlike the Poisson distribution, where the mean is assumed to equal the variance). 
Other distributions you may have heard of are the normal distribution and the 
binomial distribution. 
 
If you look at the histogram from your data from Farm 1 below (graph for Farm 2 is 
similar), it looks like a negative binomial distribution is the best fit for your data: 
 
 
I tested the fit of the data in R using a chi-squared goodness of fit test. This 
confirmed that the NBD fits your data, while the Poisson distribution does not, as 
expected. Sometimes, this kind of count data is even better described by what is 
called a zero-inflated negative binomial distribution. This is essentially the same as 
the NBD, except that there are an increased number of individuals with zero counts. 
You would expect this to occur in cases where the chances of having a zero count are 
controlled by a separate process to the one controlling the rest of the distribution 
(there is some more information about this here: http://en.wikipedia.org/wiki/Zero-
inflated_model). I tested this on your data, but using a zero-inflated negative 
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binomial distribution did not improve the fit for your data (I evaluated this by doing 
a test that compares whether a model fits the data better than another called the 
"likelihood ratio test"). So your data is best described by a negative binomial 
distribution. This is useful to know if you want to do any testing on hypothetical 
populations of sheep, for example if you need to know what happens when your 
flock size is doubled. 
 
Do you need to resample the same 20 sheep? 
Whether or not you need to resample the same 20 sheep, or can sample any 20 sheep 
will depend on a number of factors. The first factor is individual variation (the 
variance/spread of your data). The higher the spread of your data, the less likely it 
will be that the results from two different sheep will be comparable. This will likely 
vary by farm. The second factor is the number of sheep in the flock. If you have a 
small flock, you are more likely to pick at least some sheep that you have sampled 
the first time. In a large flock, you are likely to sample different sheep. Finally, the 
degree of correlation between pre-treatment and post treatment counts is important 
also. If the correlation is high, then testing the same sheep is better, relatively 
speaking, than sampling different sheep (you can check this on your pre and post-
treatment data using Spearman's or Pearson's correlation). 
 
For the farm where you have samples from 105 sheep, you can estimate the accuracy 
of taking samples from 20 sheep: The mean FEC for all sheep on this farm is 5.90 
eggs per 5g of faeces. If we randomly sample 20 of these sheep and calculate the 
mean FEC (per 5g) and do this 10,000 times here is a histogram of the results: 
 
 
 
You can see that the mean values are also following the NBD (this is due to the 
small sample size of 20). You can also see that there is a wide spread of means. 
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Actually, the calculated mean from 20 samples only falls within the range of the 
'true' mean +/- 5% in 5.3% of cases (farm 2). Doing the same thing for farm 1, the 
result is slightly better at 10.5%. This is because the variance is lower on this farm 
and the total number of sheep is lower also. You can work out a 95% confidence 
interval for this mean, but since the results are not normally distributed, this can be a 
little tricky. It is approximately 11.7-55.6 and 0.6-15.25 eggs per 5g for Farm 1 and 
Farm 2, respectively). 
 
If we compare a random sample of 20 sheep from Farm 2 to another random sample 
of 20 sheep from Farm 2 (and repeat this 10,000 times), then we find a reduction of 
95% or more in FEC 0.5% of the time (so on a farm where treatment has no effect on 
FEC at all, we would get a false negative for resistance 0.5% of the time). On the 
other hand, if we assumed that at the next sampling each individual sheep had 
exactly a 95% reduction in FEC then we would detect that in only 49.4% of cases if 
we sample different sheep at each visit (so we would get a false positive for 
resistance more than 50% of the time). However, your calculated FEC reduction is 
not just a binary variable - the actual percentage FEC reduction value gives you 
additional valuable information. For research purposes I think you need this to be 
fairly accurate, otherwise your results will be poorly comparable to other studies. 
Therefore we would resample the same 20 sheep (if your purpose was to diagnose 
resistance then the loss of accuracy may be less important). 
 
One thing I think you still need to do is check the degree of correlation between pre- 
and post-treatment values for the 21 or so sheep where you have this data. If they 
correlate poorly, you may want to think about increasing your sample size. 
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APPENDIX 4.5 
The use of different management practises in the different 7 sheep farm. 
Management Factor/Farm ID 1 2 3 4 5 6 7 
Sheep move to current pasture 
a) 1 to 3 months 
b) Within the last month 
c) Housed at Christmas for    
         lambing in March 
d) Housed the ewes mid-January  
 
b 
 
d 
 
a 
 
b 
 
a 
 
a 
 
a 
Used grazing with other livestock 
a) Yes before the sheep 
b) Yes after the sheep 
c) No 
 
 
a, b 
 
a, b 
 
** 
 
b 
 
a, b 
 
c 
 
a, b 
If yes, grazing with beef cattle 
a) Yes 
b) No 
 
 
No 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
** 
 
Yes 
Let sheep for winter grazing 
a) Yes 
b) No 
 
Yes 
 
Yes 
 
Yes 
 
Yes  
 
Yes 
 
Yes 
 
No 
Type of forage that produced 
a) Hay 
b) Silage 
c) Straw 
 
 
b 
 
a, b 
 
a, b 
 
b 
 
a, b 
 
a, c  
 
a, b 
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Fertilise fields grazed by sheep 
a) commercial fertilise 
b) manure 
c) slurry 
d) lime 
e) slag 
 
 
a, b  
 
b, d 
 
a, b, d 
 
a, b d, 
e 
 
a, b d, 
e 
 
   a 
 
b, d 
Main water source for your sheep 
a) through 
b) piped 
c) stream 
d) spring 
 
 
c, d 
 
a, c, d 
 
c, d 
 
a, b, c, d 
 
   d 
 
a, b, d 
 
a, b, c 
Rate the drainage of the grazing field 
 
very 
good 
average average average poor good poor 
Get ‘boggy fields’ on farm 
a) Yes 
b) No 
 
 
No 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
Method for improved drainage 
a) Harrowing 
b) Rolling 
c) Aeration 
d) Sub-soiling 
e) Maintain existing drains 
f) None 
 
 
a 
 
a, d 
 
e 
 
a, d, e 
 
  c 
 
  f 
 
f 
Clean ditches 
a) Yes 
b) No 
 
No 
 
Yes 
 
NA 
 
Yes 
 
NA 
 
NA 
 
No 
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c) NA 
 
** missing data; NA (not applicable) 
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